Sentence,class,file
http://www.idrc.ca/en/ev-84057-201-1-DO_ TOPIC.html .,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
http://ped.sagepub.com/ content/17/1_suppl/76 .,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
http://www.who.int/tobacco/resources/publications/ tobaccocontrol_handbook/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
http://apps.who.int/fctc/text_ download/en/ .Capacity building in Vietnam 453,Non-OADS,/arxiv_data1/oa_pdf/d7/ac/dat005.PMC4130373.pdf
"2013. http://www.chinabiot oday.com/articles/20130408_1 (13 March 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/23/50/dku146.PMC4130381.pdf
"Jones1,2, John P. Rathjen3, Vardis Ntoukakis1 1School of Life Sciences, University of Warwick 2The Sainsbury Laboratory, Norwich Research Park 3Research School of Biology, The Australian National University Correspondence to: Vardis Ntoukakis at V.Ntoukakis@warwick.ac.uk URL: http://www.jove.com/video/51095 DOI: doi:10.3791/51095 Keywords: Plant Biology, Issue 84, plant-microbe interactions, protein complex purification, mass spectrometry, protein phosphorylation, Prf, Pto, AvrPto, AvrPtoB Date Published: 2/22/2014 Citation: Piquerez, S.J.M., Balmuth, A.L., Sklenář, J., Jones, A.M., Rathjen, J.P., Ntoukakis, V. Identification of Post-translational Modifications of Plant Protein Complexes.",Non-OADS,/arxiv_data1/oa_pdf/b7/ca/jove-84-51095.PMC4130472.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51095/ Introduction Immune pathways rely on various post-translational modifications (PTMs) of proteins to rapidly transduce signals and activate immune responses1.,Non-OADS,/arxiv_data1/oa_pdf/b7/ca/jove-84-51095.PMC4130472.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.351Optical Coherence Tomography to  Evaluate Dengue Dear Editor, The recent report you published on the use of optical co - herence tomography (OCT) to evaluate dengue was very  interesting [1].",Non-OADS,/arxiv_data1/oa_pdf/39/e0/kjo-28-351.PMC4130496.pdf
"Jung Il Han Kim’s Eye Hospital, Konyang University College of Medicine,  Seoul, Korea  han66139@kimeye.comCase ReportCorrespondence  Korean J Ophthalmol 2014;28(4):351-352 http://dx.doi.org/10.3341/kjo.2014.28.4.351",Non-OADS,/arxiv_data1/oa_pdf/39/e0/kjo-28-351.PMC4130496.pdf
"Remzi Karadag , Huseyin Bayramlar Department of Ophthalmology, Istanbul Medeniyet University  School of Medicine, Istanbul, Turkey E-mail: remzi.karadag@medeniyet.edu.tr  Ozgur Cakici  Department of Ophthalmology, Istanbul Medeniyet University  Goztepe Research and Training Hospital, Istanbul, TurkeyKorean J Ophthalmol 2014;28(4):352-353 http://dx.doi.org/10.3341/kjo.2014.28.4.352Letter to the EditorConflict of Interest No potential conflict of interest relevant to this article  was reported.References 1.",Non-OADS,/arxiv_data1/oa_pdf/39/e0/kjo-28-351.PMC4130496.pdf
"Remzi Karadag , Huseyin Bayramlar Department of Ophthalmology, Istanbul Medeniyet University  School of Medicine, Istanbul, Turkey E-mail: remzi.karadag@medeniyet.edu.tr  Ozgur Cakici  Department of Ophthalmology, Istanbul Medeniyet University  Goztepe Research and Training Hospital, Istanbul, TurkeyKorean J Ophthalmol 2014;28(4):352-353 http://dx.doi.org/10.3341/kjo.2014.28.4.352Letter to the EditorConflict of Interest No potential conflict of interest relevant to this article  was reported.References 1.",Non-OADS,/arxiv_data1/oa_pdf/af/d7/kjo-28-352.PMC4130497.pdf
"http://journalofvision.org/3/5/3/, doi:10.1167/3.5.3  Fleming, R. W., Torralba, A., & Adelson, E. H. (2004).",Non-OADS,/arxiv_data1/oa_pdf/11/ef/i-perception-5-1.PMC4130504.pdf
"http://journalofvision.org/4/9/10/ , doi:10.1167/4.9.10  Fleming, R. W., & Bülthoff, H. H. (2005).",Non-OADS,/arxiv_data1/oa_pdf/11/ef/i-perception-5-1.PMC4130504.pdf
"When one pursues a moving target with one’s eyes observing the stimulus figure in peripheral vision, the yellow disc is seen to move in the same direction as the pursuit direc - tion as shown in Figure 1a (a PowerPoint file to demonstrate the illusion can be downloaded from   http://www.design.kyushu-u.ac.jp/~ito/IOM.ppt ).",Non-OADS,/arxiv_data1/oa_pdf/99/f7/i-perception-5-20.PMC4130505.pdf
Available at: http://www.psy.ritsumei.ac.jp/akitaoka/rotsnakee.html.,Non-OADS,/arxiv_data1/oa_pdf/99/f7/i-perception-5-20.PMC4130505.pdf
"The experiments were carried out in accordance with the relevant institutional and national regu- lations and legislation, and with the World Medical Association Helsinki Declaration as revised in October 2008 (http://www.wma.net/en/30publications/10policies/b3/ ).",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/i-perception-5-53.PMC4130508.pdf
The instructions used in the induction procedure are described in the online supplemental material (http://color.psych.upenn.edu/supplements /mdslightness ).,Non-OADS,/arxiv_data1/oa_pdf/d0/6d/i-perception-5-53.PMC4130508.pdf
A picture of the induction procedure appa- ratus is available in the online supplemental material for Allred and Brainard (2009; http://color.psych.,Non-OADS,/arxiv_data1/oa_pdf/d0/6d/i-perception-5-53.PMC4130508.pdf
"2.1.7  Results The dissimilarity ratings given by the observers for all test card–context pairs (that is, the dissimilarity  matrices that we analyzed) are tabulated for each observer/replication in the online supplemental mate - rial (http://color.psych.upenn.edu/supplements/mdslightness ), for this and all experiments reported in  this paper.",Non-OADS,/arxiv_data1/oa_pdf/d0/6d/i-perception-5-53.PMC4130508.pdf
"In Movie 1 (see supplementary online material at http://i-perception.perceptionweb.com/journal/I/ volume/5/article/i0643sas ) the test stimuli were two identical, low-contrast coloured portraits of  ‘Lena’, side by side.",Non-OADS,/arxiv_data1/oa_pdf/d7/56/i-perception-5-73.PMC4130509.pdf
"In this review I compare two popular solutions for code sharing, namely, GitHub (https://github.com/) and the Open Science Framework (OSF) (https://openscienceframework.org/; Nosek & Bar-Anan, 2012; Nosek et al., 2012), in the context of the needs of psychological com-munity.",Non-OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
2 GitHub WGitHub (http://github.com ; see https://github.com/qbilius/psychopy_ext  for an example repository)  is a web service for hosting projects that rely on the git version control system (http://git-scm.com/ ).,OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
"Notably, the OSF has been employed in the Reproducibility Project, an effort of more than 150 researchers to replicate a large number of publications in psychology (Open Science Collaboration, 2013; see https://osf.io/ezcuj/ ).",Non-OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
"While for some researchers merely the possibility of sharing their materials might be sufficient, in collaborative environments this is an annoying limitation, and instead services such as Dropbox ( http://dropbox.com ) appear to be more  intuitive and effective.",Non-OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
"However, a free solution for an unlimited number of private repositories is available from Bitbucket (http://bitbucket.org), another major code hosting website.",Non-OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
Other tools similar to GitHub in their functionality but more science-oriented include Banyan (http:// banyan.co ) and SciGit (http://scigit.com ).,Non-OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
"For sharing the entire research workflow (i.e., not only code), figshare (http://figshare.com ; full disclosure: I am a figshare advisor), and Zenodo (http:// zenodo.org) are recommended.",Non-OADS,/arxiv_data1/oa_pdf/df/c1/i-perception-5-75.PMC4130510.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2014:6 257–275Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  257REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S3972 8Epidemiology of human African trypanosomiasis Jose R Franco1 Pere P Simarro1 Abdoulaye Diarra2 Jean G Jannin1 1world Health Organization, Control  of Neglected Tropical Diseases,   innovative and intensified Disease  Management, Geneva, Switzerland;   2world Health Organization, inter  Country Support Team for Central  Africa, Regional Office for Africa,   Libreville, Gabon Correspondence: Jose Ramon Franco   world Health Organization, Control of   Neglected Tropical Diseases, innovative   and Intensified Disease Management,   20 Av Appia, 1211 Geneva, Switzerland   Tel +41 227 913 313   Fax +41 227 914 777   Email francoj@who.in tAbstract:  Human African trypanosomiasis (HAT), or sleeping sickness, is caused by   Trypanosoma brucei gambiense , which is a chronic form of the disease present in western and  central Africa, and by Trypanosoma brucei rhodesiense , which is an acute disease located in  eastern and southern Africa.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
http://www.who.int/neglected.diseases/ NTD_Roadmap_2012_Fullversion.pdf  114.,Non-OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
Available from: http://apps.who.int/ iris/bitstream/10665/79689/1/WHO_HTM_NTD_IDM_2013.4_eng.,OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
"Available from: http://www.who.int/ trypanosomiasis_african /country/foci_AFRO/en/index.htm l. Accessed  January 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
Available at  http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Full - version.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/82/1d/clep-6-257.PMC4130665.pdf
Available online at http://www.ada.org/1754.aspx.,Non-OADS,/arxiv_data1/oa_pdf/9f/43/AIM-22-199.PMC4130674.pdf
Available online at http://www.ncbi.nlm.nih.gov/ pubmed 11.,Non-OADS,/arxiv_data1/oa_pdf/9f/43/AIM-22-199.PMC4130674.pdf
Available online at http://www.dciindia.org/dciregu-lation_2006_pages/pdf_files/ Revised%20MDS%20Course%20Regu- lations%202007.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/9f/43/AIM-22-199.PMC4130674.pdf
Avail- able online at http://www.dciindia.org/annoncment_pdf_files/pdf_ files/ ELIGIBILITY%20 CRITERIA%20TO%20BE%20A%20PG%20TEACHER.pdf,Non-OADS,/arxiv_data1/oa_pdf/9f/43/AIM-22-199.PMC4130674.pdf
"Endoscopic Treatment of Vesicoureteral Refl  ux in Chil- dren with Dextranomer/Hyaluronic Acid - A Sin- gle Surgeon’s 6-Year Experience Hou-Chuan Chen,  Chou-Ming Yeh, and Chia-Man Chou Division of Pe-diatric Surgery,Department of Surgery,Taichung Tai- wan Diagnostic and Therapeutic Endoscopy Volume  2010 (2010), Article ID 278012, 3 pages http://dx.doi.org/10.1155/2010/278012 2.",Non-OADS,/arxiv_data1/oa_pdf/bd/29/AIM-22-167.PMC4130676.pdf
It is freely available in more than 20 languages at http://ease.org.uk/publications/author-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.archivepub.co.uk/The-Book  4.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Avail- able from http://www.biomedcentral.com/about/ duplicatepublication 5.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
European Science Editing 39(2):36-38 Avail- able from http://www.ease.org.uk/ sites/default/ files/essay_bioresources.pdf  7.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.publication-ethics.org/resources/ flowcharts 10.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Avail- able from http://www.plosmedicine.org/ article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001024  14.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://am.ascb.org/dora/files/ SFDeclarationFINAL.pdf  15.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from: http://www.ease.org.uk/ publications/ease-toolkit-authors  16.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.ease.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from: http://medicalwriting.emwa.org/ar - ticle/show/pdf/51/ 21.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www3.inter - science.wiley.com/ journal/122637800/abstract  22.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.ease.org.uk/sites/default/files/ may_2010_362.pdf  26.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://edepot.wur.nl/178013  27.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.icmje.org/urm_ main.html  28.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.cmj.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from: http://www.nlm.nih.gov/mesh/MBrowser.html  33.,OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.helsinki.fi/ kksc/language.services/AcadWrit.pdf  34.,Non-OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available from http://www.ease.org.uk/ sites/default/files/february_2011_371.,OADS,/arxiv_data1/oa_pdf/9f/ce/AIM-22-210.PMC4130677.pdf
Available at: http://www.idc.com/getdoc.jsp?containerId=prUS24645514.,Non-OADS,/arxiv_data1/oa_pdf/e4/8e/AIM-22-206.PMC4130678.pdf
Available at: http://www.epocrates.com/oldsite/statis-tics/2013%20Epocrates%20Mobile%20Trends%20Re- port_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/8e/AIM-22-206.PMC4130678.pdf
"Strength Training Programs, 2003, http://www.tru- lyhuge.com/strengthtrainingprograms.htm 7.",Non-OADS,/arxiv_data1/oa_pdf/f1/be/AIM-22-203.PMC4130681.pdf
Available at: URL://http://www.hst.org.,Non-OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available at:  URL:// http://www.emrconsultant.com/Home.,Non-OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available at: URL:// http://www.wpro.who.int.7.,Non-OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available at: URL:// http://www.rhinonet.org.,Non-OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available at:URL: http://www.emeraldinsight.com/journals.,Non-OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available  from URL: http://www.unc.edu/~kome/inls201/de-lone Information Systems Success.pdf.,OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available from URL: http://etd.lsu.edu/ docs/available/etd-04162010-001906/unrestricted/Per - ez-Mira_diss.pdf.,OADS,/arxiv_data1/oa_pdf/8a/cb/AIM-22-179.PMC4130683.pdf
Available at: http://www.cdc.gov/features/birthdefectscom - mon/.,Non-OADS,/arxiv_data1/oa_pdf/e1/97/MSM-26-158.PMC4130685.pdf
Available at: http://www.euro.who.int/__data/assets/pdf_file/0004/82435/E87325.pdf.,OADS,/arxiv_data1/oa_pdf/e1/97/MSM-26-158.PMC4130685.pdf
2012; Available from: http://www.salamatnews.com/viewNews.,Non-OADS,/arxiv_data1/oa_pdf/02/80/AIM-22-183.PMC4130691.pdf
Available at: http://vista.ir/arti-cle/6192 .,Non-OADS,/arxiv_data1/oa_pdf/02/80/AIM-22-183.PMC4130691.pdf
2014 JUN 22(3): 183-188 188   Appendix 2    List of Persian Mental Disorder Websites   Website  code  Website Name  URL Address   W1 Pezeshk Online   http://pezeshkonline.ir/   W2 Ravan Pajouh    http://www.ravanpajoh.com/   W3 Iran psychological  Association  http://iranpa.org/portal/default.aspx   W4 Ravanshenasan  http://www.ravanshenasan.com/news.php   W5 Atieh Clinic  http://www.atiehclinic.com/   W6 Afsordegi  http://afsordeg i.com/   W7 Golmakan Tohid  Old Aged Persion  http://psychology.harferooz.com/forum308.html   W8 Seemorgh  http://www.s eemorgh.com/health/default.aspx?tabid=2094&conid=2755   W9 Zohrabi Dr.  http://drzohrabi.ir/index.php?option=com_content&task=view&id=552&Itemid=1   W10  KonjKav  http://konjkav.com/health/9711   W11  Tavana Dr.  http://www.drdtavana.com/index.php/component/content/article/24.html   W12  Parseh Clinic  http://www.parsehclinic.com/VisitorPages/show.aspx?IsDetailList=true&ItemID=1748   W13  Migna  http://www.migna.ir/ravanshenasii/balini/7140   W14  Pezashkan Iran  http://www.pezeshkan.org/?p=24724   W15  Online Family  Consult  http://www.ofc.ir/fa/article/general/what_is_dejection_2006103125.html   W16  Valipour Dr.  http://www.drvalipour.ir/index.php?ToDo=ShowArticles&AID=2973   W17  Harferooz  http://psychology.harferooz.com/thread444.html   W18  Rahrakhshan Dr.  http://www.rawanshenasi.de/farsi/index.htm   W19  Ravanyar  http://www.ravanyar.com/Stress.asp   W20  Pour ali net  http://www.pourali.net/   W21  Javan emrrooz  http://www.javanemrooz.com/articles/healthy/espritual/other/article -27970.aspx   W22  Iranian Clin ical  Psychology  Association  http://www.irancpa.com/   W23  Ravanasa  http://www.ravanasa.com   W24  Zehn Aram  http://www.zehnaram.ir/post -24.aspx   W25  Ravan  http://ravvan.com/fa/service/mentaldisorder                                                                           W26  Alachigh Ravan  http://www.psychoalachigh.com /  W27  Institute for  Cognitive Science  Studies  http://www.iricss.org/fa/Pages/Default.aspx   W28  Goftegooye Dini  http://www.askdin.com/thread114.html   W29  Yek Farakav  http://1farakav.com/2010/08/10/%d9%88%d8%b3%d9%88%d8%a7%d8%b3 -%d9%87%d8%a7 /   W1 to W14 are related to anxiety disorders websites and W15 to W29 are  depression websites.,Non-OADS,/arxiv_data1/oa_pdf/02/80/AIM-22-183.PMC4130691.pdf
Available at: http://www.thel - ancet.com/themed/global-burden-of-disease (accessed: June 2014).,Non-OADS,/arxiv_data1/oa_pdf/56/18/MSM-26-213.PMC4130693.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/ed/copd-9-723.PMC4130708.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 723–733International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  723RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5011 1Influence of diet and obesity on COPD   development and outcomes Corrine Hanson1 erica P Rutten2 emiel FM wouters2,3 Stephen Rennard4 1Division of Medical Nutrition  education, School of Allied Health  Professions, University of Nebraska  Medical Center, Omaha, N e, USA;   2Research and education, Centre of  expertise for Chronic Organ Failure,   Horn, The Netherlands; 3Department  of Pulmonary Diseases, University  of Maastricht, Maastricht, The  Netherlands; 4Division of Internal  Medicine, University of Nebraska  Medical Center, Omaha, N e, USA Correspondence: Corrine Hanson   Division of Medical Nutrition education,  School of Allied Health Professionals,   University of Nebraska Medical Center,   984045 Nebraska Medical Center,   4242 Dewey Avenue, Omaha,   Ne 68198-4045, USA   Tel +1 402 559 3658   Fax +1 402 559 7565   email ckhanson@unmc.ed uAbstract:  The global increase in the prevalence and incidence of obesity has called serious  attention to this issue as a major public health concern.",Non-OADS,/arxiv_data1/oa_pdf/45/ed/copd-9-723.PMC4130708.pdf
"Available from: http://apps.who.int/bmi/index.jsp?introPage=   intro_3.htm l. Accessed December 6, 2013.1",Non-OADS,/arxiv_data1/oa_pdf/45/ed/copd-9-723.PMC4130708.pdf
"Available  from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.htm l.  Accessed December 6 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/45/ed/copd-9-723.PMC4130708.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/45/ed/copd-9-723.PMC4130708.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/ed/copd-9-723.PMC4130708.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 727–734International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  727OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6546 2Use of frameless intrauterine devices and systems  in young nulliparous and adolescent women:  results of a multicenter study Dirk Wildemeersch1 sohela Jandi2 ansgar Pett2 Kilian nolte3 Thomas Hasskamp4 Marc Vrijens5 1gynecological Outpatient clinic and  IUD Training center, ghent, Belgium;   2gynecological Outpatient clinic,   Berlin,  3gynecological Outpatient  clinic, Uetze,  4gynMünster, Münster,   germany;  5gynecological Outpatient  clinic, ghent, Belgium correspondence: Dirk Wildemeersch   gynecological Outpatient clinic and  IUD Training center, 43-44 Franklin  rooseveltlaan, ghent 9000, Belgium   email d.wildemeersch@skynet .beBackground:  The purpose of this study was to provide additional data on the experience with  frameless copper and levonorgestrel (LNG) intrauterine devices (IUDs) in nulliparous and  adolescent women.",Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
Available from: http://www.who.int/reproductivehealth/publications/ family_planning/9789241547710/en /.,Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
"Available from: http://www.R-project.or g. Accessed May  29,  2014.",Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
Available from:  http://www.medscape.com/viewarticle/76596 9.,Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/16/ijwh-6-727.PMC4130709.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/6c/ndt-10-1451.PMC4130710.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1451–1457Neuropsychiatric Disease and Treatment Background:  Serum biomarkers may be useful for early diagnosis of acute ischemic stroke,  exclusion of other diseases that may mimic stroke, and prediction of infarct volume.",Non-OADS,/arxiv_data1/oa_pdf/87/6c/ndt-10-1451.PMC4130710.pdf
"A major obstacle for patients suspected of having acute ischemic stroke is that  diagnostic evaluation may not be provided quickly.2,3 Diagnosis and treatment of small Dove press submit your manuscript | www.dovepress.co m Dove press  1451OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6766 5hasan Kara1 Murat akinci1 selim Degirmenci1 aysegul Bayir1 ahmet ak1 alaaddin Nayman2 ali Unlu3 Fikret akyurek3 Mesut sivri2 1Department of emergency  Medicine, 2Department of radiology,  3Department of Biochemistry, Faculty  of Medicine, selçuk University, Konya,   T urkey correspondence: hasan Kara   Department of emergency Medicine,  Faculty of Medicine, selçuk University,  Konya, T urkey 42250   T el +90 505 211 2473   Fax +90 332 224 4858   email hasankara42@gmail.co mhigh-sensitivity c-reactive protein, lipoprotein- related phospholipase a2, and acute ischemic  strokeJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Kara et al Running head recto: Biomarkers for acute ischemic stroke DOI: http://dx.doi.org/10.2147/NDT.S67665",Non-OADS,/arxiv_data1/oa_pdf/87/6c/ndt-10-1451.PMC4130710.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/87/6c/ndt-10-1451.PMC4130710.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1457Biomarkers for acute ischemic stroke  15.,Non-OADS,/arxiv_data1/oa_pdf/87/6c/ndt-10-1451.PMC4130710.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/a4/ijn-9-3677.PMC4130711.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3677–3686International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3677OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6651 1Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Pan-In et al Running head recto: Anticancer activity of G. mangostana nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S66511 Cellular trafficking and anticancer activity  of Garcinia mangostana  extract-encapsulated  polymeric nanoparticles Porntip Pan-In1,2 supason  Wanichwecharungruang3,4 Justin hanes2,5 Anthony J Kim2,6,7 1Program in Biotechnology, Faculty  of Science, Chulalongkorn University,   Bangkok, Thailand; 2center for  Nanomedicine, Johns Hopkins  University School of Medicine,   Baltimore, MD, USA; 3Department  of Chemistry, Faculty of Science,   Chulalongkorn University, Bangkok,   Thailand; 4Nanotec-CU Center  of excellence on Food and  Agriculture, Bangkok, Thailand;   5Department of Ophthalmology,   Biomedical Engineering, Chemical  and Biomolecular Engineering,   Neurosurgery, and Oncology,   Johns Hopkins University School  of Medicine, 6Department of  Neurosurgery, University of Maryland  School of Medicine, 7Department of  Pharmaceutical Sciences, University  of Maryland School of Pharmacy,   Baltimore, MD, USA Correspondence: Anthony J Kim   Neurosurgery and Pharmaceutical  Sciences, University of Maryland,  Baltimore, 655 West Baltimore Street,  Baltimore, MD 21201, USA   email akim@smail.umaryland.ed u Abstract:  Garcinia mangostana  Linn extract (GME) is a natural product that has received  considerable attention in cancer therapy, and has the potential to reduce side effects of chemo - therapeutics and improve efficacy.",Non-OADS,/arxiv_data1/oa_pdf/6e/a4/ijn-9-3677.PMC4130711.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6e/a4/ijn-9-3677.PMC4130711.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3686Pan-In et al Supplementary material % cell viabilit y GME-EC/MC GME-EC GME in water GME in DMSO Concentration 100 µg/mL** * *25 20 15 10 5 0 Figure S1 Cytotoxic activity of different formulation of 100 µg/mL free GME and GME-encapsulated nanoparticles in HeLa cells.,Non-OADS,/arxiv_data1/oa_pdf/6e/a4/ijn-9-3677.PMC4130711.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/ijwh-6-719.PMC4130712.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 719–725International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  719RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3768 5Hyperemesis gravidarum: current perspectives Fergus P McCarthy1 Jennifer e Lutomski2 Richard A Greene2 1The Irish Centre for Fetal and  Neonatal Translational Research,   University College Cork, 2National  Perinatal epidemiology Centre, Cork  University Maternity Hospital, Wilton,   Cork, Ireland Correspondence: Fergus P McCarthy   The Irish Centre for Fetal and Neonatal  Translational Research, University College  Cork, Cork University Maternity Hospital,  Wilton, Cork, Ireland   T el +353 21 4205023   email fergusmccarthy@gmail.co mAbstract:  Hyperemesis gravidarum is a complex condition with a multifactorial etiology  characterized by severe intrac table  nausea and vomiting.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/ijwh-6-719.PMC4130712.pdf
Available from: http://apps.who.int/classifications/apps/ icd/icd10online2007 /.,OADS,/arxiv_data1/oa_pdf/8a/09/ijwh-6-719.PMC4130712.pdf
Available from: http://clinicaltrials.gov/show/ NCT0079556 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/ijwh-6-719.PMC4130712.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/8a/09/ijwh-6-719.PMC4130712.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/09/ijwh-6-719.PMC4130712.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/1a/jmdh-7-349.PMC4130713.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 349–354Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  349Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S6614 7Pediatricians’ perceptions of clinical practice  guidelines Mohamed a Hendaus ahmed H alhammadi eshraga a razig lulwa alnaimi general Pediatrics Division,   Department of Pediatrics, Hamad  Medical corporation, Doha, Qatar correspondence: Mohamed a Hendaus   general Pediatrics Division,   Department of Pediatrics,   Hamad Medical corporation,   PO Box 3050, Doha, Qatar 3050   Tel +974 4439 2239   Fax +974 4443 9571   email mhendaus@yahoo.co mBackground:  Clinical practice guidelines (CPGs) are propositions for health care provid - ers about the care of patients and are usually described as “systematically developed state - ments to assist practitioners’ and patients’ decisions about appropriate health care for specific  circumstances”.",Non-OADS,/arxiv_data1/oa_pdf/a2/1a/jmdh-7-349.PMC4130713.pdf
"Available  from: http://www.uptodate.com/contents/clinical-practice-guideline s.  Accessed December 23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a2/1a/jmdh-7-349.PMC4130713.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/a2/1a/jmdh-7-349.PMC4130713.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/1a/jmdh-7-349.PMC4130713.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/a4/ppa-8-1061.PMC4130714.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1061–1071Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1061OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6411 1subcutaneously administered methotrexate for  rheumatoid arthritis, by prefilled syringes versus  prefilled pens: patient preference and comparison  of the self-injection experience Winfried Demary1 Holger Schwenke2 Karin Rockwitz3 Peter Kästner4 Anke Liebhaber5 Ulrich schoo6 Georg Hübner7 Uwe Pichlmeier8 Cécile Guimbal-Schmolck8 Ulf Müller-Ladner9 1Private practice, hildesheim,   germany; 2Private practice, Dresden,   germany; 3Private practice, goslar,   germany; 4Outpatient rheumatism  center, erfurt, germany; 5Private   practice, halle, germany; 6Private  practice, rheine, germany; 7Private   practice, Lingen, Germany; 8medac   GmbH, Hamburg, Germany;   9Department of Rheumatology and  Clinical Immunology, Kerckhoff-Klinik  gmbh, Bad nauheim, germany Correspondence: Ulf Müller-Ladner   Department of Rheumatology and  Clinical Immunology, Kerckhoff-Klinik  GmbH, Benekestrasse 2-8, D-61231 Bad  nauheim, germany   T el +49 6032 996 2101   Fax +49 6032 996 2104   email u.mueller-ladner@kerckhoff-klinik.d ePurpose:  This multicenter, randomized, crossover study compared preference, ease of use,  acceptability, satisfaction, and safety of repeated subcutaneous (SC) self-administrations with  prefilled pens and prefilled syringes delivering methotrexate (MTX), in patients with rheuma - toid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/1f/a4/ppa-8-1061.PMC4130714.pdf
"The parenteral administration shows an improved and more reliable   bioavailability compared with the oral formulation,4,5 and an improved efficacy, as Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Demary et al Running head recto: High-concentration MTX for subcutaneous self-administration DOI: http://dx.doi.org/10.2147/PPA.S64111",Non-OADS,/arxiv_data1/oa_pdf/1f/a4/ppa-8-1061.PMC4130714.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/1f/a4/ppa-8-1061.PMC4130714.pdf
Avail - able from: http://www.ich.org/products/guidelines/efficacy/efficacy- single/article/good-clinical-practice.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/a4/ppa-8-1061.PMC4130714.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/51/copd-9-759.PMC4130715.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 759–773International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  759OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6134 7Serum cytokine profiling and enrichment   analysis reveal the involvement of immunological   and inflammatory pathways in s table patients   with chronic obstructive pulmonary disease geetanjali Bade1 Meraj Alam Khan2 Akhilesh Kumar Srivastava1 Parul Khare1 Krishna Kumar Solaiappan1 randeep guleria3 nades Palaniyar2 anjana Talwar1 1Department of Physiology, All India  Institute of Medical Sciences, New  Delhi, India;  2Program in Physiology  and Experimental Medicine,   The Hospital for Sick Children,   Department of laboratory Medicine  and Pathobiology, and Institute of  Medical Sciences, Faculty of Medicine,   University of T oronto, T oronto, ON,   Canada;  3Department of Pulmonary  Medicine and Sleep Disorders, All  India Institute of Medical Sciences,   New Delhi, India Correspondence: anjana Talwar   Department of Physiology, All India   Institute of Medical Sciences,   New Delhi, India (PIN-110029)   Tel +91 98 1150 5070  email anjanatalwar@gmail.co mAbstract:  Chronic obstructive pulmonary disease (COPD) is a major global health problem.",Non-OADS,/arxiv_data1/oa_pdf/55/51/copd-9-759.PMC4130715.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/55/51/copd-9-759.PMC4130715.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/51/copd-9-759.PMC4130715.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/1f/jmdh-7-341.PMC4130716.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2014:7 341–347Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  341Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S6261 9improvement of quality and safety   in health care as a new interprofessional   learning module – evaluation from students Kristian gjessing1 cristina Joy T orgé2 Mats Hammar3,4 Johanna Dahlberg3 T omas Faresjö1 1Department of Medical and  Health sciences/ general Practice,   2Department of social and Welfare  studies,  3Department of clinical and  experimental Medicine,  4Obstetrics  and gynecology, linköping University,   sweden correspondence: Kristian gjessing   Department of Medical and Health   sciences, Faculty of Health sciences,   linköping University, se-581  83   linköping, sweden   email kristian.gjessing@liu.s eBackground:  Interprofessional teamwork is in many ways a norm in modern health care, and  needs to be taught during professional education.",Non-OADS,/arxiv_data1/oa_pdf/62/1f/jmdh-7-341.PMC4130716.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/62/1f/jmdh-7-341.PMC4130716.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNanotechnology, Science and Applications 2014:7 63–71Nanotechnology, Science and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  63Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSA.S3940 9Nanotechnology in agriculture: prospects   and constraints Siddhartha S Mukhopadhyay electron Microscopy and Nanoscience  Laboratory, Punjab Agricultural  University, Ludhiana, india Correspondence: Siddhartha S  Mukhopadhyay   electron Microscopy and Nanoscience  Laboratory, Punjab Agricultural  University, Ludhiana  141004, india   email ssmukho@pau.ed uAbstract:  Attempts to apply nanotechnology in agriculture began with the growing realization  that conventional farming technologies would neither be able to increase productivity any  further nor restore ecosystems damaged by existing technologies back to their pristine state;  in particular because the long-term effects of farming with “miracle seeds”, in conjunction  with irrigation, fertilizers, and pesticides, have been questioned both at the scientific and policy  levels, and must be gradually phased out.",Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://urlm.co/www.nanoforum.or g.  4.,OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://www.ifpri.org/sites/default/files/ publications/ifpridp01064.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
"Available from:  http://www.google.co.nz/url?sa =t&rct=j&q=&esrc=s&frm=1&source =web&cd=2&ved=0CCMQFjAB&url =ftp%3A%2F%2Fftp.fao.org% 2Fagl%2Fagll%2Fdocs%2Ffpnb13.pdf&ei =7CmWU4vdG8mZkgXB yICQDw&usg =AFQjCNEcuUKmq0hWB4SEtB-Hnf8-CjgMxw&sig 2=8GiuR Yt9k5ApqfDLexbOO g. Accessed June  9, 2014.",OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available  from: http://www.epa.gov/osainter/pdfs/nanotech/epa-nanotechnology- whitepaper-0207.pdf.,OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://e-drexler.com/p/06/00/EOC_Cover.html.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://www.ifpri.org/sites/default/ files/pubs/pubs/ib/ib11.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://www2.pacinst.org/reports/ international_ security_gleick_1993.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
"Nanotechnology, Science and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nanotechnology-science-and-applications-journa lNanotechnology, Science and Applications is an international, peer- reviewed, open access journal that focuses on the science of nanotech - nology in a wide range of industrial and academic applications.",Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://www.epa.gov/climatechange/ ghgemissions/sources.html.,OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://www.nap.edu/catalog.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
Available from: http://www.azonano.com/ article.aspx?ArticleID =1429.,Non-OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
"Available from: http://www.unmillenniumproject.org/reports/ tf_science.ht m. Accessed June  9, 2014.",OADS,/arxiv_data1/oa_pdf/bf/97/nsa-7-063.PMC4130717.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/d4/ijn-9-3687.PMC4130718.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3687–3706International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3687OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5666 1support for the initial attachment,   growth and differentiation of Mg-63 cells:   a comparison between nano-size hydroxyapatite  and micro-size hydroxyapatite in composites elena Filová1 T omáš suchý2,3 Zbyněk Sucharda2 Monika Šupová2 Margit Žaloudková2 Karel Balík2 Věra Lisá1 Miroslav Šlouf4 Lucie Bačáková1 1Department of Biomaterials  and Tissue engineering, Institute  of Physiology, 2Department of  composite and carbon Materials,   Institute of Rock Structure and  Mechanics, academy of sciences of  the czech republic, 3laboratory  of Biomechanics, Department  of Mechanics, Biomechanics and  Mechatronics, Faculty of Mechanical  engineering, cTU in Prague,   4Department of Morphology and  rheology of Polymer Materials,   Institute of Macromolecular  chemistry, academy of sciences of  the czech republic, Prague, czech  republic correspondence: elena Filová   Department of Biomaterials and Tissue  engineering, Institute of Physiology,  academy of sciences of the czech  Republic, Videnska 1083, 142 20,   Praha 4-Krc, czech republic   Tel +420 296 443 742   Fax +420 241 062 488   email filova@biomed.cas.c zAbstract:  Hydroxyapatite (HA) is considered to be a bioactive material that favorably influ - ences the adhesion, growth, and osteogenic differentiation of osteoblasts.",Non-OADS,/arxiv_data1/oa_pdf/76/d4/ijn-9-3687.PMC4130718.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/76/d4/ijn-9-3687.PMC4130718.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/d4/ijn-9-3687.PMC4130718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/26/copd-9-825.PMC4130719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 825–836International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  825RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5105 7Update on the pathological processes, molecular  biology, and clinical utility of N-acetylcysteine   in chronic obstructive pulmonary disease Hoi Nam Tse Cee Zhung Steven Tseng Medical and Geriatric Department,   Kwong wah Hospital, Hong Kong  Special Administrative Region Correspondence: Hoi Nam Tse   Medical and Geriatric Department,  Kwong wah Hospital, waterloo  Road, Yau Ma Tei, Hong Kong Special  Administrative Region   Tel +852 2332 2311  Fax +852 3517 6209  email drhoinam@gmail.co mAbstract:  Chronic obstructive pulmonary disease (COPD) is a common and morbid disease  characterized by high oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/f0/26/copd-9-825.PMC4130719.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f0/26/copd-9-825.PMC4130719.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/26/copd-9-825.PMC4130719.pdf
"We pro - vide experimental data showing that this property can be effi - ciently employed in tumor cytoreduction protocols as a tool interfering with interstrand crosslink (ICL) repair following  *Correspondence to: Sergey S Bogachev; Email: labmolbiol@mail.ru Submitted: 06/20/2014; Accepted: 07/07/2014; Published Online: 07/17/2014http://dx.doi.org/10.4161/cbt.29854Identification of cancer stem cells and a strategy  for their elimination evgenia V Dolgova1, ekaterina a a lyamkina1, Yaroslav R e fremov1,2, Valeriy P Nikolin1, Nelly a Popova1,2, Tamara V Tyrinova3,  artem V Kozel2, alexandra M Minkevich2, Oleg M andrushkevich2, evgeniy L Zavyalov1, alexander V Romaschenko1,  sergey I Bayborodin1,2, Oleg s Taranov4, Vladimir V Omigov4, ekaterina Ya s hevela3, Vyacheslav V s tupak5, sergey V Mishinov5,  Vladimir a  Rogachev1, anastasia s  Proskurina1, Vladimir I Mayorov6, Mikhail a  shurdov7, alexander a  Ostanin3,  elena R Chernykh3, and s ergey s Bogachev1,* 1Institute of Cytology and Genetics; s iberian Branch of the Russian a cademy of s ciences; Novosibirsk, Russia; 2Novosibirsk s tate University; Novosibirsk, Russia;   3Institute of Clinical Immunology; s iberian Branch of the Russian a cademy of Medical s ciences; Novosibirsk, Russia; 4The s tate Research Center of Virology   and Biotechnology V eCTOR; Koltsovo, Russia; 5Novosibirsk Research Institute of Traumatology and Orthopaedics; Novosibirsk, Russia;   6Mercer University s chool of Medicine; Macon, G a Usa; 7LLC Panagen; Gorno- altaisk, Russia Keywords:  tumor-initiating stem cells, TAMRA-labeled DNA, ascites form of Krebs-2 tumor, human glioma neurosphere,  cyclophosphamide Abbreviations:  CP, cyclophosphamide; DSB, double-strand break; dsDNA, double-stranded DNA; ICL, interstrand crosslink;  HR, homologous recombination; NER, nucleotide excision repair; TAMRA, fluorescent dye (carboxy tetramethyl-rhodamine);  TISCs, tumor-initiating stem cells It has been established previously that up to 40% of mouse CD34+ hematopoietic stem cells are capable of internalizing  exogenous dsDN a fragments both in vivo and ex vivo.",Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Oncogene  2004 ; 23:7274 -82;  PMID :15378087 ; http://dx.doi.org/10.1038/ sj.onc.1207947 4.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Cancer Res 2006 ; 66:9339 -44;  PMID:16990346 ; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3126 5.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Nat Med  1997 ; 3:730- 7; PMID:9212098 ; http://dx.doi.org/10.1038/ nm0797-730 7.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
BMC Gastroenterol   2011 ; 11:71; PMID:21669008 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Methods Mol Biol  2007 ;  407:83-95; PMID:18453250 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Clin Cancer Res 2010 ;  16:3113 -20; PMID:20530701 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Stem  Cells Dev  2009 ; 18:1515-22; PMID:19260804 ;  http://dx.doi.org/10.1089/scd.2008.0302 15.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Gene   2012 ; 495:134-45; PMID:22227496 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Gene   2013 ; 528:74-83; PMID:23911305 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
gvt-journal.com/content/7/1/12 ; PMID:19682353 ;  http://dx.doi.org/10.1186/1479-0556-7-12 .,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Mutat Res  2009 ; 669:155- 61; PMID:19540246 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
J Chromatogr B Biomed Sci Appl 1999 ; 722:225- 54; PMID:10068143 ; http://dx.doi.org/10.1016/ S0378-4347(98)00313-2 24 .,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
J Cell Biol 1993 ; 123:1761- 75; PMID:7506266 ; http://dx.doi.org/10.1083/ jcb.123.6.1761 25.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Toxicolog y   2004 ; 198:329-40; PMID :15138059 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Annu Rev Pathol  2006 ; 1:119-50; PMID:18039110 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Nat Cell Biol 2010 ; 12:468- 76; PMID:20418870 ; http://dx.doi.org/10.1038/ ncb2048 29.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Nat Rev  Drug Discov  2013 ; 12:217-28; PMID:23449307 ;  http://dx.doi.org/10.1038/nrd3870 30.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Mol Cell Biol   2000 ; 20:7980 -90; PMID:11027268 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Nature   2007 ; 447:338-41; PMID:17429354 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Mini Rev Med Chem  2014 ; 14:20-34; PMID:24195662 ; http://dx.doi.org /10.2174/13895575113136660107 34.,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
Expert Opin Ther Targets 2010 ; 14:621- 32; PMID:20426697 ; http://dx.doi.org/10.1517/147 12598.2010.485186,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/cbt-15-1378.PMC4130731.pdf
"27-29 However, the simultaneous administration of different  medications may increase the likelihood that toxicity will occur.23 *Correspondence to: Lisa J Wood; Email: ljwood@mghihp.edu Submitted: 03/10/2014; Revised: 07/10/2014; Accepted: 07/13/2014; Published Online: 07/21/2014 http://dx.doi.org/10.4161/cbt.29922Production of IL-1 β by bone marrow-derived  macrophages in response   to chemotherapeutic drugs Synergistic effects of doxorubicin and vincristine John Wong1, Lisa T Tran1, eli a Magun2, Bruce e Magun1, and Lisa J Wood1,* 1school of Nursing; Massachusetts General h ospital Institute of h ealth Professions; Boston, M a Usa; 2Department of Dermatology; Oregon h ealth & s cience University;  Portland, OR U sa Keywords:  inflammasome, cytokines, nilotinib, ponatinib, sorafenib Abbreviations:  5-FU, 5-fluorouracil; BMDM, bone marrow-derived macrophages; GAPDH, glyceraldehyde phosphate  dehydrogenase; LPS, lipopolysaccharide; MAPK, mitogen activated protein kinase; TCA, trichloroacetic acid cytotoxic chemotherapeutic drugs, especially when used in combination, are widely employed to treat a variety of  cancers in patients but often lead to serious symptoms that negatively affect physical functioning and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Invest 2000; 18:11-9; PMID:10701362 ;  http://dx.doi.org/10.3109/07357900009023057 2.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Nurs  1994; 17:367-78;  PMID:7954384 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
J Pain Symptom Manage 1999; 18:233-42;  PMID:10534963 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
J Natl Cancer Inst Monogr 2004;  76-8;  PMID:15263044 ; http://dx.doi.org/10.1093/ jncimonographs/lgh008 7.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Curr Opin Support Palliat Care 2013; 7:54-9; PMID:23314015 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Res 2005; 65:11752-61; PMID:16357188 ;  http://dx.doi.org/10.1158/0008-5472.CAN-05-1658 10.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Treat Rev  2007; 33:448-60;  PMID:17507164 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Biol Res Nurs 2006; 8:157-69; PMID:17003255 ;  http://dx.doi.org/10.1177/1099800406290932 14.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Immunol Immunother  1998; 46:104-12;  PMID:9558006 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Immunol Lett  1992; 34:183-8;  PMID:1487305 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Brain Behav Immun 2007; 21:413-27;  PMID:17178209 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
PLoS One 2013; 8:e81234; PMID:24339912 ; http://dx.doi.org/10.1371/jour - nal.pone.0081234 19.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Brain Behav Immun 2012; 26:699-705;  PMID:22251605 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Brain Behav Immun 2014; 38:66-76;  PMID:24412646 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Brain Behav  Immun 2013; 30(Suppl):S99-108;  PMID:22884417 ;  http://dx.doi.org/10.1016/j.bbi.2012.07.01522.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Case Rep Med 2012;  2012:468452;  PMID:22685470 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
JAMA  2004; 292:470-84;  PMID :15280345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Blood 2011; 118:6123- 31; PMID:21926351 ; http://dx.doi.org/10.1182/ blood-2010-02-269811 25.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Drug Discov Today 2007; 12:34- 42; PMID:17198971 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer 2008; 113(Suppl):1857- 87; PMID:18798529 ; http://dx.doi.org/10.1002/ cncr.23651 28.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
N Engl J Med 2007; 357:299-300; PMID:17634467 ; http://dx.doi.org/10.1056/ NEJMcibr072593 29.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Lett 2007; 251:1- 16; PMID:17125914 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Drug Resist Updat 2001; 4:253- 67; PMID:11991680 ; http://dx.doi.org/10.1054/ drup.2001.0214 32.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Trends Mol Med 2004; 10:125-9;  PMID :15102355 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Biol Ther 2010; 10:258- 66; PMID:20559024 ; http://dx.doi.org/10.4161/ cbt.10.3.12367 34.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Biol Ther 2013; 14:56-63; PMID:23114643 ;  http://dx.doi.org/10.4161/cbt.22628,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Curr Opin Immunol 2007; 19:615- 22; PMID:17977705 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Immunity 2006; 24:317-27; PMID:16546100 ;  http://dx.doi.org/10.1016/j.immuni.2006.02.004 37.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Crit Rev Immunol 2014; 34:41- 80; PMID:24579701 ; http://dx.doi.org/10.1615/ CritRevImmunol.2013008686 38.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Curr Opin Microbiol 2013; 16:23-31; PMID:23318142 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Nat Rev Immunol  2013; 13:397-411;  PMID:23702978 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Nat Med 2013; 19:57-64; PMID:23202296 ;  http://dx.doi.org/10.1038/nm.2999 41.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Cancer Biol Ther 2011; 11:1008-16;  PMID:21464611 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
J Clin Invest  1991; 88:1445-51;  PMID:1834696 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
PLoS One 2012; 7:e36044; PMID:22606244 ;  http://dx.doi.org/10.1371/journal.pone.003604444.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Br J Cancer  2006; 94:1765-9;  PMID:16721371 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Curr Med Chem 2012;  19:938-44;  PMID:22214462 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
J Leukoc Biol 2007; 82:259-64; PMID:17470531 ;  http://dx.doi.org/10.1189/jlb.1206755 48.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Antimicrob Agents Chemother  2013; 57:1262-9;  PMID:23263005 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Immunopharmacology 1990;  19:131-8;  PMID:2351535 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
J Leukoc Biol 2003; 74:764-71;  PMID:12960277 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Am J Physiol Lung Cell Mol Physiol 2006; 290:L622-45;  PMID :16531564 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Toxicol Appl Pharmacol 2013; 272:238- 44; PMID:23770382 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
PLoS One 2012; 7:e37735;  PMID:22662203 ; http://dx.doi.org/10.1371/jour - nal.pone.0037735 55.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
PLoS One 2009; 4:e7520;  PMID:19841739 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
Am J Pathol  2005; 166:323-39;  PMID:15632024 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/8f/cbt-15-1395.PMC4130732.pdf
"http://www.jcog.jp/doctor/tool/ctcae.html  (accessed February 28, 2014 ).",OADS,/arxiv_data1/oa_pdf/05/85/cro-0007-0435.PMC4130819.pdf
2013. http://www.who.int/topics/obesity/en/.,Non-OADS,/arxiv_data1/oa_pdf/4a/81/nne-0004-0108.PMC4130824.pdf
"Key Words :  Clinical Endoscopy; Seminar; Highlight; Live demonstration; Hands-on courseOpen Access Received:  July 4, 2014    Accepted:  July 8, 2014   Correspondence:  Ki Baik Hahm Department of Gastroenterology, CHA Bundang Medical Center, CHA Uni - versity, 59 Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5005, Fax: +82-31-780-5219, E-mail:  hahmkb@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.285",Non-OADS,/arxiv_data1/oa_pdf/6e/44/ce-47-285.PMC4130881.pdf
"Key Words :  Stricture; Esophagus; Stents; Endoscopic treatmentOpen Access Received:  March 7, 2014    Revised:  April 15, 2014 Accepted:  April 15, 2014 Correspondence:  Gwang Ha Kim Department of Internal Medicine, Pusan National University Hospital, Pusan  National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602- 739, Korea Tel: +82-51-240-7869, Fax: +82-51-244-8180, E-mail:  doc0224@pusan.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.295",Non-OADS,/arxiv_data1/oa_pdf/da/cc/ce-47-295.PMC4130882.pdf
"Key Words :  Caustic injury; Acids; AlkaliesOpen Access Received:  March 21, 2014    Revised:  April 13, 2014 Accepted:  April 14, 2014 Correspondence:  Kyung Sik Park Department of Internal Medicine, Keimyung University Dongsan Medical  Center, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu,  Daegu 700-712, Korea Tel: +82-53-250-7088, Fax: +82-53-250-7088, E-mail:  seenae99@dsmc.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.301",Non-OADS,/arxiv_data1/oa_pdf/01/1c/ce-47-301.PMC4130883.pdf
"Key Words :  Acute variceal bleeding; Hemostasis; EndoscopyOpen Access Received:  March 26, 2014    Revised:  April 9, 2014 Accepted:  April 10, 2014 Correspondence:  Y oung Dae Kim Division of Gastroenterology and Hepatology, Department of Internal Medi - cine, Chosun University School of Medicine, 309 Pilmun-daero, Dong-gu,  Gwangju 501-759, Korea Tel: +82-62-230-3364, Fax: +82-62-224-5494, E-mail:  giydkim@chosun.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.308",Non-OADS,/arxiv_data1/oa_pdf/27/25/ce-47-308.PMC4130884.pdf
"Key Words :  Nonvariceal upper gastrointestinal bleeding; Hemostasis; EndoscopyOpen Access Received:  March 31, 2014    Revised:  July 4, 2014 Accepted:  July 8, 2014 Correspondence:  Soon Man Yoon Department of Internal Medicine, Chungbuk National University Hospital,  Chungbuk National University College of Medicine, 776 1(il)sunhwan-ro,  Heungdeok-gu, Cheongju 361-711, Korea Tel: +82-43-261-3692, Fax: +82-43-273-3252 E-mail:  smyoon@chungbuk.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.315",Non-OADS,/arxiv_data1/oa_pdf/f3/78/ce-47-315.PMC4130885.pdf
"Key Words :  Endoscopy; Antithrombotics; Hemorrhage; ThromboembolismOpen Access Received:  March 29, 2014    Accepted:  April 10, 2014 Correspondence:  Hyung-Geun Oh Department of Neurology, Soonchunhyang University Cheonan Hospital, Soon - chunhyang University College of Medicine, 31 Suncheonhyang 6-gil, Dong - nam-gu, Cheonan 330-721, Korea Tel: +82-41-570-3833, Fax: +82-41-579-9021, E-mail:  oh906@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.320",Non-OADS,/arxiv_data1/oa_pdf/2d/e4/ce-47-320.PMC4130886.pdf
"Key Words :  Colonoscopy; Medication; Sedation; PreparationOpen Access Received:  March 31, 2014    Revised:  May 13, 2014 Accepted:  June 11, 2014 Correspondence:  Yun Jeong Lim Department of Internal Medicine, Dongguk University Ilsan Hospital, Dong - guk University College of Medicine, 27 Dongguk-ro, Ilsandong-gu, Goyang  410-773, Korea Tel: +82-31-961-7133, Fax: +82-31-961-9339, E-mail:  limyj@dumc.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.324",Non-OADS,/arxiv_data1/oa_pdf/b0/3b/ce-47-324.PMC4130887.pdf
Available from: http://www.bsg.org.uk/ clinical-guidelines/endoscopy/prescription-and-administration-of- oral-bowel-cleansing-agents.html.,Non-OADS,/arxiv_data1/oa_pdf/b0/3b/ce-47-324.PMC4130887.pdf
"Key Words :  Image enhancement; Narrow band imaging; Colorectal polypOpen Access Received:  April 14, 2014    Revised:  July 3, 2014 Accepted:  July 5, 2014 Correspondence:  Ja Seol Koo Division of Gastroenterology and Hepatology, Department of Internal Medi - cine, Korea University Ansan Hospital, Korea University College of Medicine,  123 Jeokgeum-ro, Danwon-gu, Ansan 425-707, Korea Tel: +82-31-412-5580, Fax: +82-31-412-5582, E-mail:  jskoo@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.330 INTRODUCTION Colonoscopy has been used for colorectal cancer screening  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/98/79/ce-47-330.PMC4130888.pdf
"Key Words :  Cholangiopancreatography, endoscopic retrograde; Complications; GuidewireOpen Access Received:  March 23, 2014    Revised:  Arpil 13, 2014 Accepted:  April 13, 2014 Correspondence:  Tae Hoon Lee Division of Gastroenterology, Department of Internal Medicine, Soonchunhy - ang University Cheonan Hospital, Soonchunhyang University College of Medi - cine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, Korea Tel: +82-41-570-3662, Fax: +82-41-574-5762, E-mail:  thlee9@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.334",Non-OADS,/arxiv_data1/oa_pdf/51/8e/ce-47-334.PMC4130889.pdf
"Key Words :  Cholangiopancreatography, endoscopic retrograde; Perforation; StentsOpen Access Received:  March 31, 2014    Revised:  July 4, 2014 Accepted:  July 8, 2014 Correspondence:  Kwang Bum Cho Division of Gastroenterology and Hepatology, Department of Internal Medi - cine, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu,  Daegu 700-712, Korea Tel: +82-53-250-7007, Fax: +82-53-250-7088, E-mail:  chokb@dsmc.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.341 INTRODUCTION Endoscopic retrograde cholangiopancreatography (ERCP)  is an invasive procedure carrying potential complications  such as pancreatitis, hemorrhage, perforation, cholangitis,  cholecystitis and cardiopulmonary abnormalities.1 Because of  these complications, ERCP is used primarily for treatment  rather than diagnostic purposes.",Non-OADS,/arxiv_data1/oa_pdf/2d/54/ce-47-341.PMC4130890.pdf
"Key Words :  Primary duodenal tuberculosis; 18F-FDG PET/CT; QuantiFERON-TB GOLDOpen Access Received:  May 27, 2013    Revised:  July 11, 2013 Accepted:  August 27, 2013 Correspondence:  Seong Hwan Kim Department of Internal Medicine, Eulji General Hospital, Eulji University  School of Medicine, 68 Hangeulbiseong-ro, Nowon-gu, Seoul 139-711, Korea Tel: +82-2-970-8209, Fax: +82-2-972-0068, E-mail:  shkim@eulji.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.346",Non-OADS,/arxiv_data1/oa_pdf/8d/42/ce-47-346.PMC4130891.pdf
"Key Words :  Thyroid; Papillary cancer; Endosonography; Biopsy, fine-needle; EsophagusOpen Access Received:  August 3, 2013    Revised:  September 1, 2013 Accepted:  September 21, 2013 Correspondence:  Amer A. Alkhatib Division of Gastroenterology, Cancer Treatment Centers of America, 10109 E.  79th St, Tulsa, OK 74133, USA Tel: +1-918-286-5000, Fax: +1-918-286-5070 E-mail:  khatibamer@yahoo.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.350",Non-OADS,/arxiv_data1/oa_pdf/da/80/ce-47-350.PMC4130892.pdf
"Key Words :  High-grade dysplasia; Endoscopic full-thickness resection; Endoscopic submucosal dissectionOpen Access Received:  September 9, 2013    Revised:  December 4, 2013 Accepted:  January 12, 2014 Correspondence:  Jae Y oung Jang Department of Internal Medicine, Kyung Hee University School of Medicine,  26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-701, Korea Tel: +82-2-958-8200, Fax: +82-2-968-1848, E-mail:  jyjang@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.353",Non-OADS,/arxiv_data1/oa_pdf/69/45/ce-47-353.PMC4130893.pdf
"Key Words :  Xanthomatosis; Esophagus; Histiocytes; EndoscopyOpen Access Received:  September 13, 2013    Revised:  October 25, 2013 Accepted:  October 29, 2013 Correspondence:  Y eon Soo Kim Department of Internal Medicine, Hallym University Chuncheon Sacred Heart  Hospital, Hallym University College of Medicine, 77 Sakju-ro, Chuncheon 200- 704, Korea Tel: +82-33-240-5645, Fax: +82-33-241-8064 E-mail:  kimyeonsoo@hallym.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.358",Non-OADS,/arxiv_data1/oa_pdf/0e/d5/ce-47-358.PMC4130894.pdf
"cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.362",Non-OADS,/arxiv_data1/oa_pdf/96/31/ce-47-362.PMC4130895.pdf
"2, Supplementary Video 1  [available online at http://www.e-ce.org/]).",Non-OADS,/arxiv_data1/oa_pdf/96/31/ce-47-362.PMC4130895.pdf
"Key Words :  Afferent loop syndrome; Enterolith; Electrohydraulic lithotripsyOpen Access Received:  October 17, 2013    Revised:  December 6, 2013 Accepted:  December 8, 2013 Correspondence:  Tae Hoon Lee Division of Gastroenterology, Department of Internal Medicine, Soonchun - hyang University Cheonan Hospital, Soonchunhyang University College of  Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-721, Korea Tel: +82-41-570-3662, Fax: +82-41-574-5762, E-mail:  thlee9@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2014.47.4.367",Non-OADS,/arxiv_data1/oa_pdf/03/13/ce-47-367.PMC4130896.pdf
- Korean J Orthod 2014;44:88-95 http://dx.doi.org/10.4041/kjod.2014.44.4.155155www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/0f/b7/kjod-44-155.PMC4130910.pdf
"156 www.e-kjo.org http://dx.doi.org/10.4041/kjod.2014.44.4.155This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.heads were covered with mucosa due to inflammation.",Non-OADS,/arxiv_data1/oa_pdf/0f/b7/kjod-44-155.PMC4130910.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.157",Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
"Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 158 http://dx.doi.org/10.4041/kjod.2014.44.4.157 INTRODUCTION   As there has been a recent increase in orthodontic  treatments of adult patients with aesthetic requirements,  the use of ceramic brackets and resin brackets is in - creasing.",Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
"Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 159 http://dx.doi.org/10.4041/kjod.2014.44.4.157 coated wires (Hubit Co., Ltd., Uiwang, Korea) and non- coated wires (Tomy Inc., Futaba, Japan) using 0.016-inch  nickel titanium (NiTi) wires, 0.016 × 0.022-inch NiTi  wires, and self-ligation brackets.",OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 160 http://dx.doi.org/10.4041/kjod.2014.44.4.157 cm cut on the upper arch of the wire was used in the  experiment.,OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 161 http://dx.doi.org/10.4041/kjod.2014.44.4.157 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
"Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 162 http://dx.doi.org/10.4041/kjod.2014.44.4.157 Comparison of maximum static frictional forces between  the bracket and 0.017 × 0.025-inch SS wire with  different coatings and angulations (Table 2, Figure 4B)   When the angles between the brackets and the wires  were 0°, the maximum static frictional forces were not  significantly different between the control group and the  P group ( p > 0.05), but they were significantly greater in  the R group compared to the other two groups ( p < 0.05).",Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 163 http://dx.doi.org/10.4041/kjod.2014.44.4.157 DISCUSSION   Frictional force is the force that resists the relative motion of surfaces sliding against each other.,Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 164 http://dx.doi.org/10.4041/kjod.2014.44.4.157 kinetic frictional force that appears during movement.,Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 165 http://dx.doi.org/10.4041/kjod.2014.44.4.157 only the maximum kinetic frictional force because it  was difficult to reproduce the kinetic frictional force in  the oral cavity.,Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
"Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 166 http://dx.doi.org/10.4041/kjod.2014.44.4.157 the bracket’s slot corner, and notching, which is a per- ma nent deformation of the wires.",Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
Kim et al • Frictional forces of aesthetic orthodontic coated wires www.e-kjo.org 167 http://dx.doi.org/10.4041/kjod.2014.44.4.157 10.,Non-OADS,/arxiv_data1/oa_pdf/2a/bf/kjod-44-157.PMC4130911.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.168",Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
"Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 169 http://dx.doi.org/10.4041/kjod.2014.44.4.168 INTRODUCTION   In general, orthodontic treatment focuses on impro - ving functional occlusion and facial appearance.1 Awa- reness of how facial appearance affects quality of life  has rapidly increased the demand for such treatment.",Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 170 http://dx.doi.org/10.4041/kjod.2014.44.4.168 responding to the first questionnaire.,Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
"Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 171 http://dx.doi.org/10.4041/kjod.2014.44.4.168 DISCUSSION   In this study, the absence of significant differences  in the prevalence and severity of impacts on OHRQoL  in any therapeutic phase among the groups proves our  hypothesis.",Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 172 http://dx.doi.org/10.4041/kjod.2014.44.4.168 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
"Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 173 http://dx.doi.org/10.4041/kjod.2014.44.4.168 gular, with nearly 90-degree corners between the slot  bottom and the walls.",Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
"Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 174 http://dx.doi.org/10.4041/kjod.2014.44.4.168 was inserted in both the conventional and the ASL  groups, elastomeric ligatures in the conventional group could have complicated the situation.",Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
"Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 175 http://dx.doi.org/10.4041/kjod.2014.44.4.168 and the domains mostly affected were “physical pain”  and “psychological discomfort,” with “food stuck in  between teeth” being the most common effect reported.",Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
Othman et al • OHRQoL of patients wearing braces www.e-kjo.org 176 http://dx.doi.org/10.4041/kjod.2014.44.4.168 on how you assess them?,Non-OADS,/arxiv_data1/oa_pdf/33/23/kjod-44-168.PMC4130912.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.177",Non-OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
Katić et al • Mechanical properties of mini-implants www.e-kjo.org 178 http://dx.doi.org/10.4041/kjod.2014.44.4.177 INTRODUCTION   Versatile temporary anchorage device (TAD) systems  offer fixed anchorage to improve the efficiency of  orthodontic treatment.,Non-OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
"Katić et al • Mechanical properties of mini-implants www.e-kjo.org 179 http://dx.doi.org/10.4041/kjod.2014.44.4.177 tion torque was measured for the duration of the inser- tion up to the implant collar, and measured values of  MIT (expressed as Nmm) were digitalized and saved  using PicoLog® 5.14.6 (Pico® Technology Ltd., St. Neots,  UK) data acquisition software.",OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
Katić et al • Mechanical properties of mini-implants www.e-kjo.org 180 http://dx.doi.org/10.4041/kjod.2014.44.4.177   Institutional review board approval was not needed for  this study.,Non-OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
"Katić et al • Mechanical properties of mini-implants www.e-kjo.org 181 http://dx.doi.org/10.4041/kjod.2014.44.4.177 combination will enhance the primary stability of the  TAD and thus, the success of orthodontic therapy.",Non-OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
"Katić et al • Mechanical properties of mini-implants www.e-kjo.org 182 http://dx.doi.org/10.4041/kjod.2014.44.4.177 during insertion, which corresponds to the MIT.",OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
Katić et al • Mechanical properties of mini-implants www.e-kjo.org 183 http://dx.doi.org/10.4041/kjod.2014.44.4.177 40:697-703.,OADS,/arxiv_data1/oa_pdf/27/17/kjod-44-177.PMC4130913.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.184",Non-OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
"Denize et al • Profile attractiveness parameters www.e-kjo.org 185 http://dx.doi.org/10.4041/kjod.2014.44.4.184 INTRODUCTION     A growing body of evidence suggests that perceptions  of facial profile attractiveness have changed and will  continue to change over time.1,2 For the lips, some  authors have suggested that fuller, more prominent lips  may be perceived as more youthful and consequently,  more desirable from an aesthetic viewpoint.1,2 If this  change in perception is true, particularly since modern  orthodontics is partly demanded and undertaken to  improve facial attractiveness, it would have potentially  important consequences to both orthodontic treatment  planning and hard and soft tissue surgery, which can  influence lip prominence.",Non-OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
Denize et al • Profile attractiveness parameters www.e-kjo.org 186 http://dx.doi.org/10.4041/kjod.2014.44.4.184 prominence of the lips may be related to a true vertical  line passing through subnasale.12   The purpose of this investigation was to evaluate the  relative importance of bilabial prominence in relation to  the overall facial profile attractiveness and the relative  prominences of other facial profile parameters in a  normal population by using a different approach to  traditional attractiveness perception research.,Non-OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
"Denize et al • Profile attractiveness parameters www.e-kjo.org 187 http://dx.doi.org/10.4041/kjod.2014.44.4.184 tiveness in order to rate each profile parameter that  may influence the perceptions of attractiveness (e.g.,  do you think the chin is too far forward, just right,  or too far back, etc.).",Non-OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
Denize et al • Profile attractiveness parameters www.e-kjo.org 188 http://dx.doi.org/10.4041/kjod.2014.44.4.184 (stimulus photographs) were shown to a different and  unrelated group of King’s College London students aged  18−24 years (n = 45).,Non-OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
"Denize et al • Profile attractiveness parameters www.e-kjo.org 189 http://dx.doi.org/10.4041/kjod.2014.44.4.184 RESULTS   The BIC inferred that the zero-meridian line to the  pro nasale (pr), zero-meridian line to the labrale inferius  (ll), labrale inferius to Rickett’s E-line (lle), zero-meridian  line to the soft tissue pogonion (poe), nasofrontal angle  (nfr), upper lip curl (ulc), and lower lip curl (llc) had the  greatest effect on how observers answered question 1  (Table 1).",OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
Denize et al • Profile attractiveness parameters www.e-kjo.org 190 http://dx.doi.org/10.4041/kjod.2014.44.4.184 al.11 used a different age group (7−17 years) that did not  overlap with the age group of observers in this study.,OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
"Denize et al • Profile attractiveness parameters www.e-kjo.org 191 http://dx.doi.org/10.4041/kjod.2014.44.4.184 best described statistically by the subset of 8 variables  in Figure 10 and Table 7 (i.e., the ul, ll, nla, lnla, mla,  nfa, sml, and ulc).",OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
"Denize et al • Profile attractiveness parameters www.e-kjo.org 192 http://dx.doi.org/10.4041/kjod.2014.44.4.184 too prominent, it is most likely that this response was  influenced by the ulc value and least likely influenced by  the lcta value.",OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
Denize et al • Profile attractiveness parameters www.e-kjo.org 193 http://dx.doi.org/10.4041/kjod.2014.44.4.184 CONCLUSION   Perceptions of facial profile attractiveness are multifac- torial.,Non-OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
Denize et al • Profile attractiveness parameters www.e-kjo.org 194 http://dx.doi.org/10.4041/kjod.2014.44.4.184 TR.,OADS,/arxiv_data1/oa_pdf/f2/d6/kjod-44-184.PMC4130914.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.195",Non-OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
"Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 196 http://dx.doi.org/10.4041/kjod.2014.44.4.195 INTRODUCTION   Fixed orthodontic appliances increase the incidence  of white spot lesions (WSLs) on the facial surface of  teeth because the appliances provide spaces for plaque  retention.1-3 After the removal of the orthodontic  brackets or bands, the WSLs can be arrested because  of changes in the oral environment.",Non-OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 197 http://dx.doi.org/10.4041/kjod.2014.44.4.195 nail varnish leaving a 3 × 3 mm area exposed.,Non-OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 198 http://dx.doi.org/10.4041/kjod.2014.44.4.195 observed in the case of positive control.,OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
"Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 199 http://dx.doi.org/10.4041/kjod.2014.44.4.195 was used, the removed depth was 2.7 times greater than  that observed in the case of the 37% H3PO4 only group,  and in the case of the sponge applicator, the removed  depth also increased by 1.7 times.",OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 200 http://dx.doi.org/10.4041/kjod.2014.44.4.195 be assumed that the mechanical friction caused by the  sponge applicator was probably less than that caused by  the brush applicator.,OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
"Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 201 http://dx.doi.org/10.4041/kjod.2014.44.4.195 HCl, which resulted in only chemical effects.",OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
Yim et al • Surface pretreatment of white spot lesions www.e-kjo.org 202 http://dx.doi.org/10.4041/kjod.2014.44.4.195 13.,OADS,/arxiv_data1/oa_pdf/bb/b0/kjod-44-195.PMC4130915.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Case Reprot pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.203",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 204 http://dx.doi.org/10.4041/kjod.2014.44.4.203 INTRODUCTION   Soft tissue pressure is a factor that influences cranio- facial growth and development patterns.1,2 Further,  prior reports have indicated that a correlation exists  between tongue position and malocclusion.3,4 A low  tongue posture or tongue-thrusting habit can produce  an anterior open-bite and mandibular prognathism.",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 205 http://dx.doi.org/10.4041/kjod.2014.44.4.203 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 206 http://dx.doi.org/10.4041/kjod.2014.44.4.203 tongue in a higher than usual position, which is accom- plished by the sheer volume of the acrylic base.",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 207 http://dx.doi.org/10.4041/kjod.2014.44.4.203 and tension, and results in comfort to the patient.",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 208 http://dx.doi.org/10.4041/kjod.2014.44.4.203 TREATMENT ALTERNATIVES   Depending on the individual causative factors, various  approaches including orthodontic extrusion of anterior  teeth, intrusion of posterior teeth, and a combination  of orthodontic and orthognathic surgeries can be used  to treat anterior open-bite.",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 209 http://dx.doi.org/10.4041/kjod.2014.44.4.203 Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 210 http://dx.doi.org/10.4041/kjod.2014.44.4.203 Figure 9.,Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 211 http://dx.doi.org/10.4041/kjod.2014.44.4.203 RESULTS Treatment results and relapse after 3-year follow-up   A class I molar and canine relationship, and a positive  overbite were obtained over an 11-month treatment  course using the described technique (Figures 5B, 7,  and 8).",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 212 http://dx.doi.org/10.4041/kjod.2014.44.4.203 the overbite was retained in the corrected position (Figure  13).,Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 213 http://dx.doi.org/10.4041/kjod.2014.44.4.203   Soft tissue pressure, in particular the pressure that  results from tongue position and function, has been  reported to affect anterior open-bite, and could pose  a potential risk for long-term stability of treatment  results.5,6 Although previous studies have investigated  the effects of tongue posture and function,28,29 clini cal  examination of the tongue is both limited and sub - jective, due to its muscular nature and surrounding  anatomic structures.",Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 214 http://dx.doi.org/10.4041/kjod.2014.44.4.203 Figure 14.,OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 215 http://dx.doi.org/10.4041/kjod.2014.44.4.203 servative approaches in the treatment of abnormal ton- gue positions include habit appliances such as a tongue  crib or spur.,Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
Seo et al • Treatment of anterior openbite without surgical intervention www.e-kjo.org 216 http://dx.doi.org/10.4041/kjod.2014.44.4.203 11.,Non-OADS,/arxiv_data1/oa_pdf/f2/63/kjod-44-203.PMC4130916.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Case Report pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2014.44.4.217",Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
"Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 218 http://dx.doi.org/10.4041/kjod.2014.44.4.217 INTRODUCTION   Currently, a single-tooth implant has become a  common treatment option for adults that has survival  rates of about 90% after 10 years.1-5 Obtaining an  esthetically satisfactory solution that mimics the adjacent  natural teeth, however, represents a great challenge for  clinicians, especially if an implant-supported crown is  anticipated to be part of the treatment plan for a highly  esthetically demanding area in a young adult who has a  long life expectancy.5,6   The lack of an adequate recipient site secondary to  alveolar bone resorption, as a result of a root fracture,  does not create an ideal three-dimensional implant  position and limits the predictability of a long-term  esthetic result with an implant-supported crown because  the gingival tissue follows the osseous crest, resulting  in gingival recession and exposure of the crown mar - gins.1,6 Progressive remodeling of the alveolar bone that  was initiated by tooth extraction leads to a physiological  reduction in thickness and height of the alveolar ridge, a  concerning condition, which occurs at the buccal aspect  of the anterior maxillary teeth where the cortical plate is  anatomically thin and porous.7-9 Moreover, to remove an  apical root-fractured fragment, surgical instrumentation  can further increase resorption of the alveolar bone.",Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 219 http://dx.doi.org/10.4041/kjod.2014.44.4.217 this visit.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 220 http://dx.doi.org/10.4041/kjod.2014.44.4.217 points.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 221 http://dx.doi.org/10.4041/kjod.2014.44.4.217 or fracture was observed in the socket walls at the time  of implant insertion.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 222 http://dx.doi.org/10.4041/kjod.2014.44.4.217 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 223 http://dx.doi.org/10.4041/kjod.2014.44.4.217 over time (Figures 8B and 9B).,Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
"Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 224 http://dx.doi.org/10.4041/kjod.2014.44.4.217 plant site before extraction is an orthodontic extru - sion.6,9,11,13,14,22   In the present case report, a 4-month orthodontic ex- trusion followed by a 3-month retention phase created  a greater volume of alveolar bone tissue without any  surgical augmentation procedures.",Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
Alessandri Bonetti et al • Orthodontic extrusion of a root-fractured maxillary central incisor www.e-kjo.org 225 http://dx.doi.org/10.4041/kjod.2014.44.4.217 Bone healing and soft tissue contour changes  following single-tooth extraction: a clinical and  radio   graphic 12-month prospective study.,Non-OADS,/arxiv_data1/oa_pdf/2e/43/kjod-44-217.PMC4130917.pdf
"Laboratory Investigation • Received : December 30, 2013  • Revised : February 14, 2014  • Accepted : May 15, 2014 • Address for reprints : Joo Han Kim, M.D., Ph.D.  Department of Neurosurgery, Guro Hospital, College of Medicine, Korea University, 148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea  Tel : +82-2-2626-3097,  Fax : +82-2-863-1684,  E-mail : nskjh94@korea.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 237-243, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.237 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/69/41/jkns-55-237.PMC4130947.pdf
"Laboratory Investigation • Received : July 23, 2013  • Revised : January 15, 2014  • Accepted : May 15, 2014 • Address for reprints : Gi-Taek Yee, M.D., Ph.D.  Department of Neurosurgery, Gil Medical Center, Gachon University, 774 Namdong-daero, Namdong-gu, Incheon 405-760, Korea   Tel : +82-32-460-3304,  Fax : +82-32-460-3899,  E-mail : gtyee@gilhospital.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 244-247, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.244 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/79/4e/jkns-55-244.PMC4130948.pdf
"Clinical Article • Received : October 15, 2013  • Revised : January 15, 2014  • Accepted : May 15, 2014 • Address for reprints : Seung Won Park, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea  Tel : +82-2-6299-3910,  Fax : +82-2-6299-2069,  E-mail : nspsw@cau.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 248-254, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.248 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/06/58/jkns-55-248.PMC4130949.pdf
"Clinical Article • Received : November 20, 2013  • Revised : February 1, 2014  • Accepted : May 15, 2014 • Address for reprints : Seung Hwan Yoon, M.D., Ph.D.  Department of Neurosurgery, Inha University College of Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea  Tel : +82-32-890-2370,  Fax : +82-32-890-2374,  E-mail : nsyoon@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 255-260, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.255 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/0d/4d/jkns-55-255.PMC4130950.pdf
"Key Words :  Interspinous spacer · Interspinous space · Supraspinous ligament depth · Interspinous ligament depth · Interspinous distance.Clinical Article • Received : August 6, 2013  • Revised : February 14, 2014  • Accepted : May 15, 2014 • Address for reprints : Seoungwoo Park, M.D., Ph.D.  Department of Neurosurgery, School of Medicine, Kangwon National University, 1 Gangwondaehak-gil, Chuncheon 200-701, Korea  Tel : +82-33-258-2410,  Fax : +82-33-258-2146,  E-mail : nsped@kangwon.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 261-266, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.261 Copyright © 2014 The Korean Neurosurgical Society  Print  ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/52/50/jkns-55-261.PMC4130951.pdf
"Department of Neurosurgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel : +82-2-2072-2350,  Fax : +82-2-744-8459,  E-mail : chungc@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 267-272, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.267 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/62/40/jkns-55-267.PMC4130952.pdf
"Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University School of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-703, Korea  Tel : +82-53-620-3790,  Fax : +82-53-620-3770,  E-mail : jyjns@yu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 273-276, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.273 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/73/5b/jkns-55-273.PMC4130953.pdf
"Department of Neurology, Near East University Faculty of Medicine Hospital, Near East Avenue, Nicosia 922022, Cyprus  Tel : +90-392-675-1000-1371,  Fax : +90-392-675-1090,  E-mail : ambereker@yahoo.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 277-279, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.277 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/71/3d/jkns-55-277.PMC4130954.pdf
"Department of Neurosurgery, Eulji University, Eulji Hospital, 14 Hangeulbiseok-gil, Nowon-gu, Seoul 139-872, Korea  Tel : +82-2-970-8266,  Fax : +82-2-979-8268,  E-mail : grimi2@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 280-283, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.280 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/65/ea/jkns-55-280.PMC4130955.pdf
"Department of Neurosurgery, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan  Tel : +81-52-744-2360,  Fax : +81-52-744-2353,  E-mail : umebayad@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 284-288, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.284 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/8b/ca/jkns-55-284.PMC4130956.pdf
"Department of Neurosurgery, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea  Tel : +82-2-440-8402,  Fax : +82-2-440-8404,  E-mail : apuzzo@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 289-292, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.289 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/55/61/jkns-55-289.PMC4130957.pdf
"2, Neihu District, Taipei 11490, Taiwan  Tel : +886-2-87923311 ext.13813,  Fax : +886-2-87927034,  E-mail : qqww0139@yahoo.com.tw • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 293-295, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.293 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/1e/9e/jkns-55-293.PMC4130958.pdf
"Key Words :  Pronator teres syndrome · Pronation test · Thenar muscle atrophy · Tinel sign.Case Report • Received : August 19, 2013  • Revised : December 23, 2013  • Accepted : May 15, 2014 • Address for reprints : Ilsup Kim, M.D., Ph.D.  Department of Neurosurgery, The Catholic University of Korea, St. Vincent’s Hospital, 93-6 Jungbu-daero, Paldal-gu, Suwon 442-723, Korea  Tel : +82-31-249-7196,  Fax : +82-31-249-5208,  E-mail : nsman72@hanmail.net  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 296-299, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.296 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ca/1a/jkns-55-296.PMC4130959.pdf
"Department of Neurosurgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan  Tel : +81-4-2995-1656,  Fax : +81-4-2996-5207,  E-mail : s.takeuchi@room.ocn.ne.jp • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  (5) : 300-302, 2014http://dx.doi.org/10.3340/jkns.2014.55.5.300 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/cc/c8/jkns-55-300.PMC4130960.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 23194 - http://dx.doi.org/10.3402/fnr.v58.23194 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 23194 - http://dx.doi.org/10.3402/fnr.v58.23194",Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
"d‘FV’: Fruit and vegetables.Free school fruit and overweight Citation: Food & Nutrition Research 2014, 58: 23194 - http://dx.doi.org/10.3402/fnr.v58.23194 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 23194 - http://dx.doi.org/10.3402/fnr.v58.23194",Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
http://ec.europa.eu/agriculture/ newsroom/111_en.htm [cited 5 July 2013].,Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
http://www.fns.,Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
"*Nina C. Øverby Department of Public Health, Sport and NutritionUniversity of Agder Service box 422, NO-4604 Kristiansand, Norway Email: nina.c.overby@uia.noFree school fruit and overweight Citation: Food & Nutrition Research 2014, 58: 23194 - http://dx.doi.org/10.3402/fnr.v58.23194 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/70/33/FNR-58-23194.PMC4131001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-com mercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Pathobiology of Aging & Age-related Diseases 2014, 4: 24824 - http://dx.doi.org/10.3402/pba.v4.24824 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/83/ea/PBA-4-24824.PMC4131002.pdf
"2 (page number not for citation purpose)Citation: Pathobiology of Aging & Age-related Diseases 2014, 4: 24824 - http://dx.doi.org/10.3402/pba.v4.24824",Non-OADS,/arxiv_data1/oa_pdf/83/ea/PBA-4-24824.PMC4131002.pdf
"2014; 4(4): 378 /C184.Tumor stromal cells in old mice Citation: Pathobiology of Aging & Age-related Diseases 2014, 4: 24824 - http://dx.doi.org/10.3402/pba.v4.24824 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/83/ea/PBA-4-24824.PMC4131002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"For quantification of heterologous protein expression, 30 mg of OMVs were loaded onto 4 /C112% SDS-polyacrylamide gels along with increasing concentrations of the corre- sponding purified recombinant protein used as standard.Table I. Oligonucleotide primers used in this study Name Sequence slo-F ACCGTAGCGCAGGCCAACAAACAAAACACTGCTAGTACAG slo-R GTGATGGTGATGTTACTACTTATAAGTAATCGAACCATATGSpyCEP-F3 ACCGTAGCGCAGGCCGCAGCAGATGAGCTAAGCACAATGAGCGAACC SpyCEP-R3 GTGATGGTGATGTTATTAGGCTTTTGCTGTTGCTGAGGTCGTTGACTTGGTTGG Bla-omp-F ACCGTAGCGCAGGCCCGGTAAGATCCTTGAGATTTTTCGBla-omp-R GTGATGGTGATGTTATTACCAATGCTTAATCAGTGAGGComprev GGCCTGCGCTACGGTAGCGAAAnohisflag TAACATCACCATCACCATCACGATTACAAAGAompA-1 GATCGGTTGGTTGGCAGATompA-2 CACCAGGATTTATTTATTCTGCGTTTTTGCGCCTCGTTATCATompA-3 TACTGCGATGAGTGGCAGGCGCAGGCTTAAGTTCTCGTC ompA-4 AAAATCTTGAAAGCGGTTGG CMR-for CGCAGAATAAATAAATCCTGGTGCMR-rev CCTGCCACTCATCGCAGTASpy0269-F ACCGTAGCGCAGGCCGATGATAGAGCCTCAGGAGAAACGSpy0269-R GTGATGGTGATGTTATCACTTAGATTCCTTACGGAACCSAM_1372-F ACCGTAGCGCAGGCCGACGACGCAACAACTGATACSAM_1372-R GTGATGGTGATGTTAGGTTACTTTTTTGTTTTGAACTTGTTGGGPet-rev CATATGTATATCTCCTTCTTAAAGTTAAAC Slo-F-no GGAGATATACATATGAACAAACAAAACACTGCTAGTACAG Spycep-F-no GGAGATATACATATGGCAGCAGATGAGCTAAGCACAATGAGCGAACCSpy_0269-F-no GGAGATATACATATGGATGATAGAGCCTCAGGAGAAACGSAM_1372-F-no GGAGATATACATATGGACGACGCAACAACTGATACOMVs carrying heterologous antigens in their lumen Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"Antigens used for expression in OMVs Antigen Pathogen Functional assay Protective immune responses SpyCEP S. pyogenes IL-8 cleavage Neutralizing Ab and mouse challenge Streptolysin O S. pyogenes Haemolysis Neutralizing Ab and mouse challenge Spy0269 S. pyogenes Not available Mouse challenge SAM_1372 S. agalactiae Not available Opsonophagocytic activity R-TEM b-lac E. coli Hydrolysis of Nitrocefin Not availableOMVs carrying heterologous antigens in their lumen Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"The data indicate that all recombinant antigens are localized in the lumen of OMVs.OMVs carrying heterologous antigens in their lumen Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"Graphs represent the OD values obtained for each serum dilution.OMVs carrying heterologous antigens in their lumen Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"After 2 weeks, mice were challenged intraperitoneally with a LD 80dose of M1 3348 GAS (2 /C29106 CFUs) and survival was followed over a period of 7 days.OMVs carrying heterologous antigens in their lumen Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"Speciﬁc C-terminal cleavage and inactivationOMVs carrying heterologous antigens in their lumen Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"2013;2:20181, doi: http://dx.doi.org/10.3402/jev.v2i0.20181 28.",Non-OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24015 - http://dx.doi.org/10.3402/jev.v3.24015",OADS,/arxiv_data1/oa_pdf/4a/2e/JEV-3-24015.PMC4131003.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 499 Korean J Urol 2014;55:499-504http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .499&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.499 Review Article Current Status of Robot-Assisted Laparoscopic Surgery in Pediatric   Urology Sang Hoon Song, Kun Suk Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Laparoscopic procedures for urological diseases in children have been proven to be safe   and effective.",Non-OADS,/arxiv_data1/oa_pdf/01/04/kju-55-499.PMC4131076.pdf
"Keywords:  Minimal invasive surgery; Pediatrics; Robotics; Surgery This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 5 March, 2014 accepted 13 June, 2014 Corresponding Author: Kun Suk Kim Department of Urology, Asan Medical Center, University of  Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea TEL: +82-2-3010-3740 FAX: +82-2-477-8928E-mail: kskim2@amc.seoul.kr INTRODUCTION Minimally invasive surgery has advanced dramatically  during the past few decades.",Non-OADS,/arxiv_data1/oa_pdf/01/04/kju-55-499.PMC4131076.pdf
http://dx.doi.org/10.1111/iju.12483.,Non-OADS,/arxiv_data1/oa_pdf/01/04/kju-55-499.PMC4131076.pdf
http://dx.doi.org/10.1016/j.jpurol.2014.01.028.,OADS,/arxiv_data1/oa_pdf/01/04/kju-55-499.PMC4131076.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 505 Korean J Urol 2014;55:505-510http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .505&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.505 Original Article - Urological Oncology Associations Between Presenting Symptoms, Clinicopathological  Parameters, and Prognosis in a Contemporary Series of Patients With Renal Cell Carcinoma Sebastian L. Hofbauer1,*, Michela de Martino1,*, Christoph Seemann1, Nura Zamani1, Ilaria Lucca1,2,  Andrea Haitel3, Shahrokh F. Shariat1, Tobias Klatte1 1Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria, 2Department of Urology, Centre  Hospitalier Universitaire Vaudois, Lausanne, Switzerland, 3Clinical Institute of Pathology, Medical University of Vienna, Vienna General   Hospital, Vienna, Austria Purpose:  To evaluate the impact of presenting symptoms on survival in a contemporary   series of patients with renal cell carcinoma (RCC).",Non-OADS,/arxiv_data1/oa_pdf/90/95/kju-55-505.PMC4131077.pdf
"Keywords:  Diagnosis; Prognosis; Renal cell carcinoma; Symptoms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 February, 2014 accepted 17 June, 2014 Corresponding Author: Tobias KlatteDepartment of Urology, Medical  University of Vienna, Währinger  Gürtel 18-20, A-1090 Vienna, Austria TEL: +43-1-40400-26020 FAX: +43-1-40400-23320E-mail: tobias.klatte@gmx.de *These authors contributed  equally to this study.",Non-OADS,/arxiv_data1/oa_pdf/90/95/kju-55-505.PMC4131077.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 511 Korean J Urol 2014;55:511-514http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .511&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.511 Original Article - Laparoscopy/Robotics Should We Place Ureteral Stents in Retroperitoneal Laparoscopic   Ureterolithotomy?",Non-OADS,/arxiv_data1/oa_pdf/f2/b7/kju-55-511.PMC4131078.pdf
"Keywords:  Laparoscopy; Ureteral ca lculi; Ureteral catheter This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 5 March, 2014 accepted 21 May, 2014 Corresponding Author: Myung Ki Kim Department of Urology, Chonbuk National University Hospital,  Chonbuk National University  Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju 561-712,  Korea TEL: +82-63-250-2574FAX: +82-63-250-1564 E-mail: mkkim@jbnu.ac.kr INTRODUCTION Retroperitoneal laparoscopic ureterolithotomy (RLU) is  recognized as a method that can replace open ureter-olithotomy as a first-line treatment for large impacted up-per or midureteral calculi and as a salvage treatment for use when ureteroscopic removal of stone (URS) or ex-tracorporal shock wave lithotri psy (ESWL) has failed [1-3].",Non-OADS,/arxiv_data1/oa_pdf/f2/b7/kju-55-511.PMC4131078.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 515 Korean J Urol 2014;55:515-519http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .515&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.515 Original Article - Endourology/Urolithiasis Multimodal Treatments of Cystine Stones: An Observational,  Retrospective Single-Center Analysis of 14 Cases Myungsun Shim, Hyung Keun Park Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To document the experiences of a single  institution in evaluating the clinical  courses and treatment outcomes of patients with cystine stones.",Non-OADS,/arxiv_data1/oa_pdf/ce/5a/kju-55-515.PMC4131079.pdf
"Keywords:  Calculi; Cystinuria; Nephrolithiasis; Urolithiasis This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 March, 2014 accepted 7 May, 2014 Corresponding Author: Hyung Keun Park Department of Urology, Asan  Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu,  Seoul 138-736, Korea TEL: +82-2-3010-3737FAX: +82-2-477-8928 E-mail: hkpark@amc.seoul.kr INTRODUCTION Cystinuria is an autosomal recessive genetic disorder that  leads to defects in the transe pithelial transporters for the  dibasic amino acids, including cystine, ornithine, lysine,  and arginine [1].",Non-OADS,/arxiv_data1/oa_pdf/ce/5a/kju-55-515.PMC4131079.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 520 Korean J Urol 2014;55:520-526http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .520&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.520 Original Article - Voiding Dysfunction/Female Urology Impact of Transobturator Tape Treatment on Overactive Bladder   Symptoms, Particularly Nocturia, in Patients With Mixed Urinary   Incontinence Sang Keun Lee, Ho Won Kang, Won Tae Kim, Yong-June Kim, Seok Joong Yun, Sang-Cheol Lee,  Wun-Jae Kim Department of Urology, Chungbuk National University Hospital, Cheongju, Korea Purpose:  We assessed the impact of transobturator tape (TOT) treatment on overactive  bladder (OAB) symptoms with a particular focus on nocturia in patients with mixed  urinary incontinence (MUI).Materials and Methods:  In this retrospective cohort st udy, the medical records of 237  women who underwent TOT surgery for the treatment of MUI were reviewed.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/kju-55-520.PMC4131080.pdf
"Keywords:  Nocturia; Questionnaires; Transobturat or tape; Stress urinary incontinence This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 9 April, 2014 accepted 5 June, 2014 Corresponding Author: Seok Joong Yun Department of Urology, Chungbuk National University  College of Medicine and Institute  for Tumor Research, 410 Sunbong-ro, Heungdeok-gu,  Cheongju 361-763, Korea TEL: +82-43-269-6371FAX: +82-43-269-6144 E-mail: sjyun@chungbuk.ac.kr INTRODUCTION Nocturia and urinary incontin ence (UI) are common both- ersome symptoms that are well  known to affect health-re- lated quality of life (HRQoL) [1 -3].",Non-OADS,/arxiv_data1/oa_pdf/98/0f/kju-55-520.PMC4131080.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 527 Korean J Urol 2014;55:527-532http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .527&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.527 Original Article - Infection/Inflammation Effect of Histological Inflammation on Total and Free Serum  Prostate-Specific Antigen Values in Patients Without Clinically Detectable Prostate Cancer Goran Stimac, Borislav Spajic, Ante Reljic, Josip Katusic, Alek Popovic, Igor Grubisic, Davor Tomas1 Clinical Department of Urology, 1""Ljudevit Jurak"" Department of Pathology, ""Sestr e milosrdnice"" University Hospital Center, Zagreb,  Croatia Purpose:  We are often confronted with patients in the “gray zone” (p rostate-specific an- tigen [PSA] ＜10 ng/mL) whose biopsies reveal no malignancy but only inflammation.",Non-OADS,/arxiv_data1/oa_pdf/c5/fc/kju-55-527.PMC4131081.pdf
"Keywords:  Biopsy; Inflammation; Prostate-sp ecific antigen; Prostatic neoplasms;   Prostatitis  This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 17 March, 2014 accepted 28 April, 2014 Corresponding Author: Goran Stimac Clinical Department of Urology,  ""Sestre milosrdnice"" University Hospital Center, Vinogradska  cesta 29, 10000, Zagreb, Croatia TEL: +385 91 5061548FAX: +385 1 3768305 E-mail: goran.stimac2@ zg.t-com.hr INTRODUCTION Prostate-specific antigen (PSA) is the most widely used  marker for the early detection of prostate cancer (PC) [1].",Non-OADS,/arxiv_data1/oa_pdf/c5/fc/kju-55-527.PMC4131081.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 533 Korean J Urol 2014;55:533-535http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .533&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.533 Original Article - Pediatric Urology Adolescent Varicocele: Are Somatometric Parameters a Cause?",Non-OADS,/arxiv_data1/oa_pdf/8d/63/kju-55-533.PMC4131082.pdf
"Keywords:  Body height; Body mass index; Varicocele This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 2 September, 2013 accepted 6 May, 2014 Corresponding Author: Jae Shin Park Department of Urology, Daegu  Catholic University Medical Center, 33 Duryugongwon-ro  17-gil, Nam-gu, Daegu 705-718,  KoreaTEL: +82-53-650-4662 FAX: +82-53-623-4660 E-mail: jspark@cu.ac.kr INTRODUCTION Varicocele is an abnormal tortuous dilatation of the pampi- niform plexus in the scrotal po rtion of spermatic veins that  drains blood from the testis.",Non-OADS,/arxiv_data1/oa_pdf/8d/63/kju-55-533.PMC4131082.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 536 Korean J Urol 2014;55:536-541http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .536&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.536 Original Article - Pediatric Urology Are Clinical, Laboratory, and Imaging Markers Suitable Predictors   of Vesicoureteral Reflux in Children With Their First Febrile  Urinary Tract Infection?",Non-OADS,/arxiv_data1/oa_pdf/94/3c/kju-55-536.PMC4131083.pdf
"Keywords:  99mTc-Dimercaptosuccinic acid scan; Se dimentation rate; Urinary tract   infections; Vesicoureteral reflux This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 March, 2014 accepted 20 June, 2014 Corresponding Author: Abolfazl Mahyar  Department of Pediatrics, Qazvin  Children Hospital, Qazvin University of Medical Sciences,  Qazvin, Iran  TEL: +982813334807FAX: +982813344088 E-mail: Abolfazl473@yahoo.com INTRODUCTION  Urinary tract infection (UTI) is a common disease in chil- dren [1].",Non-OADS,/arxiv_data1/oa_pdf/94/3c/kju-55-536.PMC4131083.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 542 Korean J Urol 2014;55:542-550http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .542&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.542 Original Article - Basic and Translational Research Altered Gene Expression Profile After Exposure to Transforming  Growth Factor 1 in the 253J Human Bladder Cancer Cell Line Changho Lee1,2, Sang-Han Lee3, Doo Sang Kim1, Yun Soo Jeon1, Nam Kyu Lee1, Sang Eun Lee4 1Department of Urology, Soonchunhyang University Cheonan Hospital, Cheonan, 2Department of Urology, Seoul National University  College of Medicine, Seoul, 3Department of Biochemistry, Soonchunhyang University College of Medicine, Cheonan, 4Department of  Urology, Seoul National University Bundang Hospital, Seongnam, Korea Purpose:  Transforming growth factor 1 (TGF-1) inhibits the growth of bladder cancer   cells and this effect is prominent and co nstant in 253J bladder cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/78/8b/kju-55-542.PMC4131084.pdf
"Keywords:  Cell line; Gene expression; Microarray analysis; Transforming growth factor   beta; Urinary bladder neoplasms This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 March, 2014 accepted 9 May, 2014 Corresponding Author: Sang Eun Lee Department of Urology, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil,  Bundang-gu, Seongnam 463-707, Korea TEL: +82-31-787-7341 FAX: +82-31-787-4057E-mail: selee@snubh.org /  urology@snu.ac.kr INTRODUCTION Transforming growth factor  (TGF-) is a member of a fam- ily of dimeric polypeptide growth factors that includes bone morphogenic proteins and activins [1].",Non-OADS,/arxiv_data1/oa_pdf/78/8b/kju-55-542.PMC4131084.pdf
Functional annotation of ge nes was performed according  to the Gene Ontology Consortium (http://www.geneontolo-gy.org/index.shtml) by use of GeneSpring 7.1.,OADS,/arxiv_data1/oa_pdf/78/8b/kju-55-542.PMC4131084.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 551 Korean J Urol 2014;55:551-553http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .551&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.551 Images in Urology Adrenal Cortical Scintigraphy for Lateralization of Bilateral  Adrenal Nodules in Primary Aldosteronism Insang Hwang, Ari Chong1, Jong Beom Kim, Kwang Ho Kim, Dongdeuk Kwon Department of Urology, Chonnam National University Hospital, Gwangju, 1Department of Nuclear Medicine, Chosun University Hospital,   Gwangju, Korea Corresponding Author: Dongdeuk Kwon Department of Urology, Chonnam National Univ ersity Hospital, Chonnam National University  Medical School, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6700 FAX: +82-62-227-1643 E-mail: urokwon@gmail.comArticle History: received 2 September, 2013 accepted 18 October, 2013 This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/23/kju-55-551.PMC4131085.pdf
"Korean Journal of Urology ⒸThe Korean Urological Association, 2014 554 Korean J Urol 2014;55:554-556http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.8 .554&domain=pdf&date_stamp=2014-08-16www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.8.554 Case Report Management of an Iatrogenic Injury in a Crossed Ectopic Kidney   Without Fusion Tarun Jindal, Mir Reza Kamal, Satyadip Mukherjee, Soumendra Nath Mandal, Dilip Karmakar Department of Urology, Calcutta National Medical College, Kolkata, India Crossed renal ectopia is a condition in which a kidney is located on the side opposite  of its ureteral insertion.",Non-OADS,/arxiv_data1/oa_pdf/53/40/kju-55-554.PMC4131086.pdf
"Keywords:  Acute renal injury; Cong enital abnormalities; Urogenital abnormalities This is an Open Access article distributed under the te rms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 May, 2012 accepted 11 October, 2012 Corresponding Author: Tarun Jindal Department of Urology, Calcutta  National Medical College, 92-B, First Floor, Jhowtala Road,  Kolkata-700017, India TEL: +91-9674444929FAX: +91-9674444929, E-mail: drtarunjindal@gmail.com INTRODUCTION Crossed renal ectopia without fusion is a rare condition.",Non-OADS,/arxiv_data1/oa_pdf/53/40/kju-55-554.PMC4131086.pdf
Source: http://www.omim.org.,Non-OADS,/arxiv_data1/oa_pdf/29/32/gim201411a.PMC4131122.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim ACKNOWLEDGMENTS The authors thank the Loeys–Dietz Syndrome Foundation for its financial sponsorship of these management tools and Stephen Zeiler for reviewing the neurovascular review.,Non-OADS,/arxiv_data1/oa_pdf/29/32/gim201411a.PMC4131122.pdf
"University of  Washington: Seattle, WA, 1993. http://www.ncbi.nlm.nih.gov/books/NBK1133/ (accessed January 7th, 2013).",Non-OADS,/arxiv_data1/oa_pdf/29/32/gim201411a.PMC4131122.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-nd/3.0/ GENETICS in MEDICINE  |   Volume 16  |  Number 8  |  August 2014",Non-OADS,/arxiv_data1/oa_pdf/29/32/gim201411a.PMC4131122.pdf
"Methods The Cancer Genome Atlas dataset In this study, we evaluated TCGA breast cancer dataset and all data were obtained from the TCG A breast cancer online portal (https://tcga-data.nci.nih.gov/docs/publications/brca_2012/ ).",OADS,/arxiv_data1/oa_pdf/b2/72/10549_2014_Article_3056.PMC4131128.pdf
"[16], (i.e., basal one, basal two, immunomodulatory, luminal androgen receptor, mesenchymal, mesenchymalstem cell, and unstable), we submitted the raw gene expression data of each individual dataset of basal-like disease to the TNBC type online predictor ( http://cbc.mc.",OADS,/arxiv_data1/oa_pdf/b2/72/10549_2014_Article_3056.PMC4131128.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)SAG-UPS regulates macrophage death or survival SC Chang and JL Ding 1398 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/5c/d4/cdd201454a.PMC4131172.pdf
Microarray data were analyzed with R (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/92/f5/cdd201469a.PMC4131181.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Sp1 is a key determinant of p53-mediated apoptosis HL i et al 1502 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/92/f5/cdd201469a.PMC4131181.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Cell Death and Differentiation (2014) 21, 1503 &2014 Macmillan Publishers Limited All rights reserved 1350-9047/14 www.nature.com/cdd",Non-OADS,/arxiv_data1/oa_pdf/af/dc/cdd201491a.PMC4131185.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/1f/srep06046.PMC4131213.pdf
Available at: ‘‘http://www.meti.go.jp/english/earthquake/nuclear/ roadmap/pdf/20130807_01.pdf’’ and ‘‘http://www.meti.go.jp/earthquake/nuclear/pdf/131009/131009_02a.pdf’’ (in Japanese) (updated on October 11 2013).,Non-OADS,/arxiv_data1/oa_pdf/6b/54/srep06053.PMC4131215.pdf
Available at: ‘‘http://www.jaea.go.jp/fukushima/decon04/ english/3-1%20Decontamination_Technology_Demonstration_Test_Project.,Non-OADS,/arxiv_data1/oa_pdf/6b/54/srep06053.PMC4131215.pdf
pdf’’ and ‘‘http://fukushima.jaea.go.jp/pdf/techdemo_report.pdf’’ (in Japanese) (updated on October 23 2012).,Non-OADS,/arxiv_data1/oa_pdf/6b/54/srep06053.PMC4131215.pdf
Available at: ‘‘http://fukushima.jaea.go.jp/initiatives/cat01/pdf07/130627.pdf’’ (inJapanese).,Non-OADS,/arxiv_data1/oa_pdf/6b/54/srep06053.PMC4131215.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6b/54/srep06053.PMC4131215.pdf
"Several samples from South Africa, suchas amaXhosa, showed mixed ancestry between Click Speaker and theNiger-Congo components, consistent with linguistic evidence thatisiXhosa is a language in the Niger-Congo family with ,15% Khoekhoe vocabulary [http://www.ethnologue.com/language/xho].The Niger-Congo and Nilo-Saharan ancestral components diverged917 generations or ,28,000 years ago (Fig.",Non-OADS,/arxiv_data1/oa_pdf/eb/55/srep06055.PMC4131216.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/55/srep06055.PMC4131216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6055 | DOI: 10.1038/srep06055 9",Non-OADS,/arxiv_data1/oa_pdf/eb/55/srep06055.PMC4131216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6047 | DOI: 10.1038/srep06047 8",Non-OADS,/arxiv_data1/oa_pdf/6e/b9/srep06047.PMC4131218.pdf
The test data are 30 laser scanning microscope images of the Drosophila and downloadedfrom http://penglab.janelia.org/proj/brainaligner/BrainAligner/Download.html.,OADS,/arxiv_data1/oa_pdf/0a/1e/srep06050.PMC4131219.pdf
"The test images are 30 serial ssTEM sections of the Drosophila first instar larva ventral nerve cord (VNC) anddownloaded from http://www.ini.uzh.ch/ ,acardona/data.html.",Non-OADS,/arxiv_data1/oa_pdf/0a/1e/srep06050.PMC4131219.pdf
http://www.mathworks.com/ matlabcentral/fileexchange/28300-opensurf-including-image-warp (2010) Date of access:01/08/2012.,Non-OADS,/arxiv_data1/oa_pdf/0a/1e/srep06050.PMC4131219.pdf
"U.S. National Institutes of Health , http://imagej.nih.gov/ij/ (1997–2012) Date of access:1/8/2012.",Non-OADS,/arxiv_data1/oa_pdf/0a/1e/srep06050.PMC4131219.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6050 | DOI: 10.1038/srep06050 12",Non-OADS,/arxiv_data1/oa_pdf/0a/1e/srep06050.PMC4131219.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/f6/srep06044.PMC4131220.pdf
"Integrated Genomic Viewer (IGV; http://www.broadinstitute.org/igv) wasthen used to eliminate false positives, which included distortions due to reads mapping outside the normal transcription area, a high abundance of non-unique reads, and projected non-protein codingRNA sequences.",OADS,/arxiv_data1/oa_pdf/4a/d1/srep06048.PMC4131221.pdf
Visualization of the mapped reads was accomplished using the Integrative Genomic Viewer (http://www.broadinstitute.org/igv).,OADS,/arxiv_data1/oa_pdf/4a/d1/srep06048.PMC4131221.pdf
Raw data files and processed expression files are available online in the Gene Expression Omnibus at http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/4a/d1/srep06048.PMC4131221.pdf
CRISPR knockouts .Candidate target sequences for CRISPR were designed using ZiFiT Targeter Version 4.2 (http://zifit.partners.org/ZiFiT/).,OADS,/arxiv_data1/oa_pdf/4a/d1/srep06048.PMC4131221.pdf
TALEN assembly and generation of KO cells .Candidate DckTALENs were designed using TALE-NT (https://boglab.plp.iastate.edu/node/add/talen).,OADS,/arxiv_data1/oa_pdf/4a/d1/srep06048.PMC4131221.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: Yes there is potential Competing Interest.,Non-OADS,/arxiv_data1/oa_pdf/4a/d1/srep06048.PMC4131221.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6049 | DOI: 10.1038/srep06049 8",Non-OADS,/arxiv_data1/oa_pdf/27/7b/srep06049.PMC4131222.pdf
Version 2.75 http://mesquiteproject.org (2011).,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/srep06042.PMC4131224.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a3/f7/srep06042.PMC4131224.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6045 | DOI: 10.1038/srep06045 10",Non-OADS,/arxiv_data1/oa_pdf/39/a9/srep06045.PMC4131225.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)5-Azacytidine sensitizers and response predictor JM Bogenberger et al 1665 &2014 Macmillan Publishers Limited Leukemia (2014) 1657 – 1665",Non-OADS,/arxiv_data1/oa_pdf/bc/96/leu201444a.PMC4131248.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)MGCD0103 inhibits autophagy in primary CLL cells V El-Khoury et al 1646 Leukemia (2014) 1636 – 1646 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3e/79/leu201419a.PMC4131250.pdf
LITERATURE SEARCH A systematic computer‑assisted search was performed  concerning the prevalence of H. pylori  and its resistance  toward different antibiotics in Saudi Arabia in comparison  to the global scenario using PubMed (http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/0f/58/SJG-20-212.PMC4131303.pdf
Available from: http://www.saudiembassy.net/about/ country‑information/.,Non-OADS,/arxiv_data1/oa_pdf/0f/58/SJG-20-212.PMC4131303.pdf
Available from: http://www.Enotes.Com/topics/ illness‑sick‑role‑behavior [Last accessed in 2013 Dec 27].,Non-OADS,/arxiv_data1/oa_pdf/39/61/SJG-20-233.PMC4131306.pdf
Available from: http://www.cms.gov/.,Non-OADS,/arxiv_data1/oa_pdf/8a/d1/IJO-62-748.PMC4131341.pdf
Available from: http://www.orbitz.com.,Non-OADS,/arxiv_data1/oa_pdf/8a/d1/IJO-62-748.PMC4131341.pdf
Available from: http://www.cms.gov/.,Non-OADS,/arxiv_data1/oa_pdf/13/98/IJO-62-749.PMC4131342.pdf
Available from: http://www.orbitz.com.,Non-OADS,/arxiv_data1/oa_pdf/13/98/IJO-62-749.PMC4131342.pdf
Available from: http://www.planningcommission.nic.in/reports/genrep/rep_uhc0812.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/7f/IJPI-4-109.PMC4131381.pdf
Available from: http://www.un.org/ millenniumgoals/pdf/MDG_Report_2009_ENG.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/7f/IJPI-4-109.PMC4131381.pdf
"Available  from: http://www.oecd.org/document/25/0,2340, en_2649_37407_34967193_1_1_1_37407,00.htm.",Non-OADS,/arxiv_data1/oa_pdf/9d/7f/IJPI-4-109.PMC4131381.pdf
Available from:  http://www.pwc.com/en_GX/gx/healthcare/pdf/emerging-market-report-hc-in-india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9d/7f/IJPI-4-109.PMC4131381.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/95/c0/IJPI-4-112.PMC4131382.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/6a/fd/WJNM-12-51.PMC4131387.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/6a/fd/WJNM-12-51.PMC4131387.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ac/8a/WJNM-12-52.PMC4131388.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/31/29/WJNM-12-76.PMC4131396.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/0f/f1/WJNM-12-79.PMC4131397.pdf
Available  from:  http://www.wipo.int/pctdb/en/wo.jsp.,OADS,/arxiv_data1/oa_pdf/0d/a0/JAPTR-5-140.PMC4131405.pdf
"Original Article Biomol  Ther 22(4), 314-320 (2014) *Corresponding Author E-mail: kiwan@chungbuk.ac.kr Tel: +82-43-261-2827, Fax: +82-43-261-2827Received  Apr 21, 2014  Revised  May 22, 2014  Accepted  Jun 13, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.045 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/7f/bt-22-314.PMC4131518.pdf
"316Biomol  Ther  22(4), 314-320 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.045Primary cell culture Primary cultures of hypothalamus were prepared from of  8 days old Sprague-Dawley rats as previously described (Ma et al., 2007).",Non-OADS,/arxiv_data1/oa_pdf/aa/7f/bt-22-314.PMC4131518.pdf
"318Biomol  Ther  22(4), 314-320 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.045ing behaviors through the synthesis of GABA, 8 days primary  cultured neuronal cells were treated with broader range of PA concentration (5 and 50 μM, respectively) for 1 h and they  were sacri ﬁ ced to examine the effects of these drugs on the  abundance of GAD 65/67 in the hypothalamus.",Non-OADS,/arxiv_data1/oa_pdf/aa/7f/bt-22-314.PMC4131518.pdf
"320Biomol  Ther  22(4), 314-320 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.045Chen, F. P., Jong, M. S., Chen, Y. C., Kung, Y. Y., Chen, T. J., Chen, F.  J. and Hwang, S. J.",OADS,/arxiv_data1/oa_pdf/aa/7f/bt-22-314.PMC4131518.pdf
"Using transgenic technology, extra DNA that encodes Invited Review Biomol  Ther 22(4), 267-274 (2014) *Corresponding Author E-mail: ho25lee@ncc.re.kr Tel: +82-31-920-2265, Fax: +82-31-920-2279Received  Jun 17, 2014  Revised  Jul 14, 2014  Accepted  Jul 15, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.074 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/38/bt-22-267.PMC4131519.pdf
"268Biomol  Ther  22(4), 267-274 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.074the gene of interest can be integrated into the mouse genome;  using knockout or knock-in technology, speci ﬁ c regions of the  mouse genome can be selectively deleted or modi ﬁ ed.",Non-OADS,/arxiv_data1/oa_pdf/45/38/bt-22-267.PMC4131519.pdf
"270Biomol  Ther  22(4), 267-274 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.074cus in ES cells, the RMCE approach readily enables the gen- eration of targeted ES cell clones and transgenic mice.",Non-OADS,/arxiv_data1/oa_pdf/45/38/bt-22-267.PMC4131519.pdf
"272Biomol  Ther  22(4), 267-274 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.074generate RNAi transgenic mice.",Non-OADS,/arxiv_data1/oa_pdf/45/38/bt-22-267.PMC4131519.pdf
"274Biomol  Ther  22(4), 267-274 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.074T., Rode, A., Heimann, C., Faust, N. and Kauselmann, G. (2003)  Rapid generation of inducible mouse mutants.",OADS,/arxiv_data1/oa_pdf/45/38/bt-22-267.PMC4131519.pdf
"MPP+, the active neurotoxic  metabolite converted from MPTP by monoamine oxidase-B in Original Article Biomol  Ther 22(4), 275-281 (2014) *Corresponding Author E-mail: hoyang@kist.re.kr Tel: +82-33-650-3501, Fax: +82-33-650-3529Received  Jun 5, 2014  Revised  Jun 30, 2014  Accepted  Jul 4, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.068 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/bt-22-275.PMC4131520.pdf
"276Biomol  Ther  22(4), 275-281 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.068astrocytes, is the proximal neurotoxin destroying the nigros- triatal pathway in animals.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/bt-22-275.PMC4131520.pdf
"278Biomol  Ther  22(4), 275-281 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.068TP53INP2/DOR and GATE16 showed tendency to increase  with CA treatment (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2e/de/bt-22-275.PMC4131520.pdf
"280Biomol  Ther  22(4), 275-281 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.068Currently in clinics, Levo-dopa is used for PD patients to  increase dopamine concentration in the brain and other neu-rodegenerative diseases (Chen et al., 2003; Bollimuntha et  al., 2005; Bae et al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/2e/de/bt-22-275.PMC4131520.pdf
"These effects may help to delay the aging process in the skin (Robinson et al., 2005; Abu Samah and  Heard, 2011).Original Article Copyright  © 2014 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: yhshin@ks.ac.kr (Shin YH), dhna@knu.ac.kr (Na DH) Tel: +82-51-663-4886 (Shin YH), +82-53-950-8579 (Na DH)Fax: +82-51-663-4809 (Shin YH), +82-53-950-8557 (Na DH)Received  May 9, 2014  Revised  Jun 17, 2014  Accepted  Jun 19, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.053 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/99/bt-22-321.PMC4131521.pdf
"322 http://dx.doi.org/ 10.4062/biomolther.2014.053Biomol  Ther  22(4), 321-327 (2014) Although several studies have reported the clinical ad- vantages of KTTKS and its derivatives, there are few in vitro   studies supporting dermal delivery of KTTKS and pal-KTTKS (Pouillot et al., 2008; Gorouhi and Maibach, 2009; Abu Samah  and Heard, 2011).",Non-OADS,/arxiv_data1/oa_pdf/bb/99/bt-22-321.PMC4131521.pdf
"324 http://dx.doi.org/ 10.4062/biomolther.2014.053Biomol  Ther  22(4), 321-327 (2014) 120 min at 37oC.",Non-OADS,/arxiv_data1/oa_pdf/bb/99/bt-22-321.PMC4131521.pdf
"326 http://dx.doi.org/ 10.4062/biomolther.2014.053Biomol  Ther  22(4), 321-327 (2014) permeability of pal-KTTKS.",OADS,/arxiv_data1/oa_pdf/bb/99/bt-22-321.PMC4131521.pdf
"The CB1 receptor is predominately ex-Original Article Biomol  Ther 22(4), 363-369 (2014) *Corresponding Author E-mail: hosa33@korea.kr Tel: +82-43-719-5253, Fax: +82-43-719-5200Received  Apr 1, 2014  Revised  May 13, 2014  Accepted  Jun 2, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.039 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/5a/bt-22-363.PMC4131522.pdf
"364Biomol  Ther  22(4), 363-369 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.039pressed in the central nervous system, particularly in areas  such as the hippocampus, basal ganglia, cortex, amygdala, and cerebellum (Mackie, 2005).",Non-OADS,/arxiv_data1/oa_pdf/cf/5a/bt-22-363.PMC4131522.pdf
"366Biomol  Ther  22(4), 363-369 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.039The competition receptor binding assay was performed  with a similar protocol as the saturation binding assay de-scribed above.",Non-OADS,/arxiv_data1/oa_pdf/cf/5a/bt-22-363.PMC4131522.pdf
"368Biomol  Ther  22(4), 363-369 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.039alkylindoles.",Non-OADS,/arxiv_data1/oa_pdf/cf/5a/bt-22-363.PMC4131522.pdf
"Progesterone (P4) Original Article Biomol  Ther 22(4), 347-354 (2014) *Corresponding Author E-mail: yssong@sookmyung.ac.kr Tel: +82-2-2077-7231, Fax: +82-2-710-9871Received  May 7, 2014  Revised  Jun 14, 2014  Accepted  Jun 19, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.050 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/4b/bt-22-347.PMC4131523.pdf
"348Biomol  Ther  22(4), 347-354 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.050bound to the progesterone receptor (PR) is important in mam- mary gland and reproductive tract development, especially in the uterus and ovaries (Graham and Clarke, 1997; Mulac-Jer-icevic et al., 2003).",Non-OADS,/arxiv_data1/oa_pdf/aa/4b/bt-22-347.PMC4131523.pdf
"350Biomol  Ther  22(4), 347-354 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.050ed with the plasmid containing the ERE in the promoter region  of the luciferase reporter gene (pERE-Luc).",Non-OADS,/arxiv_data1/oa_pdf/aa/4b/bt-22-347.PMC4131523.pdf
"352Biomol  Ther  22(4), 347-354 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.050indicated in Fig.",Non-OADS,/arxiv_data1/oa_pdf/aa/4b/bt-22-347.PMC4131523.pdf
"354Biomol  Ther  22(4), 347-354 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.050Konno, C., Lu, Z.",OADS,/arxiv_data1/oa_pdf/aa/4b/bt-22-347.PMC4131523.pdf
"Accordingly, compounds that modu-late PPARs function are attractive for the treatment of type Original Article Biomol  Ther 22(4), 334-340 (2014) *Corresponding Author E-mail: yhk@cnu.ac.kr (YH Kim), shshim29@ynu.ac.kr (SH Shim) Tel: +82-42-821-5933, Fax: +82-42-823-6566Received  Apr 23, 2014  Revised  May 26, 2014  Accepted  Jun 2, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.047 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/79/bt-22-334.PMC4131524.pdf
"336Biomol  Ther  22(4), 334-340 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.047CA, USA) containing 10% heat-inactivated fetal bovine se- rum, 100 units/mL penicillin, and 10 μg/mL streptomycin, at  37ºC and 5% CO2.",Non-OADS,/arxiv_data1/oa_pdf/4a/79/bt-22-334.PMC4131524.pdf
"338Biomol  Ther  22(4), 334-340 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.047Statistical analysis Unless otherwise stated, all experiments were performed  with triplicate samples and repeated at least three times.",Non-OADS,/arxiv_data1/oa_pdf/4a/79/bt-22-334.PMC4131524.pdf
"340Biomol  Ther  22(4), 334-340 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.047HPLC-ELSD and principal component analysis.",OADS,/arxiv_data1/oa_pdf/4a/79/bt-22-334.PMC4131524.pdf
"Various studies also indicate that  sili binin, a major polyphenolc ﬂ avonoid in silymarin, exhibits Original Article Biomol  Ther 22(4), 282-287 (2014) *Corresponding Author E-mail: yjjeon@chosun.ac.kr Tel: +82-62-230-6338, Fax: +82-62-232-9213  †The fi  rst two authors contributed equally to this work.Received  Jun 12, 2014  Revised  Jun 19, 2014  Accepted  Jun 24, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.072 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/ca/bt-22-282.PMC4131525.pdf
"284Biomol  Ther  22(4), 282-287 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.072showed that silymarin inhibited iNOS production (Fig.",OADS,/arxiv_data1/oa_pdf/26/ca/bt-22-282.PMC4131525.pdf
"286Biomol  Ther  22(4), 282-287 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.072These results indicate that silymarin reduces the DNA-binding  activity of NF- κB, which is important in the regulation of iNOS  gene expression by CM in pancreatic beta cells.",Non-OADS,/arxiv_data1/oa_pdf/26/ca/bt-22-282.PMC4131525.pdf
"The activation of AP-1 can be mediated by sulfhydryl modi ﬁ cation of critical cysteine residues found on Original Article Biomol  Ther 22(4), 308-313 (2014) *Corresponding Author E-mail: mp89@dongguk.edu Tel: +82-31-961-5219, Fax: +82-31-961-5206Received  May 19, 2014  Accepted  May 26, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.057 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/5d/bt-22-308.PMC4131526.pdf
"310Biomol  Ther  22(4), 308-313 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.057Dual luciferase assays HaCaT cells were seeded on 70% con ﬂ uence in six-well  plate and transfected with 3 μg pGL3-AP-1- ﬁ reﬂ y luciferase  plasmid and 3 μg Renilla luciferase reporter plasmid.",Non-OADS,/arxiv_data1/oa_pdf/3d/5d/bt-22-308.PMC4131526.pdf
"312Biomol  Ther  22(4), 308-313 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.057tri-methylation at Lys9 (Lomberk et al., 2006).",Non-OADS,/arxiv_data1/oa_pdf/3d/5d/bt-22-308.PMC4131526.pdf
"Using Phos- phoMotif Finder program (http://www.hprd.org/PhosphoMo-tif_ﬁ nder), we have observed that HP1 γ at Ser93 can serve as  a potential phosphorylation site for several kinases, such as PKA, PKC and PAK2.",Non-OADS,/arxiv_data1/oa_pdf/3d/5d/bt-22-308.PMC4131526.pdf
"Original Article Biomol  Ther 22(4), 341-346 (2014) *Corresponding Author E-mail: jmsdxjianjie@163.com Tel: +86-335-8074662, Fax: +86-335-8074662Received  Dec 16, 2013  Revised  Jun 11, 2014  Accepted  Jun 16, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2013.106 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/24/bt-22-341.PMC4131527.pdf
"342Biomol  Ther  22(4), 341-346 (2014) http://dx.doi.org/ 10.4062/biomolther.2013.106MATERIALS AND METHODS Materials Paeonol was obtained from Shenyang Pharmaceutical Uni- versity (Shenyang, China).",Non-OADS,/arxiv_data1/oa_pdf/37/24/bt-22-341.PMC4131527.pdf
"344Biomol  Ther  22(4), 341-346 (2014) http://dx.doi.org/ 10.4062/biomolther.2013.106ine the expression of Bcl-2, Bax and Caspase-8.",Non-OADS,/arxiv_data1/oa_pdf/37/24/bt-22-341.PMC4131527.pdf
"346Biomol  Ther  22(4), 341-346 (2014) http://dx.doi.org/ 10.4062/biomolther.2013.106a considerable increase in caspase 8 and caspase 3 expres- sions, which indicated that paeonol promoted caspase 8 and caspase 3 activation.",OADS,/arxiv_data1/oa_pdf/37/24/bt-22-341.PMC4131527.pdf
"The seedcases of mangosteen-fruit have been traditionally used for treating skin infections and wounds Original Article Biomol  Ther 22(4), 288-294 (2014) *Corresponding Author E-mail: iyjeong@kaeri.re.kr Tel: +82-63-570-3150, Fax: +82-63-570-3159 †The fi  rst two authors contributed equally to this work.Received  May 8, 2014  Revised  Jun 5, 2014  Accepted  Jun 10, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.052 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/83/bt-22-288.PMC4131528.pdf
"290Biomol  Ther  22(4), 288-294 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.052Cytotoxicity assay Cell viability was measured using an EZ-Cytox cell viability  assay kit (DAEIL lab, Seoul, Korea) according to the manufac-turer’s instruction.",OADS,/arxiv_data1/oa_pdf/5d/83/bt-22-288.PMC4131528.pdf
"292Biomol  Ther  22(4), 288-294 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.052activity was signi ﬁ cantly increased in the LPS-treated cells  when compared with the untreated cells ( p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/5d/83/bt-22-288.PMC4131528.pdf
"294Biomol  Ther  22(4), 288-294 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.052B.",Non-OADS,/arxiv_data1/oa_pdf/5d/83/bt-22-288.PMC4131528.pdf
"Thus, fully Original Article Copyright  © 2014 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: jhk im1@chonbuk.ac.kr (Kim JH), jaecho@skku.edu (Cho JY) Tel: +82-63-270-2563 (Kim JH), +82-31-290-7868 (Cho JY)Fax: +82-63-270-3780 (Kim JH), +82-31-290-7870 (Cho JY)Received  May 12, 2014  Revised  Jun 9, 2014  Accepted  Jun 10, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.055 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/16/bt-22-295.PMC4131529.pdf
"296 http://dx.doi.org/ 10.4062/biomolther.2014.055Biomol  Ther  22(4), 295-300 (2014) activated macrophages need ﬂ exible structural changes to  engulf infected materials and to digest these in intracellular compartments.",Non-OADS,/arxiv_data1/oa_pdf/7a/16/bt-22-295.PMC4131529.pdf
"298 http://dx.doi.org/ 10.4062/biomolther.2014.055Biomol  Ther  22(4), 295-300 (2014) that Cyto B was able to strongly suppress the mRNA expres- sion of in ﬂ ammatory genes in LPS-treated RAW264.7 cells  (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7a/16/bt-22-295.PMC4131529.pdf
"300 http://dx.doi.org/ 10.4062/biomolther.2014.055Biomol  Ther  22(4), 295-300 (2014) while, considering that Src is a critical enzyme linked to actin  cytoskeleton (Kim et al., 2010), a possibility that actin cyto- skeleton-controlled Src is able to modulate the phosphoryla-tion of VASP and HSP27 could be hypothesed.",Non-OADS,/arxiv_data1/oa_pdf/7a/16/bt-22-295.PMC4131529.pdf
"These in vitro  results suggested that ADSCs could be  a potential substitute for keratinocytes in cocultures with me-Original Article Biomol  Ther 22(4), 328-333 (2014) *Corresponding Author E-mail: lay5604@naver.com Tel: +82-31-961-7250, Fax: +82-31-961-7258Received  Jun 1, 2014  Revised  Jun 25, 2014  Accepted  Jun 28, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.065 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/b1/bt-22-328.PMC4131530.pdf
"330Biomol  Ther  22(4), 328-333 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.065nation in skin specimens stained with H&E suggested that the  number of melanocytes was not increased in all groups, until 3-week post-grafting.",Non-OADS,/arxiv_data1/oa_pdf/7a/b1/bt-22-328.PMC4131530.pdf
"332Biomol  Ther  22(4), 328-333 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.065accordingly determined the in vivo  effectiveness in this study.",Non-OADS,/arxiv_data1/oa_pdf/7a/b1/bt-22-328.PMC4131530.pdf
"Curcumin, called as  the Indian solid gold, which is the main component of curry Original Article Biomol  Ther 22(4), 355-362 (2014) *Corresponding Author E-mail: jeongyunkim@dankook.ac.kr Tel: +82-41-550-1255, Fax: +82-41-561-1256Received  Jun 23, 2014  Revised  Jun 29, 2014  Accepted  Jul 2, 2014 Published online  Jul 31, 2014http://dx.doi.org/10.4062/biomolther.2014.078 Copyright  © 2014 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/44/bt-22-355.PMC4131531.pdf
"356Biomol  Ther  22(4), 355-362 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.078powder, is one of the natural components used to enhance  the cancer cell sensitivity to TRAIL for treating cancer cells at lower concentrations, thereby minimizing the damage to nor-mal cells.",Non-OADS,/arxiv_data1/oa_pdf/91/44/bt-22-355.PMC4131531.pdf
"358Biomol  Ther  22(4), 355-362 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.078curcumin contained medium for 24 hrs followed by 20 ng/ml  TRAIL treatment for 24 hrs.",Non-OADS,/arxiv_data1/oa_pdf/91/44/bt-22-355.PMC4131531.pdf
"360Biomol  Ther  22(4), 355-362 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.078TRAIL.",Non-OADS,/arxiv_data1/oa_pdf/91/44/bt-22-355.PMC4131531.pdf
"362Biomol  Ther  22(4), 355-362 (2014) http://dx.doi.org/ 10.4062/biomolther.2014.078Kim, J., Hegde, M. and Jayaraman, A.",OADS,/arxiv_data1/oa_pdf/91/44/bt-22-355.PMC4131531.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2014 |  84  | e51208 | Page 1 of 4Video Article Capsular Serotyping of Streptococcus pneumoniae  Using the Quellung Reaction Maha Habib1, Barbara D. Porter1, Catherine Satzke1,2 1Pneumococcal Research, Murdoch Childrens Research Institute 2Department of Microbiology & Immunology, The University of Melbourne Correspondence to: Catherine Satzke at catherine.satzke@mcri.edu.au URL: http://www.jove.com/video/51208 DOI: doi:10.3791/51208 Keywords: Immunology, Issue 84, Streptococcus pneumoniae , Quellung, serotyping, Neufeld, pneumococcus Date Published: 2/24/2014 Citation: Habib, M., Porter, B.D., Satzke, C. Capsular Serotyping of Streptococcus pneumoniae  Using the Quellung Reaction.",Non-OADS,/arxiv_data1/oa_pdf/43/80/jove-84-51208.PMC4131683.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51208/ Introduction Streptococcus pneumoniae (the pneumococcus) is responsible for the death of an estimated 800,000 children under the age of five annually, with the burden of disease falling predominantly in resource-poor countries1.",Non-OADS,/arxiv_data1/oa_pdf/43/80/jove-84-51208.PMC4131683.pdf
http://www.ssi.dk/ssidiagnostica (2013).,OADS,/arxiv_data1/oa_pdf/43/80/jove-84-51208.PMC4131683.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/56/main.PMC4131694.pdf
E-mail  address:  kevin.messacar@childrenscolorado.org  (K.  Messacar).Contents  lists  available  at  ScienceDirect IDCases jo  u  rn  al  ho  m  epag  e:  ww  w.els  evier  .c  om  /lo  cat  e/idc  r http://dx.doi.org/10.1016/j.idcr.2014.04.0012214-2509/ /C223 2014  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/56/main.PMC4131694.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/56/main.PMC4131694.pdf
"2012  West  Nile  virus  human  infections  in  the  United  States;  2012, Available  from:  http://www.cdc.gov/ncidod/dvbid/westnile/surv&controlCa- seCount12_detailed.htm  [accessed  22.5.13].",Non-OADS,/arxiv_data1/oa_pdf/ab/56/main.PMC4131694.pdf
Here we present an objective comparison of particle track - ing methods based on an open competition that we organ - ized in 2012 (see http://www.bioimag eanalysis.org/track /).,Non-OADS,/arxiv_data1/oa_pdf/a5/df/41592_2014_Article_BFnmeth2808.PMC4131736.pdf
reprints and permissions information is available online at http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/a5/df/41592_2014_Article_BFnmeth2808.PMC4131736.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a5/df/41592_2014_Article_BFnmeth2808.PMC4131736.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),whichpermits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/deu152.PMC4131739.pdf
The poplar bioenergy plantation ( http://uahost.uantwerpen.be/   popfull ) was established in April 2010 on 18.4 ha of former  agricultural land.,Non-OADS,/arxiv_data1/oa_pdf/53/bc/tpu057.PMC4131770.pdf
http://www.ipcc.ch .,Non-OADS,/arxiv_data1/oa_pdf/53/bc/tpu057.PMC4131770.pdf
Available from: http://www.dive.sc.gov.br/conteudos/zoonoses/ RoedoresAves/Hantavirose/Hantavirose_no_estado_SC.pdf   3.,OADS,/arxiv_data1/oa_pdf/cc/6c/0036-4665-rimtsp-56-04-277.PMC4131810.pdf
Available from: http://www.R-project.org/  25.,Non-OADS,/arxiv_data1/oa_pdf/44/29/0036-4665-rimtsp-56-04-281.PMC4131811.pdf
HIV-1 envelope subtyping was performed by manual phylogenetic  analysis using the 2008 Alamos reference dataset (available at   http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html).,OADS,/arxiv_data1/oa_pdf/ee/f3/0036-4665-rimtsp-56-04-287.PMC4131812.pdf
"The test was registered  at the site http://clinicaltrials.gov - Identifier: NCT01301924, and  approved by the Ethics Committee on Research/IPEC under the number  0055.0.0009.000-07.",Non-OADS,/arxiv_data1/oa_pdf/41/b5/0036-4665-rimtsp-56-04-291.PMC4131813.pdf
Available  from: http://www4.bcb.gov.br/pec/conversao/conversao.asp  4.,Non-OADS,/arxiv_data1/oa_pdf/41/b5/0036-4665-rimtsp-56-04-291.PMC4131813.pdf
Available from: http://saude.teresina.pi.gov.br/zoonoses  16.,Non-OADS,/arxiv_data1/oa_pdf/9c/2b/0036-4665-rimtsp-56-04-297.PMC4131814.pdf
The edition of the nucleotide sequences  was performed and analyzed by comparing them with the sequences  available in the GenBank using the BLASTn (http://blast.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/36/f5/0036-4665-rimtsp-56-04-301.PMC4131815.pdf
Available from: http://www.aids.gov.br/publicacao/2012/boletim_epidemiologico_ de_hepatites_virais_2012,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
[cited 2011 Nov 19].Available  from: http://portal.saude.gov.br/portal/arquivos/pdf/livro_cries_3ed.pdf   5.,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
Available from: http://portal.saude.,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
Available from: http://www.cdc.gov/vaccines/vpd-vac/hepb/default.,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
Available from: http://www.health.sa.gov.au/pehs/Immunisation/ hcwguidelines-pehs-sahealth-1004.pdf   20.,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
Available from: http://www.cve.saude.,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/80/5d/0036-4665-rimtsp-56-04-307.PMC4131816.pdf
Available from: [http://imedpub.com/ojs/ index.php/acmicrob/article/view/272/260]  21.,OADS,/arxiv_data1/oa_pdf/1b/f9/0036-4665-rimtsp-56-04-341.PMC4131821.pdf
Available from: [http://microbiology.mtsinai.on.ca/ research/wellwaterstudy/PSI_doc_2004.pdf]  34.,Non-OADS,/arxiv_data1/oa_pdf/1b/f9/0036-4665-rimtsp-56-04-341.PMC4131821.pdf
Available from: [http://imedpub.com/ojs/ index.php/acmicrob/article/view/256],OADS,/arxiv_data1/oa_pdf/1b/f9/0036-4665-rimtsp-56-04-341.PMC4131821.pdf
Available  from: [http://lup.lub.lu.se/luur/download?func=downloadFile&recordOId=3045564 &fileOId=3045665]  37.,Non-OADS,/arxiv_data1/oa_pdf/1b/f9/0036-4665-rimtsp-56-04-341.PMC4131821.pdf
Available from:  http://www.who.int/docstore/wer/pdf/1998/wer7335.pdf,Non-OADS,/arxiv_data1/oa_pdf/a2/9c/0036-4665-rimtsp-56-04-366.PMC4131827.pdf
Available from:  http://www.moa.gov.cn/zwllm/tzgg/tfw/201402/t20140220_3791429.htm  8.,OADS,/arxiv_data1/oa_pdf/09/3d/0036-4665-rimtsp-56-04-367.PMC4131828.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2014 |  84  | e51225 | Page 1 of 9Video Article One Mouse, Two Cultures: Isolation and Culture of Adult Neural Stem Cells from the Two Neurogenic Zones of Individual Mice Tara L. Walker1, Gerd Kempermann1,2 1Center for Regenerative Therapies Dresden, Technische Universität Dresden 2German Center for Neurodegenerative Diseases (DZNE) Dresden Correspondence to: Tara L. Walker at tara.walker@crt-dresden.de URL: http://www.jove.com/video/51225 DOI: doi:10.3791/51225 Keywords: Neuroscience, Issue 84, precursor cell, neurosphere, adherent monolayer, subventricular zone, dentate gyrus, adult mouse Date Published: 2/25/2014 Citation: Walker, T.L., Kempermann, G. One Mouse, Two Cultures: Isolation and Culture of Adult Neural Stem Cells from the Two Neurogenic Zones of Individual Mice.",Non-OADS,/arxiv_data1/oa_pdf/8b/90/jove-84-51225.PMC4131911.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51225/ Introduction The neurosphere assay1,2 and the adherent monolayer culture3,4, both developed in the early 1990s, still remain the gold standard in vitro  neural stem cell assays.",Non-OADS,/arxiv_data1/oa_pdf/8b/90/jove-84-51225.PMC4131911.pdf
Available at http://www.derm.qld.gov.au/ air/gladstone/pdf/ﬁnal-health-risk-assessment-summary.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
"Washington, DC: United States Environmental Protection Agency; 2005.Available at http://www.epa.gov/scram001/guidance/guide/appw 05.pdf .",OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.alcoa.com/australia/en/pdf/WAG_fugitive_modelling _Oct2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.alcoa.com/australia/en/pdf/WAG_AG_AQ_Summary_Report_Final .pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.epa.gov/iris/index.html .,OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.mfe.govt.nz/ publications/hazardous/contaminated-land-mgmt-guidelines-no2/ .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.health.alberta.ca/documents/ Health-Risk-Enviro-Impact-Guide-2011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://health.gov.au/internet/main/publishing.nsf/Content/804F8795BABF B1C7CA256F1900045479/File/DoHA-EHRA-120910.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.alcoa.com/australia/en/pdf/Wagerup Reﬁnery Health Risk Assessment%20 %20Final.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available athttp://www.oehha.ca.gov/air/hot spots/pdf/HRAguideﬁnal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.alcoa.com/australia/en/pdf/hra upgraded pinjarra reﬁnery.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.alcoa.,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.epa.wa.gov.au/docs/ 2028 ERMP/ERMP WorsleyAlumina A10 V1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
Available at http://www.qal.com.au/PDFs/QAL_Summary_Report .pdf.,Non-OADS,/arxiv_data1/oa_pdf/0b/a9/joem-56-s18.PMC4131934.pdf
"Sudbury, UK: Health and Safety Executive; 2002.Available at: http://www.hse.gov.uk/research/rrhtm/rr068.htm .",Non-OADS,/arxiv_data1/oa_pdf/77/35/joem-56-s40.PMC4131938.pdf
Available at http://www.cdc.gov/niosh/hhe/reports/pdfs/ 1991-0337-2466.pdf .,OADS,/arxiv_data1/oa_pdf/77/35/joem-56-s40.PMC4131938.pdf
Available at http://monographs.iarc.fr/ ENG/Monographs/vol98/index.php.,Non-OADS,/arxiv_data1/oa_pdf/98/f7/joem-56-s05.PMC4131940.pdf
Available at http://www.osha.gov/pls/oshaweb/owadisp.,Non-OADS,/arxiv_data1/oa_pdf/98/f7/joem-56-s05.PMC4131940.pdf
Available at http://www.icmm.com/ health-and-safety-indicators .,Non-OADS,/arxiv_data1/oa_pdf/98/f7/joem-56-s05.PMC4131940.pdf
Available at http://monographs.iarc.fr/ENG/Monographs/ vol100F/100F-17-Index-tables.php .,Non-OADS,/arxiv_data1/oa_pdf/98/f7/joem-56-s05.PMC4131940.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/4a/ca/nen-73-752.PMC4131941.pdf
"Immunostaining for AT180 followed the same regional patterns of immunostaining with age as for AT8in CVN-AD mice (Figure, Supplemental Digital Content 1,http://links.lww.com/NEN/A608).",Non-OADS,/arxiv_data1/oa_pdf/4a/ca/nen-73-752.PMC4131941.pdf
"mNos2 j/j control mice did not show age-dependent differences in memory and learning from 12 to 52 weeks (Figure, Supplemental Digital Content 2, http://links.lww.com/NEN/A609).",Non-OADS,/arxiv_data1/oa_pdf/4a/ca/nen-73-752.PMC4131941.pdf
"Figure,Supplemental Digital Content 3, http://links.lww.com/NEN/A610, shows Morris water maze performance data in CVN mice versus C57Bl/6J mice at 52 weeks of age.",Non-OADS,/arxiv_data1/oa_pdf/4a/ca/nen-73-752.PMC4131941.pdf
"†http://www.alz.org/alzheimers disease myths about alzheimers.asp .association with the formation of neuroﬁbrillary changes that, with conventional silver staining, seemed similar to the neuroﬁbrillarytangles present in the brains of AD sufferers, 2–4viz: “The origin of this study is rather accidental.",Non-OADS,/arxiv_data1/oa_pdf/5a/7c/joem-56-s73.PMC4131942.pdf
Available at http://www.epa.gov/acidrain/effects/surface water.html .,OADS,/arxiv_data1/oa_pdf/5a/7c/joem-56-s73.PMC4131942.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/ijn-9-3707.PMC4132217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3707–3718International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3707OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6508 6Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Ramasamy et al Running head recto: Toxicity of surface-modified Zno NPs DOI: http://dx.doi.org/10.2147/IJN.S65086 Role of surface modification in zinc oxide  nanoparticles and its toxicity assessment   toward human dermal fibroblast cells Mohankandhasamy  ramasamy1 Minakshi Das1 seong soo a an1 Dong Kee Yi2 1Division of Bionanotechnology,   gachon University, seongnam,   2Department of chemistry, Myongji  University, Y ongin, south Korea correspondence: seong soo a an Division of Bionanotechnology, gachon  University, 1342 seongnamdaero,  sugeong-gu, seongnam, gyeonggi-do 461  701; south Korea Tel +82 31 750 8981 email seongaan@gc.gachon.ac.k r Dong Kee Yi Department of chemistry, Myongji  University, 116 Myongji-ro, cheoin-gu,  Yongin, gyeonggi-do 449 728,   south Korea Tel +82 31 330 6178 email vitalis@mju.ac.k rAbstract:  The wide-scale applications of zinc oxide (ZnO) nanoparticles (NPs) in  photocatalysts,  gas sensors, and cosmetics may cause toxicity to humans and environments.",Non-OADS,/arxiv_data1/oa_pdf/4c/b3/ijn-9-3707.PMC4132217.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4c/b3/ijn-9-3707.PMC4132217.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3718ramasamy et al  36.,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/ijn-9-3707.PMC4132217.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/61/ccid-7-215.PMC4132222.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2014:7 215–224Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  215OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S6306 7a randomized, double-blind, placebo-controlled  clinical trial evaluating Dermytol® cream   for the treatment of actinic keratoses Malkanthi evans1 Douglas Kalman2 Patricia alvarez3 Maryse Paquet4 najla guthrie1 1KgK synergize Inc., london, On ,   Canada; 2Miami research associates,   south Miami, Fl, Usa; 3latin american  research, santo Domingo, Dominican  republic; 4Department of Medicine,   Western University, london, On ,   Canada Correspondence: Malkanthi evans   KgK synergize Inc., 255 Queens avenue,  london, On n6a 5r8, Canada   Tel +1 519 438 9374 ext 239   Fax +1 519 438 8314   email mevans@kgksynergize.co mPurpose:  Actinic keratosis lesions (AKs) have the potential to develop into squamous cell  carcinoma (SCC) and thus therapies to prevent SCC development from AKs are warranted.",Non-OADS,/arxiv_data1/oa_pdf/62/61/ccid-7-215.PMC4132222.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/62/61/ccid-7-215.PMC4132222.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/61/ccid-7-215.PMC4132222.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/02/ahmt-5-159.PMC4132224.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2014:5 159–170Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  159Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S3996 9Efficacy of technology-based interventions   for obesity prevention in adolescents:   a systematic review Jyu-Lin Chen1 Mary Ellen Wilkosz2 1Department of Family Health   Care Nursing, School of Nursing,    University of California,    San Francisco, CA, 2Nursing   Department, Sonoma State   University, Rohnert Park,    CA, USA Correspondence: Jyu-Lin Chen   University of California, San Francisco,   Department of Family Health Care   Nursing, 2 Koret Way, Box 0606,   San Francisco, CA 94143, USA   Tel +1 415 502 6015   Fax +1 415 753 2161   email jyu-lin.chen@nursing.ucsf.ed uAbstract:  About one third of adolescents in the USA are overweight and/or obese.",Non-OADS,/arxiv_data1/oa_pdf/37/02/ahmt-5-159.PMC4132224.pdf
Available from: http://www.pewinternet.org/ Reports/2013/Teens-and-Tech.aspx .,Non-OADS,/arxiv_data1/oa_pdf/37/02/ahmt-5-159.PMC4132224.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/37/02/ahmt-5-159.PMC4132224.pdf
Visit http://www.dovepress.com/testimonials.php to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/02/ahmt-5-159.PMC4132224.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/b1/idr-7-199.PMC4132225.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2014:7 199–201Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  199ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S6874 2comparative analysis of the infectivity rate  of both Borrelia burgdorferi  and Anaplasma  phagocytophilum  in humans and dogs in a   new Jersey community andrea gaito1 Vedrana gjivoje2 sebastian lutz1 Ben Baxter2 1Private medical practice, somerset  county, nJ, Usa;  2Bernardsville animal  hospital, somerset county, nJ, Usa correspondence: andrea gaito   211 south Finley avenue, Basking   Ridge, nJ  07920, Usa   Tel +1 908 448 8650  email adg0339@gmail.co mAbstract:  Ticks are important vectors of disease and transmit an extensive array of bacterial,   viral and protozoan diseases to both humans and dogs within a community.",Non-OADS,/arxiv_data1/oa_pdf/b4/b1/idr-7-199.PMC4132225.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/b4/b1/idr-7-199.PMC4132225.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/b1/idr-7-199.PMC4132225.pdf
"Mobile Genetic Elements 2014;  4:e34394; http://dx.doi.org/10.4161/mge.34394 Correspondence to: Maria Pilar García Guerreiro;  Email: mariapilar.garcia.guerreiro@uab.es Commentary to: Vela D, Fontdevila A, Vieira C, García Guerreiro MP .",Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
PLoS One 2014; 9:e88992; PMID:24586475 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Mol Biol Evol 2004; 21:141- 52; PMID:14595098 ; http://dx.doi.org/10.1093/ molbev/msh006,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
J Hered 1998; 89:336- 9; PMID:9703688 ; http://dx.doi.org/10.1093/ jhered/89.4.336 5.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Heredity (Edinb)  2010; 104:329-30;  PMID:20068587 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Curr Biol 2006; 16:1322-8; PMID:16824920 ;  http://dx.doi.org/10.1016/j.cub.2006.05.045 10.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Genetics  2007; 177:2507-17;  PMID:18073443 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Nature 1998; 393:68-72;  PMID:9590690 ; http://dx.doi.org/10.1038/29985 12.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Mol Gen Genet 1994; 245:661-74; PMID:7545973 ;  http://dx.doi.org/10.1007/BF00297273 13.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
PLoS Biol 2012; 10:e1001428; PMID:23189033 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
PLoS One  2014; 9:e88992;  PMID:24586475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Plant J 2005; 41:221-30;  PMID :15634199 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
PLoS Genet  2014; 10:e1004162;  PMID:24586194 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Heredity (Edinb) 2002; 89:247-52; PMID:12242639 ; http://dx.doi.org/10.1038/ sj.hdy.6800135 20.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Gene 1997; 196:83-93;  PMID:9322744 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Science 1980; 207:606- 11; PMID:6766221 ; http://dx.doi.org/10.1126/ science.6766221 23.,Non-OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Curr Biol 2006; 16:1322-8; PMID:16824920 ;  http://dx.doi.org/10.1016/j.cub.2006.05.045 24.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Cell 2007;  129:37-44;  PMID:17418784 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
J Hered 2014; 105:381-96;  PMID:24489077 ; http://dx.doi.org/10.1093/jhered/ esu003 27.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Cell 2007; 128:1089- 103; PMID:17346786 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Curr Biol 2005; 15:171-8; PMID :15668175 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
RNA  2007; 13:1911-22;  PMID:17872506 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Nat Rev Genet 2008; 9:397- 405; PMID:18368054 ; http://dx.doi.org/10.1038/ nrg2337 32.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Cell 2009; 137:522-35; PMID:19395010 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Cell 2011; 147:1551-63;  PMID:22196730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
Cytogenet Genome Res 2005; 110:49-55;  PMID:16093657 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ce/94/mge-4-e34394.PMC4132227.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/ijgm-7-393.PMC4132228.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 393–400International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  393RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S6552 8Population-based approaches to understanding  disparities in cardiovascular disease risk   in the United States Garth Graham Department of Medicine, University  of Florida, Gainesville, FL, USA Correspondence: Garth Graham   Department of Medicine, University of  Florida, PO Box 100277, Gainesville,  FL 32610-0277, USA   email Garth.Graham@medicine.ufl.ed uAbstract:  This is a comprehensive narrative review of the literature on the current science  and evidence of population-level differences in risk factors for heart disease among different  racial and ethnic population in the US.",Non-OADS,/arxiv_data1/oa_pdf/d6/fa/ijgm-7-393.PMC4132228.pdf
Available from: http://web.archive.org/web/20080822044429/http://www.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/ijgm-7-393.PMC4132228.pdf
Available from: http://kff.org/ disparities-policy/fact-sheet/racialethnic-differences-in-cardiac-care- the-weight /.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/ijgm-7-393.PMC4132228.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/d6/fa/ijgm-7-393.PMC4132228.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/ijgm-7-393.PMC4132228.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/a5/cia-9-1295.PMC4132229.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1295–1303Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1295OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6538 2Ivana Mikolasevic1 Vesna lukenda2 sanjin racki1 sandra Milic3 Branka sladoje-Martinovic1 lidija Orlic1 1Department of nephrology, Dialysis  and Transplantation, rijeka University  hospital Center, rijeka, Croatia;   2Department of Internal Medicine,   Dr Josip Bencevic general hospital,   slavonski Brod, Croatia; 3Department  of gastroenterology, rijeka University  hospital Center, rijeka, Croatia Correspondence: Ivana Mikolasevic   Department of nephrology, Dialysis and  Transplantation, rijeka University hospital  Center, Rijeka, Croatia T ome Strižića 3,  51000 rijeka, Croatia   T el +38 55 140 7156   Fax +38 55 140 7156   email ivana.mikolasevic@gmail.co m nonalcoholic fatty liver disease (nAFlD) – a  new factor that interplays between inflammation,  malnutrition, and atherosclerosis in elderly  hemodialysis patients Background/aim:  In the past decade, in most regions of the world, an increasing number of  adults aged 65 years and older were started on renal replacement therapy each year.",Non-OADS,/arxiv_data1/oa_pdf/6e/a5/cia-9-1295.PMC4132229.pdf
"However, this changed Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Mikolasevic et al Running head recto: NAFLD impacts in elderly hemodialysis patients DOI: http://dx.doi.org/10.2147/CIA.S65382",Non-OADS,/arxiv_data1/oa_pdf/6e/a5/cia-9-1295.PMC4132229.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/6e/a5/cia-9-1295.PMC4132229.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6e/a5/cia-9-1295.PMC4132229.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/e3/ndt-10-1459.PMC4132231.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1459–1468Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1459OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6309 0correspondence: Vincent Dethier;   Joël Billieux   laboratory for experimental  Psychopathology, institute  of Psychological science, Université  catholique de louvain, Place du cardinal  Mercier, 10, B-1348 louvain-la-Neuve,  Belgium   Tel +32 10 474 122   Fax +32 10 473 774   email vincent.dethier@uclouvain.b e;   joel.billieux@uclouvain.b e Probing smoking craving with a multidimensional  approach: validation of the 12-item French-language  version of the Questionnaire on smoking Urges Vincent Dethier1 alexandre heeren1,2 laurence galanti3 Pierre Philippot1 Joël Billieux1 1laboratory for experimental  Psychopathology, Psychological  science research institute, Université  catholique de louvain, louvain-la- Neuve, Belgium; 2National Fund for  scientific research, Brussels, Belgium;   3Department of clinical Biology,   Mont-godinne University hospital,   Yvoir, BelgiumBackground:  The current study examined the psychometric properties of the 12-item  French-language version of the Questionnaire on Smoking Urges (QSU-12), a widely used  multidimensional measure of cigarette craving.",Non-OADS,/arxiv_data1/oa_pdf/6e/e3/ndt-10-1459.PMC4132231.pdf
"Indeed,  some have considered the anticipation of the drug’s consequences, the intentions  to use drugs, mental images, and drug-related affects and cognitions as part of the  concept of craving.4,15–17 This latter conception highlights the multidimensional nature  of craving.Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Dethier et al Running head recto: Probing smoking craving DOI: http://dx.doi.org/10.2147/NDT.S63090",Non-OADS,/arxiv_data1/oa_pdf/6e/e3/ndt-10-1459.PMC4132231.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6e/e3/ndt-10-1459.PMC4132231.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1468Dethier et al Supplementary material Table S1 QsU-12 items Item Factor  1.,Non-OADS,/arxiv_data1/oa_pdf/6e/e3/ndt-10-1459.PMC4132231.pdf
"Nothing would be better than smoking a cigarette right now F1  2. smoking would make me less depressed F1  3. smoking a cigarette would not be pleasant* F2  4. all i want right now is a cigarette F1  5. even if it were possible, i probably would not smoke now* F2  6. i have no desire for a cigarette right now* F2  7. smoking now would make things seem just perfect F1  8. a cigarette would not taste good right now* F2  9. i have an urge for a cigarette F1 10. i could control things better if i could smoke right now F1 11. i am going to smoke as soon as possible F2 12. i would do almost anything for a cigarette right now F1 Notes:  The French translation of these items can be obtained on request by mail or on the website of the laboratory for experimental Psychopathology: http://uclep.be .",Non-OADS,/arxiv_data1/oa_pdf/6e/e3/ndt-10-1459.PMC4132231.pdf
"Administration on Aging – Department of H ealth and Human Services, 2011. http://www.aoa.",Non-OADS,/arxiv_data1/oa_pdf/d1/5b/dee-0004-0221.PMC4132234.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/18/ijwh-6-735.PMC4132253.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 735–744International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  735ExpErt OpInIO nopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/IJWH.S6316 7role of uterine forces in intrauterine device  embedment, perforation, and expulsion norman D Goldstuck1 Dirk Wildemeersch2 1Department of Obstetrics and  Gynaecology, Faculty of Medicine  and Health Sciences, Stellenbosch  University and tygerberg Hospital,   Western Cape, South Africa;   2Gynecological Outpatient Clinic and  IUD training Center , Ghent, Belgium Correspondence: norman D Goldstuck   Department of Obstetrics and  Gynaecology, Faculty of Medicine and  Health Sciences, Stellenbosch University  and tygerberg Hospital,   101 Francie van Zyl Street, Western   Cape  7505, South Africa   tel +278 2341 8200  Email nahumzh@yahoo.co mBackground:  The purpose of this study was to examine factors that could help reduce primary  perforation during insertion of a framed intrauterine device (IUD) and to determine factors  that contribute in generating enough uterine muscle force to cause embedment and secondary  perforation of an IUD.",Non-OADS,/arxiv_data1/oa_pdf/4d/18/ijwh-6-735.PMC4132253.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/4d/18/ijwh-6-735.PMC4132253.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/18/ijwh-6-735.PMC4132253.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/5c/vhrm-10-465.PMC4132254.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 465–475Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  465ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4009 7insulin degludec/insulin aspart combination   for the treatment of type  1 and type  2 diabetes Angela Dardano Cristina Bianchi Stefano Del Prato Roberto Miccoli Department of Clinical and   experimental Medicine, Section   of Diabetes and Metabolic   Diseases, University of Pisa,    Pisa, italy Correspondence: Angela Dardano   Department of Clinical and experimental   Medicine, Section of Diabetes and   Metabolic Diseases, University of Pisa,   Via Paradisa  2, 56124, Pisa, italy   Tel +39 050 995 109  Fax +39 050 541 521  email angidardano@gmail.co mAbstract:  Glycemic control remains the major therapeutic objective to prevent or delay the  onset and progression of complications related to diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/63/5c/vhrm-10-465.PMC4132254.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/63/5c/vhrm-10-465.PMC4132254.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/63/5c/vhrm-10-465.PMC4132254.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/63/5c/vhrm-10-465.PMC4132254.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/5c/vhrm-10-465.PMC4132254.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/c2/ott-7-1375.PMC4132255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1375–1387OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1375Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6292 8Potential implications of grP58 expression   and susceptibility of cervical cancer to cisplatin  and thymoquinone-based therapy Wan abd ghani Wan nor  hafiza1,2 saiful Yazan latifah1,3 1Department of Biomedical science,   Faculty of Medicine and health  sciences, Universiti Putra Malaysia,   selangor,  2college of Medical  laboratory Technology, institute  for Medical research, Ministry of  health, Jalan Pahang, Kuala lumpur,   3laboratory of Molecular Biomedicine,   institute of Bioscience, Universiti  Putra Malaysia, selangor, Malaysia correspondence: latifah saiful Yazan   college of Medical laboratory  Technology, institute for Medical  research, Ministry of health, Jalan  Pahang,  50588 Kuala lumpur, Malaysia   Tel +603 8947 2308  Fax +603 8943 6178  email latifahsy@upm.edu.m yAbstract:  A new therapeutic approach of looking at the expression of glucose-regulated  protein (GRP) 58 as an indication of cisplatin sensitivity may eradicate fruitless treatment and  side effects in patients with cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/db/c2/ott-7-1375.PMC4132255.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/db/c2/ott-7-1375.PMC4132255.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/c2/ott-7-1375.PMC4132255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/cc/vhrm-10-451.PMC4132256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 451–464Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  451ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5752 4Heart rate variability measured early in patients   with evolving acute coronary syndrome   and 1-year outcomes of rehospitalization   and mortality Patricia R e Harris1 Phyllis K stein2 gordon l Fung3 Barbara J Drew4 1electrocardiographic Monitoring  Research laboratory, school of  nursing, Department of Physiological  nursing, University of california,   san Francisco, ca, Usa; 2Heart Rate  Variability laboratory, school of  Medicine, Division of cardiology,   Washington University, st louis, MO,   Usa; 3cardiology services, Mount  Zion, Department of Medicine,   Division of cardiology, University of  california, san Francisco, ca, Usa;   4school of nursing, Department of  Physiological nursing, Division of  cardiology, University of california,   san Francisco, ca, Usa correspondence: Patricia R e Harris   University of california, san Francisco,   2 Koret Way, Box n610, san Francisco,   ca 94143-0610, Usa   Tel +1 510 260 7307   email patricia.harris@ucsf.ed uObjective:  This study sought to examine the prognostic value of heart rate variability (HRV)  measurement initiated immediately after emergency department presentation for patients with  acute coronary syndrome (ACS).",Non-OADS,/arxiv_data1/oa_pdf/1e/cc/vhrm-10-451.PMC4132256.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/1e/cc/vhrm-10-451.PMC4132256.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/cc/vhrm-10-451.PMC4132256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/5c/opth-8-1467.PMC4132257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1467–1473Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1467Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6652 8T est-retest variability of multifocal  electroretinography in normal volunteers and  short-term variability in hydroxychloroquine users David J Browning1 Chong lee2 1Charlotte eye, ear, nose and Throat  associates, 2University of north  Carolina – Charlotte, Charlotte,    nC, Usa Correspondence: David J Browning   Charlotte eye, ear, nose and Throat  associates, 6035 Fairview rd, Charlotte,  nC 28210, Usa   T el +1 704 295 3180   Fax +1 704 295 3186   email dbrowning@ceenta.co m Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Browning and Lee Running head recto: Repeatability of mfERG in hydroxychloroquine users DOI: http://dx.doi.org/10.2147/OPTH.S66528 Purpose:  To determine measurement variability of N1P1 amplitudes and the R1/R2 ratio in  normal subjects and hydroxychloroquine users without retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/21/5c/opth-8-1467.PMC4132257.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/21/5c/opth-8-1467.PMC4132257.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1473repeatability of mferg in hydroxychloroquine users  10.,Non-OADS,/arxiv_data1/oa_pdf/21/5c/opth-8-1467.PMC4132257.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/08/srep06069.PMC4132379.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6069 | DOI: 10.1038/srep06069 9",Non-OADS,/arxiv_data1/oa_pdf/ff/08/srep06069.PMC4132379.pdf
"2014;46(3):209-222 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.209  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │209 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/a8/crt-46-3-209.PMC4132442.pdf
http://dx.doi.org/10.1007/s11010-014-2028-  0.,Non-OADS,/arxiv_data1/oa_pdf/f3/a8/crt-46-3-209.PMC4132442.pdf
http://dx.doi.org/10.1038/onc.2013.571.,Non-OADS,/arxiv_data1/oa_pdf/f3/a8/crt-46-3-209.PMC4132442.pdf
"2014;46(3):270-279 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.270  Original Article Open Access  Early Postoperative Intraperitoneal Chemotherapy for Macroscopically  Serosa-Invading Gastric Cancer Patients  1Gastric Cancer Center,  Kyungpook National University  Medical Center, Daegu,  2Department of Surgery,  Kyungpook National University Hospital,  Kyungpook National University  School of Medicine, Daegu, Korea Purpose Peritoneal recurrence is one of the most common patterns of recurrence after gastric cancer  surgery and it has a poor prognosis despite all efforts.",Non-OADS,/arxiv_data1/oa_pdf/1b/2e/crt-46-3-270.PMC4132443.pdf
"Oh Kyoung Kwon, MD 1 Ho Young Chung, MD 2 Wansik Yu, MD, FACS 1 +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Wansik Yu, MD, FACS  Gastric Cancer Center, Kyungpook National  University Medical Center, 807 Hoguk-ro,  Buk-gu, Daegu 702-210, Korea  Tel: 82-53-200-2700  Fax: 82-53-200-2027  E-mail: wyu@knu.ac.kr  Received  January 27, 2013  Accepted  October 4, 2013  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │270 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/2e/crt-46-3-270.PMC4132443.pdf
"2014;46(3):243-249 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.243  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │243 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/69/crt-46-3-243.PMC4132444.pdf
"2014;46(3):261-269 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.261  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │261 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/56/crt-46-3-261.PMC4132445.pdf
"2014;46(3):280-287 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.280  Original Article Open Access  A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule  Arising during Breast Cancer Surveillance Following Curative Surgery:  Clinical Factors That Differentiate Malignant from Benign Lesions  Departments of 1Internal Medicine,  2Surgery, 3Radiation Oncology,  4Pathology, and 5Thoracic and  Cardiovascular Surgery,  Seoul National University Hospital,  Seoul National University  College of Medicine, Seoul, Korea Purpose A newly isolated mediastinal lymph node (LN) or a small pulmonary nodule, which appears  during breast cancer surveillance, may pose a diagnostic dilemma with regard to malig - nancy.",Non-OADS,/arxiv_data1/oa_pdf/2e/ce/crt-46-3-280.PMC4132446.pdf
"However, if the  size is too small to approach or the lesion is adjacent to a Tae-Yong Kim, MD 1 Kyung-Hun Lee, MD 1 Sae-Won Han, MD 1 Do-Youn Oh, MD 1 Seock-Ah Im, MD 1 Tae-You Kim, MD 1 Wonshik Han, MD 2 Kyubo Kim, MD 3 Eui Kyu Chie, MD 3 In-Ae Park, MD 4 Young Tae Kim, MD 5 Dong-Young Noh, MD 2 Sung Whan Ha, MD 3 Yung-Jue Bang, MD 1 +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Tae-Yong Kim, MD  Department of Internal Medicine,  Seoul National University Hospital,  Seoul National University College of Medicine,  103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea  Tel: 82-2-2072-4748  Fax: 82-2-762-9662  E-mail: ktyongmd@gmail.com  Received  July 22, 2013  Accepted  November 5, 2013  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │280 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/ce/crt-46-3-280.PMC4132446.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │234 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/c0/crt-46-3-234.PMC4132447.pdf
"2014;46(3):234-242 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.234  Original Article Open Access  A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein  Inhibitor, HM30181A, in Patients with Advanced Solid Cancer  Purpose The purpose of this study is to determine the maximum tolerated dose (MTD), safety,  pharmacokinetics, and recommended phase II dose of an oral drug composed of pa - clitaxel and HM30181A, which is an inhibitor of P-glycoprotein, in patients with ad - vanced cancers.",Non-OADS,/arxiv_data1/oa_pdf/95/c0/crt-46-3-234.PMC4132447.pdf
"2014;46(3):317-321 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.317  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │317 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/a1/crt-46-3-317.PMC4132448.pdf
"2014;46(3):297-306 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.297  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │297 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/bc/crt-46-3-297.PMC4132449.pdf
The PGE2 level of each sample was  obtained by plotting against the standard curve using Curve - Expert 1.4 software (http://www.curveexpert.net).,OADS,/arxiv_data1/oa_pdf/39/bc/crt-46-3-297.PMC4132449.pdf
"2014;46(3):288-296 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.288  Original Article Open Access  Impact of Hyperglycemia on Survival and Infection-Related  Adverse Events in Patients with Metastatic Colorectal Cancer  Who Were Receiving Palliative Chemotherapy  Departments of 1Internal Medicine and  2Surgery, Chungbuk National University  College of Medicine, Cheongju, Korea Purpose Non-metastatic colorectal cancer patients with diabetes have poor overall survival than  those without diabetes.",Non-OADS,/arxiv_data1/oa_pdf/2a/88/crt-46-3-288.PMC4132450.pdf
"Convincing evidence from previ - ous studies, including a large meta-analysis, suggested that  individuals with DM are at a higher risk of developing CRC Yong Joo Hong, MD 1 Hye-Suk Han, MD, PhD 1 Yusook Jeong, MD 1 Jiwon Jeong, MD 1 Sung-Nam Lim, MD 1 Hyung Jin Choi, MD 1 Hyun-Jung Jeon, MD 1 Tae-Keun Oh, MD 1 Sang-Jeon Lee, MD 2 Ki Hyeong Lee, MD 1 +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Hye-Suk Han, MD, PhD  Department of Internal Medicine, Chungbuk  National University College of Medicine,  776 1-sunhwan-ro, Heungdeok-gu, Cheongju  361-711, Korea  Tel: 82-43-269-6306  Fax: 82-43-273-3252  E-mail: sook3529@hanmail.net  Received  July 1, 2013  Accepted  October 8, 2013  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │288 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/88/crt-46-3-288.PMC4132450.pdf
"2014;46(3):312-316 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.312  Case Report Open Access  Cyclosporine A as a Primary Treatment for Panniculitis-like T Cell  Lymphoma: A Case with a Long-Term Remission  Subcutaneous panniculitis-like T cell lymphoma (SPTL) is a distinctive cutaneous  lymphoma characterized by an infiltration of subcutaneous tissue by neoplastic T  cells, similar to panniculitis.",Non-OADS,/arxiv_data1/oa_pdf/59/61/crt-46-3-312.PMC4132451.pdf
"Won Sup Lee, MD, PhD 1 Ji-Hyen Hwang, MD 1 Moon Jin Kim, MD 1 Se-Il Go, MD 1 Anna Lee, MD 1 Haa-Na Song, MD 1 Min Jeong Lee, MD 1 Myung Hee Kang, MD, PhD 1 Hoon-Gu Kim, MD, PhD 1 Jeong-Hee Lee, MD, PhD 2 Departments of 1Internal Medicine and  2Pathology, Institute of Health Sciences,  Gyeongsang National University  School of Medicine, Jinju, Korea  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │312 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/61/crt-46-3-312.PMC4132451.pdf
"2014;46(3):250-260 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.250  Original Article Open Access  A Case-Control Study to Identify Risk Factors for Totally Implantable  Central Venous Port-Related Bloodstream Infection  1Division of Medical Oncology,  Department of Internal Medicine,  2Division of Infectious Diseases,  Department of Internal Medicine,  3Department of  Radiology,  Seoul St. Mary’s Hospital,  The Catholic University of Korea  College of Medicine, Seoul, Korea Purpose To date, the risk factors for central venous port-related bloodstream infection (CVP-  BSI) in solid cancer patients have not been fully elucidated.",Non-OADS,/arxiv_data1/oa_pdf/1a/36/crt-46-3-250.PMC4132452.pdf
"Therefore, identifi - cation of risk factors of central venous port-related blood - stream infection (CVP-BSI) is important for proper Guk Jin Lee, MD 1 Sook Hee Hong, MD 1 Sang Young Roh, MD 1 Sa Rah Park, MD 1 Myung Ah Lee, MD 1 Hoo Geun Chun, MD 1 Young Seon Hong, MD 1 Jin Hyoung Kang, MD 1 Sang Il Kim, MD 2 Youn Jeong Kim, MD 2 Ho Jong Chun, MD 3 Jung Suk Oh, MD 3 +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Jin Hyoung Kang, MD  Division of Medical Oncology, Department of  Internal Medicine, Seoul St. Mary’s Hospital,  The Catholic University of Korea College of  Medicine, 222 Banpo-daero, Seocho-gu, Seoul  137-701, Korea  Tel: 82-2-2258-6043  Fax: 82-2-599-3589  E-mail: jinkang@catholic.ac.kr  Received  July 1, 2013  Accepted  September 8, 2013  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │250 Copyright ⓒ2014 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/36/crt-46-3-250.PMC4132452.pdf
"2014;46(3):307-311 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.307  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │307 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/9a/crt-46-3-307.PMC4132453.pdf
"2014;46(3):223-233 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2014.46.3.223  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │223 Copyright ⓒ2014    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/6f/crt-46-3-223.PMC4132454.pdf
Available from http://www.statistik.at/web_de/statistiken/gesundheit/krebserkrankungen/prostata/index.html 3.,OADS,/arxiv_data1/oa_pdf/7e/a2/CEJU-67-00326.PMC4132592.pdf
Available from http://www.uroweb.org/gls/ pdf/13_Male_LUTS_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/fe/CEJU-67-00344.PMC4132596.pdf
April 2007. http://eng.synovate.ru/?trID=339 15.,Non-OADS,/arxiv_data1/oa_pdf/5f/fe/CEJU-67-00344.PMC4132596.pdf
Available from http://newsroom.lilly.com/ releasedetail.cfm?releaseid=717071.,Non-OADS,/arxiv_data1/oa_pdf/5f/fe/CEJU-67-00344.PMC4132596.pdf
Revised October 2013. http://pi.lilly.com/us/cialis–pi.pdf 48.,Non-OADS,/arxiv_data1/oa_pdf/5f/fe/CEJU-67-00344.PMC4132596.pdf
1.  http://epid.coi.waw.pl/krn   2.,Non-OADS,/arxiv_data1/oa_pdf/4d/21/CEJU-67-00367.PMC4132603.pdf
Central European Journal of Urology190   http://www.who.int/reproductivehealth/ topics/infertility/definitions/en/   4.,Non-OADS,/arxiv_data1/oa_pdf/03/83/CEJU-67-E73.PMC4132605.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/c7/ehu160.PMC4132637.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/96/awu178.PMC4132649.pdf
"Large sizesynthetic DNA, a crucial component of this field is be- comingmoreaccessibleduetotheoptionofassemblingup to genome size molecules from oligonucleotides or directlypurchasing super-size synthetic DNA up to 2 Mb ( http://sgidna.com/design.php ).Asourcapacitytoproducehigh- quality synthetic DNA molecules increases, so must our know-howtointegratefunctionalityandexpressionofsuch designerDNAmoleculesacrossspeciesbarriers.Atpresent, thechallengeingrandscalegenomeengineeringeffortssuch as whole genome modification, minimization, recoding ormodularization is not re-synthesis of the genome, but in- stead the creation of a functional cell that can effectively acceptthesyntheticgenomeorgenomesegmentsof100kbor greater.",Non-OADS,/arxiv_data1/oa_pdf/c2/18/gku509.PMC4132700.pdf
"Computational analysis Data processing and statistical analysis, including com- putation of Pearson’s and Spearman’s correlation coef- ficients, χ 2-statistics and associated P-values, were per- formed using the Enthought Python Distribution ( http:// www.enthought.com ), with IPython ( 12), NumPy version 1.6.1, SciPy version 0.10.1 and matplotlib version 1.1.0 (13).RenderingoftheAPH(3/prime)IIcrystalstructure(PDBac- cession: 1ND4) was performed using PyMOL version 1.5 (Schr¨odinger,Portland,OR,USA).Therenderingofitssec- ondarystructurewasderivedfromPDBsumatEMBL-EBI (http://www.ebi.ac.uk/pdbsum/ ).",OADS,/arxiv_data1/oa_pdf/2a/b5/gku511.PMC4132701.pdf
"Next-generation sequencing and data analysis From the GEO database ( http://www.ncbi.nlm.nih.gov/ gds/) we obtained Illumina RNA-seq data for 12 indepen- dent human adult tissue samples and 6 cell lines ( 1,25).",OADS,/arxiv_data1/oa_pdf/df/68/gku532.PMC4132704.pdf
"For 454 /Roche and PacBio, the InDelFixer software (http://www.cbg.ethz.ch/software/InDelFixer/ )w a su s e dt o first extract reads and to perform quality clipping fromboth ends of the reads with a PHRED threshold of 30.",Non-OADS,/arxiv_data1/oa_pdf/9f/ef/gku537.PMC4132706.pdf
"Global haplotype reconstruction over long genomic re- gions, including genome-wide quasispecies assembly, was alsoperformedwiththePredictHaplosoftware,version1.0 (http://bmda.cs.unibas.ch/HivHaploTyper/ ).",OADS,/arxiv_data1/oa_pdf/9f/ef/gku537.PMC4132706.pdf
The links tothedatasets and theconsensus sequencesof theindividual strains are available at https://github.com/armintoepfer/5- virus-mix .,Non-OADS,/arxiv_data1/oa_pdf/9f/ef/gku537.PMC4132706.pdf
"Probe-to-gene associa- tions were made by mapping probe sequences (provided on the Affymetrix web site, http://www.affymetrix.com ) to mouse transcript sequences (as used by motif activ- ity response analysis (MARA), downloaded from UCSC Genome Bioinformatics web site as described above).",OADS,/arxiv_data1/oa_pdf/28/4d/gku544.PMC4132708.pdf
"Furthermore, we included the bind-ing sites in the 3’UTRs of mRNAs of 85 miRNA families by incorporating aggregate P CTscores as provided by Tar- getScan ( 4) (predictions downloaded on the 27th of March 2012 from the TargetScan web site, http://www.targetscan.",OADS,/arxiv_data1/oa_pdf/28/4d/gku544.PMC4132708.pdf
"Reads were aligned to thehuman reference genome using Novoalign (v.2.0.7), run with parameters ‘-k -r Random -a’ ( http://www.novocraft.",OADS,/arxiv_data1/oa_pdf/66/9a/gku590.PMC4132716.pdf
PCR duplicates were removed using Picard (v.1.72) (http://picard.sourceforge.net/ ).,OADS,/arxiv_data1/oa_pdf/66/9a/gku590.PMC4132716.pdf
Validated SV sequences were submitted to GenBank repository ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/66/9a/gku590.PMC4132716.pdf
Sanger sequenced fusion products were analyzed by the NCBI BLAST tool ( http://blast.ncbi.nlm.nih.gov ).,OADS,/arxiv_data1/oa_pdf/66/9a/gku590.PMC4132716.pdf
Fu- sion transcript sequences are deposited in GenBank repos-itory (http://www.ncbi.nlm.nih.gov/genbank/ ) under acces- sion numbers KJ452453–KJ452457.,OADS,/arxiv_data1/oa_pdf/66/9a/gku590.PMC4132716.pdf
"), http://cgap.nci.nih.gov/Chromosomes/Mitelman .",Non-OADS,/arxiv_data1/oa_pdf/66/9a/gku590.PMC4132716.pdf
"The hrpR,hrpS,hrpVgenes,hrpL promoter and arsenic responsive sensor construct arsR- P arsRwere synthesized by GENEART following the Bio- Brick standard ( http://biobricks.org ) by eliminating the four restriction sites (EcoRI, XbaI, SpeI and PstI) forthe BioBrick standard via synonymous codon exchange and flanking with prefix and suffix sequences containing the appropriate restriction sites and ribosome binding site(RBS)sequences.ThedoubleterminatorBBa B0015(http: //partsregistry.org ) was used to terminate gene transcrip- tion in all cases.",OADS,/arxiv_data1/oa_pdf/f1/b1/gku593.PMC4132719.pdf
"NucleicAcidsResearch,2014,Vol.42,No.14 9487 andcharacterizeallthegeneticconstructsinthisstudy.The GFP (Green Fluorescent Protein, gfpmut3b , BBaE0840) reporterwasfromtheRegistryofStandardBiologicalParts (http://partsregistry.org ).ThevariousRBSsequences(Sup- plementary Table S7) for each gene construct were intro- duced by polymerase chain reaction amplification (using PfuTurbo DNA polymerase from Stratagene and an Ep-pendorfMastercyclergradientthermalcycler)withprimers containing the corresponding RBS sequences and appro- priate restriction sites.",OADS,/arxiv_data1/oa_pdf/f1/b1/gku593.PMC4132719.pdf
All plasmids used are available upon request and se- lected plasmids may be obtained from the the Registry ofStandard Biological Parts( http://partsregistry.org ).,OADS,/arxiv_data1/oa_pdf/f1/b1/gku593.PMC4132719.pdf
Immunoprecipitated protein samples from HT1080 cells expressing recombinant SAF-A RDB (twobiological samples) or FLAG-tagged GFP (Control) were thenanalyzedasdescribedinSupplementarymaterial.Spe- cific proteins pulled-down by the RBD domain of SAFAin both immuno-precipitation experiments were queried in STRING ( http://string-db.org ) to retrieve known physical interactionsbetweenthemandaninteractionlandscapewasgeneratedusingCytoscape( http://www.cytoscape.org ).Ad- ditional editingwas performedwithIllustrator.,OADS,/arxiv_data1/oa_pdf/73/c7/gku601.PMC4132723.pdf
Bound genes were annotated using the DAVID database ( http://david.abcc.ncifcrf.gov/ ).,OADS,/arxiv_data1/oa_pdf/07/5b/gku609.PMC4132727.pdf
"Differently expressed genes under- went functional analysis manually and with web-based re-sources DAVID functional annotations (The Database for Annotation, Visualization and Integrated Discovery; http: //david.abcc.ncifcrf.gov/ ) and GOrilla ( http://cbl-gorilla.cs.",Non-OADS,/arxiv_data1/oa_pdf/03/95/gku611.PMC4132729.pdf
"Gene ontology analysis Functional analysis of genes with ≥50 mapped piRNAs in both the Hiwi2 IP and adult testis was carried out in Ingenuity Pathways Analysis (Ingenuity Systems), to ob- tain broad ontologies, and also independently in GOrilla(http://cbl-gorilla.cs.technion.ac.il/ ), to obtain both broad and specific ontologies.",OADS,/arxiv_data1/oa_pdf/f5/e1/gku620.PMC4132735.pdf
pledplasmamassspectrometry(ICP-MS)attheUniversity of Georgia Center for Applied Isotope Studies to ensure that the effects are due to the trap and not bystander saltions(http://www.uga.edu/cais ).Theanalysisrevealedasto- ichiometry of one K +per molecule trap and all other ions were at trace or undetectable levels.,OADS,/arxiv_data1/oa_pdf/4e/e7/gku621.PMC4132736.pdf
"(44), ChimerDB 2.0(25)(http://ercsb.ewha.ac.kr/fusiongene ),ChiTaRS( 43) (http://chitars.bioinfo.cnio.es/ ) and the PTES dataset ( 34).",OADS,/arxiv_data1/oa_pdf/9c/47/gku643.PMC4132752.pdf
The BLAT package was downloaded fromtheEnsemblGenomeBrowserat http://www.ensembl.,OADS,/arxiv_data1/oa_pdf/9c/47/gku643.PMC4132752.pdf
2008. http://emc.medicines.org.uk/  (Accessed 04/2009)  19.,Non-OADS,/arxiv_data1/oa_pdf/24/91/pharmpract-09-001.PMC4132966.pdf
"Australian Institute of  Health and Welfare, 2008.  http://www.aihw.gov.au/publications/hwl/hwl4310677 /table_1_8_occupation_by_weekly _income.xls - 2009-03-24  (Accessed 07/2009)  25.",Non-OADS,/arxiv_data1/oa_pdf/24/91/pharmpract-09-001.PMC4132966.pdf
http://www.nice.org.uk/nicemedia/pd f/DabigatranFAD.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/91/pharmpract-09-001.PMC4132966.pdf
Available from: http://www.endo-society.org/advocacy/policy/upload/BH_Pos ition_Statement_final_10_25_06_w_Header.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://owl.english.purdue.edu/owl/resource/622/01/.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://www.google.ca/search?hl=en&def l=en&q=define:bioidentical+hormones &sa=X&ei=pOAMTKWbCcGBlAfns9SVDg &ved=0CBsQkAE.,OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://www.drpettle.com/bio-identical-hormones.htm.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://en.wikipedia.org/wiki/Bioident ical_hormone_replacement_therapy.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from: http://www.more.ca/body-and-mind/ health/bioidentical-hormones-are-they-safe/a/17.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://www.westcoastwomensclinic.c om/bioidentical_therapy.html.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available  from: http://sciencebasedpharmacy.wordpress.com/ 2009/03/13/bioidentical-hormone-replacement/.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from: http://www.womentowomen.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://www.credoreference.com/entry/ehsdorland/hormone.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://www.credoreference.com/entry/ehsdorland/endogenous.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
Available from:  http://searchenginewatch.com/3634991.,Non-OADS,/arxiv_data1/oa_pdf/1c/64/pharmpract-09-016.PMC4132968.pdf
2009   http://www.who.int/healthinfo/global_burden_disease/esti mates_country/ en/index.html (accessed Sep-2010)  25.,Non-OADS,/arxiv_data1/oa_pdf/fd/eb/pharmpract-09-037.PMC4132971.pdf
(accessed Sep-2010)  http://www.who.int/healthinfo/global_burden_disease/estimates_country/ en/index.html,Non-OADS,/arxiv_data1/oa_pdf/fd/eb/pharmpract-09-037.PMC4132971.pdf
"Iowa QuickFacts from the US Census Bureau, Acce ssed at http://quickfacts.census.g ov/qfd/states/19000.html, January  25, 2011.",OADS,/arxiv_data1/oa_pdf/5c/2e/pharmpract-09-044.PMC4132972.pdf
FOCUS (2013) Website: http://focus.jrc.ec.europa.eu/dk/ .,Non-OADS,/arxiv_data1/oa_pdf/5e/fe/11356_2013_Article_1868.PMC4133017.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/e2/sar-5-087.PMC4133028.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 87–94Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  87Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S4566 6Nalmefene: a new approach to the treatment   of alcohol dependence François Paille Hervé Martini Department of Addiction Treatment,   University Hospital, vandœuvre-lès- Nancy, France Correspondence: F Paille   Service d’Addictologie, bâtiment   P Canton, CHU de Nancy-Brabois,   Allée du Morvan, F-54500 vandœuvre- lès-Nancy, France   email secretariat.pr.paille@chu-nancy.f rAbstract:  Reduction of alcohol consumption is not yet a widely accepted treatment  objective  for alcohol-dependent patients, as abstinence is often considered to be the only possible objective  in this situation.",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/sar-5-087.PMC4133028.pdf
"Available from: http://www.nice.org.uk/ nicemedia/live/13337/53191/53191.pd f. Accessed February 21, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/sar-5-087.PMC4133028.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/d0/e2/sar-5-087.PMC4133028.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/e2/sar-5-087.PMC4133028.pdf
Available from: http://www.ema.europa.eu/ema/ index.jsp?curl =pages/medicines/human/medicines/002583/human_ med_001620.jsp&mid =WC0b01ac058001d12 4.,Non-OADS,/arxiv_data1/oa_pdf/d0/e2/sar-5-087.PMC4133028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1073–1083Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1073Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S5495 1Clinical utility and patient perspectives   on the use of extended half-life rFiXFc   in the management of hemophilia B Maricel G Miguelino Jerry S Powell Division of Hematology and Oncology,   University of California Davis Medical  Center, Sacramento, CA, USAAbstract:  Hemophilia B is an X-linked genetic disease caused by mutation of the gene for  coagulation protein factor IX (FIX), with an incidence of approximately once every 30,000 male  births in all populations and ethnic groups.",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
"The incidence of hemophilia B is approximately one in 30,000 male births,  consistently seen in various geographic and ethnic populations studied.1 When untreated, patients with severe hemophilia B have a short life expectancy of  approximately 25  years, but over the past several decades, the clinical management for  hemophilia B has improved dramatically.2,3 Factor replacement therapy has reduced the  morbidity and mortality of hemophilia B through reduction in the frequency of bleeding  episodes and improvement in the quality of life.4,5 However, while individuals with Correspondence: Jerry S Powell Division of Hematology and Oncology,  Suite 3016, University of California  Davis Medical Center, 4501 X Street,  Sacramento, CA 95817, USA Tel +1 916 734 3772 Fax +1 916 734 7946 email jspowell@ucdavis.ed uJournal name: Patient Preference and Adherence Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Miguelino and Powell Running head recto: Eftrenonacog alfa (rFIXFc) for hemophilia B DOI: http://dx.doi.org/10.2147/PPA.S54951",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
"Available from http://www.nejm.org/doi/full/10.1056/NeJMoa130507 4.29 Abbreviations: FiX, factor iX; rFiXFc, recombinant factor iX fused with the  fragment, crystallizable domain of IgG; Ig, immunoglobulin; rFIX, recombinant fix.",OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
Available from: http://www.novonordisk.com/ include/asp/exe_news_attachment.asp?sAttachmentGUID=31c49463- 5e29-4262-9e4d-f8c47e96a57b.,OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
Available from: http://www.alnylam.com/web/wp-content/ uploads/2012/12/ALNY-ASH-AT3posterXpanel-Dec2012-r.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/c9/ppa-8-1073.PMC4133029.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/21/ott-7-1409.PMC4133030.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1409–1413OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1409Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6288 1Outcomes analysis of an alternative formulation  of Pegylated liposomal doxorubicin in recurrent  epithelial ovarian carcinoma during the drug  shortage era Jessica l Berger ashlee smith Kristin K Zorn Paniti sukumvanich alexander B Olawaiye Joseph Kelley Thomas c Krivak Magee-Womens hospital, University  of Pittsburgh Medical center, Division  of gynecologic Oncology, Pittsburgh,   Pa, Usa correspondence: Thomas Krivak   Western Pennsylvania hospital,   Division of gynecologic Oncology,   4800 Friendship avenue, Pittsburgh,   Pa 15224, Usa   Tel +1 412 578 1116  Fax +1 412 578 6396  email tkrivak@wpahs.or gBackground:  In response to the critical shortage of Doxil®, the US Food and Drug   Administration (FDA) allowed temporary importation of non-FDA-approved second-generation  liposomal doxorubicin, Lipo-Dox®.",Non-OADS,/arxiv_data1/oa_pdf/a8/21/ott-7-1409.PMC4133030.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a8/21/ott-7-1409.PMC4133030.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/21/ott-7-1409.PMC4133030.pdf
"Mar Pollut Bull in press ( http://dx.doi.org/ 10.1016/j.marpolbul.2013.06.005 Lessard RR, DeMarco G (2000) The significance of oil spill dispersants.",Non-OADS,/arxiv_data1/oa_pdf/f9/b5/11356_2013_Article_2053.PMC4133038.pdf
Available from:  http://apps.who.int/medicinedocs/en/d/Js4883e/5.html (last accessed 18th April 2010).,OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from: http://www.offici al-documents.gov.uk/document/cm73/7341/ 7341.pdf (last accessed 20th April  2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitala ssets/@dh/@en/documents/digitalasset/dh_083870.pdf (last  accessed 22nd April 2010).,OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from  http://www.rpsgb.org.uk/pdfs/rpsbreganalysis09.pdf (last accessed 29th April 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from: http://www.npa.co.uk/Representing-you/Media- centre/Fast-facts-on-pharmacy/ (accessed 29th April 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from: http://www.nice.org.uk/CG76 (accessed 20th  April 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from: http://www.rp sgb.org.uk/pdfs/NICEmedsadhimplementguid.pdf (accessed  29th April 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from:  http://www.pharmj.com/pdf/contract/pj_20040918 _contract.pdf (accessed 14th May 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from:  http://www.keele.ac.uk/pharmacy/npcpl us/m4m/An%20introduction%20to%20the %20Motivation%20for%20Medicines% 20adherence%20service%20ELECTRONIC%20VERSION.pdf (accessed 27th May 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from:  http://www.nhsemployers.org/Aboutus/Publications/Doc uments/Community_Pharmacy_Guide_for_GPs.pdf (last  accessed 23rd April 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
Available from:  http://www.nhsemployers.org/Aboutus/Publications/Doc uments/Guide_to_general_practice_0410.pdf (last accessed  23rd April 2010).,Non-OADS,/arxiv_data1/oa_pdf/73/ed/pharmpract-08-077.PMC4133060.pdf
http://www.aacp.or g/resources/education/Documents/CAPE2004.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/0f/pharmpract-08-103.PMC4133063.pdf
Available at http://www.fda.gov/opacom/laws/ds hea.html.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Available at:  http://www.fda.gov/FDAC/departs/1998/198_upd.html.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Available at: http://www.ncbi.nlm .nih.gov/books/bv.fcgi?rid=hstat1.chapter.88505.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Availabl e at: http://www.fda.gov/bbs/topics/NEWS/2003/NEW00875.html.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Available at:  http://www.aafp.org/afp/990301ap/1239.html.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Available a t: http://www.cdc.gov/nchs/data/ad/ad343.pdf.,OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Downloaded from http://www.sjkdt.org.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
http://www.thequestionauthority.com/papers/supersurvey_whi te_paper_response_rates.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/4b/pharmpract-08-109.PMC4133064.pdf
Geneva: World Health Or ganization; 2006 [cited 2008 2 October]; Available from:  http://www.who.int/medicines/public ations/WHO_PSM_PAR_2006.5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/44/pharmpract-08-116.PMC4133065.pdf
The New Straits Times; 2008 [cited 2009 2  Feb]; Available from:  http://www.mma.org.my/Portals/0/No%20decision%20t o%20stop%20doctors%20from% 20dispensing%20medicine.300 308.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/44/pharmpract-08-116.PMC4133065.pdf
Walgreen Health Initiatives; 2006 [cited 2008 1 September]; Available from:  https://webapp.walgreens.com/cePharmacy /viewpdf?fileName=mederrors.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/44/pharmpract-08-116.PMC4133065.pdf
Consumer Association of Penang; 2008 [cited 2008 21  December]; Available from: http://en.cap.org.my/index .php?option=com_content&task=view&id=236&Itemid=3.,Non-OADS,/arxiv_data1/oa_pdf/cc/44/pharmpract-08-116.PMC4133065.pdf
2001 Available  from: http://www.who.int/whr/2001/en/ [Accessed 21.10.09]  3.,OADS,/arxiv_data1/oa_pdf/ab/ff/pharmpract-08-122.PMC4133066.pdf
2005 Available from: http://www.eur o.who.int/Document/MNH/edoc07.pdf [Accessed 21.10.09]  5.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/pharmpract-08-122.PMC4133066.pdf
2000  Available from: http://ec.europa.eu/education/po licies/educ/bologna/bologna.pdf [Accessed 21.10.09]  37.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/pharmpract-08-122.PMC4133066.pdf
2006 Available from:  http://www.cmwf.org/publications/publicati ons_show.htm?doc_id=414116 [Accessed 21.10.09]  41.,Non-OADS,/arxiv_data1/oa_pdf/ab/ff/pharmpract-08-122.PMC4133066.pdf
Available from  <http://www.abs.gov.au/Ausstats/abs@.,Non-OADS,/arxiv_data1/oa_pdf/8b/fe/pharmpract-08-132.PMC4133067.pdf
Available from <https://www.veteransmates.net.au/VeteransMATES/docum ents/module_materials/M8_TherBrief.pdf>.,Non-OADS,/arxiv_data1/oa_pdf/8b/fe/pharmpract-08-132.PMC4133067.pdf
Cell Cycle  2014 ; 13:622- 31; PM id:24335260 ; http://dx.doi.org/10.4161/ cc.27484 Physical mechanisms behind the large scale features of chromatin organization Chromosomes in the nucleus of eukaryotic  cells are arranged in a complex three- dimensional architecture.,OADS,/arxiv_data1/oa_pdf/de/ca/nucl-5-193.PMC4133213.pdf
epigenetics  2014 ; 9:477- 82; PM id:24492483 ; http://dx.doi.org/10.4161/ epi.27869,Non-OADS,/arxiv_data1/oa_pdf/de/ca/nucl-5-193.PMC4133213.pdf
"GG-NER is initiated by the Gearing up chromatin A role for chromatin remodeling during the transcriptional restart upon DNA damage Imke K Mandemaker, Wim Vermeulen, and Jurgen A Marteijn * Department of Genetics; Erasmus Medical Centre; Rotterdam, the Netherlands Keywords:  transcription coupled  nucleotide excision repair (TC-NER),  transcription restart, chromatin  remodeling, HIRA, DOT1l, FACT,  SPT16 *Correspondence to: Jurgen A Marteijn;   Email: J.Marteijn@erasmusmc.nl Submitted: 03/29/2014; Revised: 04/28/2014;   Accepted: 04/30/2014;   Published Online: 05/08/2014  http://dx.doi.org/10.4161/nucl.29085 Extra View to: Dinant C, Ampatziadis-Michailidis  G, Lans H, Tresini M, Lagarou A, Grosbart M,  Theil AF, van Cappellen WA, Kimura H, Bartek J,  et al.",Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell 2013; 51:469-79;  PMID:23973375; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell 2012; 46:18- 29; PMID:22405652 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
EMBO Rep 2007; 8:388- 93; PMID:17363972 ; http://dx.doi.org/10.1038/ sj.embor.7400932 4.,Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cold Spring Harb  Perspect Biol 2013; 5:a012625;  PMID:23906714 ;  http://dx.doi.org/10.1101/cshperspect.a012625 5.,Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
"Nat Rev  Mol Cell Biol 2008; 9:958-70;  PMID:19023283 ;  http://dx.doi.org/10.1038/nrm2549 6. van den Boom V, Citterio E, Hoogstraten D, Zotter  A, Egly JM, van Cappellen WA, Hoeijmakers JH,  Houtsmuller AB, Vermeulen W. DNA damage sta - bilizes interaction of CSB with the transcription  elongation machinery.",OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
J Cell Biol 2004; 166:27- 36; PMID :15226310 ; http://dx.doi.org/10.1083/ jcb.200401056 7.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell 2006; 23:471-82;   PMID:16916636 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cold Spring Harb Perspect Biol 2013; 5:a012609;   PMID:24086042 ; http://dx.doi.org/10.1101/cshper - spect.a01260910.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mech Ageing Dev  2013; 134:161-70;  PMID:23428416 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell 2009; 35:191- 205; PMID:19647516 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
DNA Repair (Amst) 2011; 10:743- 50; PMID:21622031 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Biochim Biophys Acta  2013 ; 1829:151-7;  PMID:22960598 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Curr Opin Cell Biol 1991;  3:422-8;  PMID:1892653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell 2012; 46:722-34;   PMID:22749398 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cell Cycle  2009; 8:3953-9;  PMID :19901545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
J Biol Chem 2009; 284:30424-32;   PMID:19740755 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Proc Natl Acad Sci U S A  2010; 107:17274-9;  PMID:20855601 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cell  2006; 127:481-93;  PMID:17081972 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell Biol 2000; 20:7643- 53; PMID:11003660 ; http://dx.doi.org/10.1128/ MCB.20.20.7643-7653.2000 24.,Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Nucleic Acids Res  2002; 30:782-93;  PMID:11809892 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
PLoS Genet 2013; 9:e1003407;   PMID:23637612 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cell  2013; 155:94-106;  PMID:24074863 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
PLoS Genet 2013; 9:e1003611;  PMID:23861670 ;  http://dx.doi.org/10.1371/journal.pgen.1003611 29.,Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
J Biol Chem 2013;  288:18271-82;  PMID:23653357 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Development 2013; 140:2513- 24; PMID :23715545 ; http://dx.doi.org/10.1242/ dev.091439 31.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cell Rep  2012; 1:730-40;  PMID:22813747 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
J Biol Chem 2006; 281:23297-301;   PMID:16766522 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Cell  Res 2008; 18:73-84;  PMID:18166977 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Chem Rev  2006; 106:474-88;  PMID:16464015 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Nucleic Acids Res 2013; 41:2881-93;   PMID:23325844 ; http://dx.doi.org/10.1093/nar/ gks1472 37.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell  2011; 44:928-41;  PMID:22195966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Annu Rev Genet 2009; 43:559-99;   PMID:19886812 ; http://dx.doi.org/10.1146/ annurev.genet.032608.103928 40.,Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Curr Biol 2002; 12:1052- 8; PMID:12123582 ; http://dx.doi.org/10.1016/ S0960-9822(02)00901-6 41.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
J Biol Chem  2002; 277:30421-4;  PMID:12097318 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Genes Dev 2011; 25:1345- 58; PMID:21724828 ; http://dx.doi.org/10.1101/ gad.205781143.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Nature 2004; 432:406-11;  PMID:15525939 ;  http://dx.doi.org/10.1038/nature03114 44.,Non-OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Nature  1997; 389:251-60;  PMID:9305837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell  2013; 52:291-302;  PMID:24207023 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
Mol Cell 2012; 47:622-32;   PMID:22771116 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/46/46/nucl-5-203.PMC4133215.pdf
"This structure is called the DNA torsion as a feedback mediator of transcription   and chromatin dynamics Sheila S Teves1 and Steven Henikoff2,3,* 1Molecular and Cell Biology; University of California, Berkeley; Berkeley, CA USA; 2Basic Sciences Division; Fred Hutchinson Cancer Research Center; Seattle,  WA USA;3Howard Hughes Medical Institute; Seattle, WA USA Keywords:  torsional stress, nucleosome  turnover, nascent RNA, topoisomerase,  RNA Polymerase II *Correspondence to: Steven Henikoff;   Email: steveh@fhcrc.org Submitted: 03/31/2014; Revised: 04/28/2014;   Accepted: 04/30/2014;   Published Online: 05/12/2014  http://dx.doi.org/10.4161/nucl.29086 Extra View to: Teves SS, Henikoff S. Transcrip - tion-generated torsional stress destabilizes  nucleosomes.",Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nat Struct Mol Biol 2014; 21:88-94;  PMID:24317489; http://dx.doi.org/10.1038/ nsmb.2723,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Interface Focus 2012; 2:546-54;  PMID:24098838 ;  http://dx.doi.org/10.1098/rsfs.2011.0101 3.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nature 2012; 485:376-80;  PMID:22495300 ;  http://dx.doi.org/10.1038/nature11082 5.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nat Struct Mol Biol 2013; 20:387- 95; PMID:23416946 ; http://dx.doi.org/10.1038/ nsmb.2509 6.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biophys J 1998; 74:2531- 44; PMID:9591679 ; http://dx.doi.org/10.1016/ S0006-3495(98)77961-5 7.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nature  1997; 389:251-60;  PMID:9305837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biophys J 2009;  97:3150-7;  PMID:20006952 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Proc Natl Acad Sci U S  A 1987; 84:7024-7;  PMID:2823250 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biophys J 2010;  98:824-33;  PMID:20197036 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Science 2012; 338:94- 7; PMID:22983709 ; http://dx.doi.org/10.1126/ science.1225810 14.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Cell  1997; 90:625-34;  PMID:9288743 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biochemistry 2000; 39:3520-4;  PMID :10736150 ;  http://dx.doi.org/10.1021/bi992263f 16.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Proc Natl Acad Sci U S A 2009; 106:20222- 7; PMID:19923429 ; http://dx.doi.org/10.1073/ pnas.0902454106 19.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Annu Rev Genet 1996; 30:79- 107; PMID:8982450 ; http://dx.doi.org/10.1146/ annurev.genet.30.1.79 20.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biochimie 2007; 89:456- 67; PMID:17141394 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
ACS Chem Biol 2013; 8:82-95;   PMID:23259582 ; http://dx.doi.org/10.1021/ cb300648v23.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Annu Rev Biochem 2013; 82:139-70;   PMID:23495937 ; http://dx.doi.org/10.1146/ annurev-biochem-061809-100002 24.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nature 2005; 434:671-4;  PMID :15800630 ;  http://dx.doi.org/10.1038/nature03395 25.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Proc Natl Acad Sci U S A 1993; 90:6656- 60; PMID:8393572 ; http://dx.doi.org/10.1073/ pnas.90.14.6656 26.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
EMBO  J 2010; 29:2126-34;  PMID:20526281 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Cell 1986;  44:401-7;  PMID:3002635 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nature 2007; 448:213- 7; PMID:17589503 ; http://dx.doi.org/10.1038/ nature05938 30.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
The  phosphoCTD-interacting domain of Topoisomerase  I. Biochem Biophys Res Commun 2010; 397:117- 9; PMID:20493173 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Genes Dev 1997; 11:397-407;  PMID:9030691 ;  http://dx.doi.org/10.1101/gad.11.3.397 32.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nat Struct Mol Biol  2013; 20:396-403;  PMID:23416947 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Cell 1980; 19:697-707;  PMID:6244895 ;  http://dx.doi.org/10.1016/S0092-8674(80)80046-8 34.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nucleic  Acids Res 2013; 41:9911-23;  PMID:23965305 ;  http://dx.doi.org/10.1093/nar/gkt749 35.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Genes Cells 1996; 1:17-27;  PMID:9078364 ;  http://dx.doi.org/10.1046/j.1365-2443.1996.01001.x 36.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Science 2011;  331:1328-32;  PMID:21393545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Mol Cell 2011; 44:97-107;   PMID:21981921 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
EMBO J 2006; 25:2575- 83; PMID:16710299 ; http://dx.doi.org/10.1038/ sj.emboj.7601142 39.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nature 1997; 388:598-602;  PMID:9252192 ;  http://dx.doi.org/10.1038/41587 40.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nat Struct Mol Biol  2008; 15:146-54;  PMID:18193062 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biochem Cell Biol  2005; 83:449-59;  PMID:16094448 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
J Cell Sci 2004;  117:3797-805;  PMID:15252118 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
FEBS Lett  1970; 9:121-3;  PMID:11947648 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Cell  1980; 21:773-83;  PMID:6254668 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nucleic Acids Res 2010; 38:e182;  PMID :20685815 ;  http://dx.doi.org/10.1093/nar/gkq687 46.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nat Struct Mol Biol 2006; 13:444- 50; PMID:16622406 ; http://dx.doi.org/10.1038/ nsmb108748.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Proc Natl Acad Sci U S A 2013; 110:15555-60;   PMID:24019504 ; http://dx.doi.org/10.1073/ pnas.1220313110 49.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nat Commun 2013; 4:2579;   PMID:24113677 ; http://dx.doi.org/10.1038/ ncomms3579 50.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Genes Dev 2011; 25:2387-97;  PMID:22085965 ;  http://dx.doi.org/10.1101/gad.177675.111 51.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Biochem J 2008; 412:57- 63; PMID:18271758 ; http://dx.doi.org/10.1042/ BJ20071648 53.,Non-OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Genome Biol 2007; 8:R3;  PMID:17204154 ;  http://dx.doi.org/10.1186/gb-2007-8-1-r3 55.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
Nucleic Acids Res  2009; 37:W317-22;  PMID:19465387 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b5/c3/nucl-5-211.PMC4133216.pdf
The package is freely available at http://mnmccall.com/software and as part of the Bioconductor project.,OADS,/arxiv_data1/oa_pdf/41/4a/btu239.PMC4133581.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/4a/btu239.PMC4133581.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f8/b2/srep06076.PMC4133703.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6076 | DOI: 10.1038/srep06076 9",Non-OADS,/arxiv_data1/oa_pdf/f8/b2/srep06076.PMC4133703.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/17/5d/srep06073.PMC4133705.pdf
The authors acknowledge the NOAA Air Resources Laboratory (ARL) for making the HYSPLIT transport and dispersion modelavailable on the Internet (http://www.arl.noaa.gov/ready.html).,Non-OADS,/arxiv_data1/oa_pdf/f2/5a/srep06091.PMC4133707.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/5a/srep06091.PMC4133707.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6091 | DOI: 10.1038/srep06091 7",Non-OADS,/arxiv_data1/oa_pdf/f2/5a/srep06091.PMC4133707.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/2f/srep06077.PMC4133708.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Figure 8 |Comparison of calculated spectra for the random structure and an ordered one.",Non-OADS,/arxiv_data1/oa_pdf/fd/2f/srep06077.PMC4133708.pdf
"6): (i) lncRNA screening: lncRNAs that were up- or down-regulatedfold change $3.0 and P-value ,0.05 were first retained; then to enhance the data reliability, lncRNA whose sequences have not been recorded in ENCODE were removed; (ii) lncRNA-miRNA interactions were predicted by miRcode (http://www.mircode.org/); (iii) mRNAs that were targeted by miRNAs with experimental support were from TarBase (http://www.microrna.gr/tarbase).",OADS,/arxiv_data1/oa_pdf/b3/31/srep06088.PMC4133709.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Xing, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/68/10/srep06086.PMC4133711.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6086 | DOI: 10.1038/srep06086 8",Non-OADS,/arxiv_data1/oa_pdf/68/10/srep06086.PMC4133711.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0f/0f/srep06072.PMC4133712.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6072 | DOI: 10.1038/srep06072 7",Non-OADS,/arxiv_data1/oa_pdf/0f/0f/srep06072.PMC4133712.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/37/10/srep06074.PMC4133715.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6074 | DOI: 10.1038/srep06074 9",Non-OADS,/arxiv_data1/oa_pdf/37/10/srep06074.PMC4133715.pdf
"It should be noticed that Bombyx mori genes for the orthologous proteins for mTOR and ILK are found (BGIBMGA008952 and BGIBMGA012119, respectively) in genome database of the silkworm (http://silkworm.swu.edu.cn/silkdb/).Thus, 30% phosphorylation on S473 could be explained by endogen- ousBombyx orthologs of mTOR and/or ILK.",Non-OADS,/arxiv_data1/oa_pdf/38/31/srep06016.PMC4133716.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/31/srep06016.PMC4133716.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6016 | DOI: 10.1038/srep06016 8",Non-OADS,/arxiv_data1/oa_pdf/38/31/srep06016.PMC4133716.pdf
"http://www.cdc.gov/drugresistance/threat-report-2013/, Threat Report 2013; date of access 10/12/2013.",OADS,/arxiv_data1/oa_pdf/25/89/srep06090.PMC4133717.pdf
"2. http://www.who.int/mediacentre/factsheets/fs194/en/, Antimicrobial Resistance, date of access 10/12/2013.",Non-OADS,/arxiv_data1/oa_pdf/25/89/srep06090.PMC4133717.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6090 | DOI: 10.1038/srep06090 6",Non-OADS,/arxiv_data1/oa_pdf/25/89/srep06090.PMC4133717.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/88/66/srep06089.PMC4133718.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6089 | DOI: 10.1038/srep06089 6",Non-OADS,/arxiv_data1/oa_pdf/88/66/srep06089.PMC4133718.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/65/srep06038.PMC4133719.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6038 | DOI: 10.1038/srep06038 8",Non-OADS,/arxiv_data1/oa_pdf/11/65/srep06038.PMC4133719.pdf
"Supplemental Information :Supplemental Information includes Supplemental Experimental Procedures, six figures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2013.10.028 .",OADS,/arxiv_data1/oa_pdf/ea/46/nihms616981.PMC4133736.pdf
Nef Model Building Mutations of I123L and L146F were inserted into the SIVmac239 Nef structure and displayed using the program PyMOL ( http://www.pymol.org ).,OADS,/arxiv_data1/oa_pdf/ea/46/nihms616981.PMC4133736.pdf
Molecular diagrams were drawn with PyMOL (http://www.pymol.org ).,OADS,/arxiv_data1/oa_pdf/ea/46/nihms616981.PMC4133736.pdf
"2013. http://www.psych.org/practice/dsm/dsm5  [accessed 21.04.13] Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR.",OADS,/arxiv_data1/oa_pdf/6e/cc/nihms598057.PMC4133781.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/5f/37/ncomms5619.PMC4133791.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Tan, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/ncomms5619.PMC4133791.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5619 12 NATURE COMMUNICATIONS | 5:4619 | DOI: 10.1038/ncomms5619 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5f/37/ncomms5619.PMC4133791.pdf
"http://dx.doi.org/10.5483/BMBRep.2012.45.11.137 Received 2 July 2012, Revised 4 July 2012, Accepted 16 July 2012Keywords:  Glycoprotein, Hemagglutinin, Influenza, Pandemic Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Surface glycoproteins determine the feature of the 2009  pandemic H1N1 virus Jin Il Kim1,2,#, Ilseob Lee1,2,#, Sehee Park1,2,# & Man-Seong Park1,2,* 1Department of Microbiology, 2Center for Medical Science Research, College of Medicine, Hallym University, Chuncheon 200-702, Korea After the outbreak of the swine-origin influenza A H1N1 virus in  April 2009, World Health Organization declared this novel H1N1 virus as the first pandemic influenza virus (2009 pH1N1)  of the 21 st century.",Non-OADS,/arxiv_data1/oa_pdf/29/b5/BMB-45-653.PMC4133798.pdf
654 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/29/b5/BMB-45-653.PMC4133798.pdf
655 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/29/b5/BMB-45-653.PMC4133798.pdf
"656 BMB Reports http://bmbreports.org2009 pandemic strain K/09 NS1 was determined to be a weak in- terferon blocker, with activity similar to that of WSN (Fig.",Non-OADS,/arxiv_data1/oa_pdf/29/b5/BMB-45-653.PMC4133798.pdf
"657 http://bmbreports.org BMB Reportslected at 24 hpi, UV treated, and incubated with prepared Vero  cells for 16 hours.",Non-OADS,/arxiv_data1/oa_pdf/29/b5/BMB-45-653.PMC4133798.pdf
658 BMB Reports http://bmbreports.org14.,Non-OADS,/arxiv_data1/oa_pdf/29/b5/BMB-45-653.PMC4133798.pdf
"Tel: +86-10-69155945; Fax: +86-10-65240  529; E-mail: pengxiaozhong@pumc.edu.cnhttp://dx.doi.org/10.5483/BMBRep.2012.45.11.097 Received 3 May 2012, Revised 4 June 2012, Accepted 22 June 2012Keywords:  Cell proliferation, Glioma, miR-214, Sumoylation, UBC9 Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.microRNA-214-mediated UBC9 expression in glioma  Zhiqiang Zhao, Xiaochao Tan, Ani Zhao, Liyuan Zhu, Bin Yin, Jiangang Yuan, Boqin Qiang & Xiaozhong Peng * The National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and  Peking Union Medical College, Beijing 100005, PR China It has been reported that ubiquitin-conjugating enzyme 9 (Ubc9),  the unique enzyme2 in the sumoylation pathway, is up-regulated in many cancers.",Non-OADS,/arxiv_data1/oa_pdf/c3/02/BMB-45-641.PMC4133799.pdf
642 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/BMB-45-641.PMC4133799.pdf
643 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/BMB-45-641.PMC4133799.pdf
644 BMB Reports http://bmbreports.orglated in human glioma tissues and T98G cells.,OADS,/arxiv_data1/oa_pdf/c3/02/BMB-45-641.PMC4133799.pdf
"645 http://bmbreports.org BMB ReportsGreen PCR Master Mix kit (Takara, Japan) according to the  manufacturer's instructions on the ABI Prism 7500 sequence detection system.",Non-OADS,/arxiv_data1/oa_pdf/c3/02/BMB-45-641.PMC4133799.pdf
646 BMB Reports http://bmbreports.orghibits apoptosis in breast tumor-initiating cells.,Non-OADS,/arxiv_data1/oa_pdf/c3/02/BMB-45-641.PMC4133799.pdf
"http://dx.doi.org/10.5483/BMBRep.2012.45.11.086 Received 26 April 2012, Revised 14 May 2012, Accepted 6 June 2012Keywords: Cell migration, Cell proliferation, Hepatocellular carci- noma, Stanniocalcin 2 Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.STC2 is upregulated in hepatocellular carcinoma and promotes  cell proliferation and migration in vitro Haixiao Wang1,4,#, Kuangjie Wu1,#, Yuan Sun5, Yandong Li2,3, Mingyu Wu1, Qian Qiao1, Yuanjiang Wei1, Ze-Guang  Han2,3,* & Bing Cai1,* 1Department of Hepatobiliary Surgery, Wuxi People's  Hospital of Nanjing Medical University, Jiangsu, 2Chinese National Human Genome  Center, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 3Shanghai-MOST Key Laboratory for Disease and  Health Genomics, Chinese National Human Genome Center at Shanghai, 4Department of General Surgery, Huaian No.",Non-OADS,/arxiv_data1/oa_pdf/20/d1/BMB-45-629.PMC4133800.pdf
630 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/d1/BMB-45-629.PMC4133800.pdf
631 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/d1/BMB-45-629.PMC4133800.pdf
632 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/20/d1/BMB-45-629.PMC4133800.pdf
"633 http://bmbreports.org BMB ReportsMATERIALS AND METHODS Tissue specimens and cell culture In this study, paired HCCs and adjacent paratumor liver tissues  from 44 patients incorporating HCCs were obtained with in-formed consent.",OADS,/arxiv_data1/oa_pdf/20/d1/BMB-45-629.PMC4133800.pdf
634 BMB Reports http://bmbreports.orgperiment was performed at least in duplicate.,OADS,/arxiv_data1/oa_pdf/20/d1/BMB-45-629.PMC4133800.pdf
"Tel: +82-2-2258-6221; Fax: +82-2-3482-  8268; E-mail: tykimder@catholic.ac.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.11.003 Received 2 January 2012, Revised 12 February 2012,  Accepted 5 June 2012 Keywords: EC-SOD, IFN γ, Keratinocytes, Melanoma, PKC δ Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.IFNγ-mediated inhibition of cell proliferation through increased  PKCδ-induced overexpression of EC-SOD Yoon-Jae Jeon1, Hyun Yoo1, Byung Hak Kim1, Yun Sang Lee1, Byeongwook Jeon1, Sung-Sub Kim2,* & Tae-Yoon Kim1,* 1Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul 137-040, 2Department of New Drug Discovery  and Development New Drug Development, Chungnam National University, Daejeon 305-764, Korea Extracellular superoxide dismutase (EC-SOD) overexpression  modulates cellular responses such as tumor cell suppression and is induced by IFN γ.",Non-OADS,/arxiv_data1/oa_pdf/ec/d5/BMB-45-659.PMC4133801.pdf
660 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/d5/BMB-45-659.PMC4133801.pdf
661 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/d5/BMB-45-659.PMC4133801.pdf
662 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/d5/BMB-45-659.PMC4133801.pdf
"663 http://bmbreports.org BMB Reportsrum (FBS), and antibiotics (penicillin/streptomycin) were pur- chased from Gibco BRL (Rockville, MD, USA).",Non-OADS,/arxiv_data1/oa_pdf/ec/d5/BMB-45-659.PMC4133801.pdf
664 BMB Reports http://bmbreports.org(2003) Secretion of extracellular superoxide dismutase  from muscle transduced with recombinant adenovirus in-hibits the growth of B16 melanomas in mice.,Non-OADS,/arxiv_data1/oa_pdf/ec/d5/BMB-45-659.PMC4133801.pdf
"Tel: +86-23-68251753; Fax: +86-23-6825  1128; E-mail: zhaop@swu.edu.cn.http://dx.doi.org/10.5483/BMBRep.2012.45.11.261 Received 2 December 2011, Revised 20 March 2012,  Accepted 9 April 2012 Keywords: Bombyx mori , Chitin-binding proteins, LTQ-Orbitrap, Peritrophic matrix, Proteome Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Shotgun analysis on the peritrophic membrane of the  silkworm Bombyx mori Xiaowu Zhong, Liping Zhang,Yong Zou, Qiying Yi, Ping Zhao *, Qingyou Xia & Zhonghuai Xiang State Key Laboratory of Silkworm Genome Biology, Southwest University, Chongqing 400716, China The insect midgut epithelium is generally lined with a unique  chitin and protein structure, the peritrophic membrane (PM), which facilitates food digestion and protects the gut epithe- lium.",Non-OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
666 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
667 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
668 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
"669 http://bmbreports.org BMB Reports100 to 2,000 for full mass range.",Non-OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
Database search  The databases were constructed using ‘silkworm’ as a keyword in  searching from the NCBI (http://www.ncbi.nlm.nih.gov/) protein database.,OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
"In addition, the open reading frames of silkworm were  obtained from silkworm genome sequences, which were down- loaded from silkDB (http://silkworm.swu.edu.cn/silkdb/doc/ download.html).",OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
Bioinformatics analysis Gene Ontology (GO) IDs of the proteins identified in the present study were obtained from the Gene Ontology (http://www.ge- neontology.org/).,OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
GO classifications of these proteins were con- ducted using WEGO (http://wego.genomics.org.cn/) following the method described by Ye et al.,OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
"The EC numbers of the  identified proteins were acquired (if available) with E-value ≤  e−15 by using KEGG GENES BLASTP (http://blast.genome.jp/),  and then were subjected to search against the KEGG reference  pathway database (http://www.genome.jp/kegg/tool/search_path- way.html).",OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
The pathways with at least three EC numbers were accepted and class ified according to the defin ition of KEGG  (http://www.genome.ad.jp/kegg/pathway.html).,OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
"670 BMB Reports http://bmbreports.orgGordon, K. H. (2008) Proteomic analysis of the peri- trophic matrix from the gut of the caterpillar, Helicoverpa  armigera .",OADS,/arxiv_data1/oa_pdf/3d/7b/BMB-45-665.PMC4133802.pdf
"Tel: +55-51-3308-5566; Fax: +55-51-3308-  5540; E-mail: marciodutra5@yahoo.com.br http://dx.doi.org/10.5483/BMBRep.2012.45.11.094 Received 2 May 2012, Revised 13 July 2012, Accepted 30 July 2012Keywords:  Carbonylation, Dietary reduction, Food intake, Oxida- tive stress  Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Effects of chronic caloric restriction on kidney and heart redox  status and antioxidant enzyme activities in Wistar rats Márcio Ferreira Dutra *, Ivi Juliana Bristot, Cristiane Batassini, Núbia Broetto Cunha, Adriana Fernanda Kuckartz Vizuete,  Daniela Fraga de Souza, José Cláudio Fonseca Moreira & Carlos-Alberto Gonçalves  Departamento de Bioquímica, Instituto de Ciências Básicas da Sáude, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS , Brazil Caloric restriction (CR) has been associated with health  benefits and these effects have been attributed, in part, to modulation of oxidative status by CR; however, data are still  controversial.",Non-OADS,/arxiv_data1/oa_pdf/c9/33/BMB-45-671.PMC4133804.pdf
672 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c9/33/BMB-45-671.PMC4133804.pdf
673 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c9/33/BMB-45-671.PMC4133804.pdf
674 BMB Reports http://bmbreports.org(26).,OADS,/arxiv_data1/oa_pdf/c9/33/BMB-45-671.PMC4133804.pdf
675 http://bmbreports.org BMB Reportsrate of decrease in hydrogen peroxide (H 2O2) absorbance in a  spectrophotometer at 240 nm (32).,OADS,/arxiv_data1/oa_pdf/c9/33/BMB-45-671.PMC4133804.pdf
676 BMB Reports http://bmbreports.orgdative damage.,OADS,/arxiv_data1/oa_pdf/c9/33/BMB-45-671.PMC4133804.pdf
"Tel: +82-2-710-9414; Fax: +82-2-2077-7322; E-mail: parkjh@sookmyung.ac.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.11.210 Received 12 October 2012Keywords: Cancer metastasis, Cancer therapy, Gene family,  Hematopoiesis, Immune system, T umorigenesis ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong & Jong Hoon Park * Department of Biological Science, Sookmyung Women’s University, Seoul 140-742, Korea Human Ly-6/uPAR molecules are a superfamily composed of  two subfamilies; one is the membrane bound proteins with a GPI-anchor and the other are secreted proteins without the  GPI-anchor.",Non-OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 596 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 597 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
"Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 598 BMB Reports http://bmbreports.orgman cancers, such as colon cancer and malignant kidney can- cer (25).",OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 599 http://bmbreports.org BMB Reportsceptive immunogen with germ cell specificity because a mon- oclonal antibody specific to SP-10 inhibits sperm penetration (75).,Non-OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 600 BMB Reports http://bmbreports.org609-614.,OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 601 http://bmbreports.org BMB Reports36.,OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
"Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 602 BMB Reports http://bmbreports.orgF., Kellen, E., Zeegers, M. P., Kumar, R., Rudnai, P.,  Gurzau, E., Koppova, K., Mayordomo, J. I., Sanchez, M., Saez, B., Lindblom, A., de Verdier, P., Steineck, G., Mills,  G. B., Schned, A., Guarrera, S., Polidoro, S., Chang, S. C.,  Lin, J., Chang, D. W., Hale, K. S., Majewski, T., Grossman, H. B., Thorlacius, S., Thorsteinsdottir, U.,  Aben, K. K., Witjes, J.",OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
"Characterization and function of human Ly-6/uPAR molecules Hyun Kyung Kong and Jong Hoon Park 603 http://bmbreports.org BMB Reportstors, their inhibitors, and urokinase receptor emerge in  late stages of melanocytic tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/00/90/BMB-45-595.PMC4133805.pdf
"Tel: +82-41-570-2442; Fax: +82-41-579-  6080; E-mail: m1037624@sch.ac.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.11.111 Received 17 May 2012, Revised 4 July 2012, Accepted 28 July 2012Keywords:  Chemoresistance, Clofarabine, Mesothelioma, Nrf2,  Resveratrol Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Synergistic inhibition of mesothelioma cell growth by the  combination of clofarabine and resveratrol involves Nrf2 downregulation  Yoon-Jin Lee1,2, Jae-Hyuk Im3, David M. Lee4, Ji-Sung Park3, Seong Youn Won2, Moon-Kyun Cho2, Hae-Seon Nam2,  Yong-Jin Lee1 & Sang-Han Lee1,3,* 1Soonchunhyung Environmental Health Center for Asbestos, 2Division of Molecular Cancer Research, Soonchunhyang Medical Research  Institute and 3Department of Biochemistry, College of Medicine, Soonchunhyang University, Cheonan 330-090, Korea, 4Cell Biology and  Genetics in Biological Sciences, College of Computer, Mathematical, and Natural Sciences, University of Maryland, College Park,  MD  20742, USA We previously reported that MSTO-211H cells have a higher  capacity to regulate Nrf2 activation in response to changes in the cellular redox environment.",Non-OADS,/arxiv_data1/oa_pdf/41/92/BMB-45-647.PMC4133806.pdf
648 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/92/BMB-45-647.PMC4133806.pdf
649 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/41/92/BMB-45-647.PMC4133806.pdf
"650 BMB Reports http://bmbreports.orglogical activities, the antioxidative role of resveratrol has been  well characterized in many studies and is most likely asso-ciated with its ability to induce antioxidant molecules.",Non-OADS,/arxiv_data1/oa_pdf/41/92/BMB-45-647.PMC4133806.pdf
"651 http://bmbreports.org BMB Reportsthelioma cells containing the highest MnSOD activity has  been known to exhibit high resistance to oxidants such as me-nadione and H2O2, and to cytotoxic drugs, such as epirubicin  (21).",Non-OADS,/arxiv_data1/oa_pdf/41/92/BMB-45-647.PMC4133806.pdf
652 BMB Reports http://bmbreports.orgCancer Res .,OADS,/arxiv_data1/oa_pdf/41/92/BMB-45-647.PMC4133806.pdf
"Tel: +81-11-611-2111; Fax: +81-11-622-  1918; E-mail: hsuzuki@sapmed.ac.jphttp://dx.doi.org/10.5483/BMBRep.2012.45.11.227 Received 10 October 2012Keywords: Biomarker, Cancer, Gene regulation, Histone mod- ification, LincRNA, Long noncoding RNA, Oncogene, Tumor sup-pressor ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Long noncoding RNA in volvement in cancer Reo Maruyama & Hiromu Suzuki * Department of Molecular Biology, Sapporo Medical University, Sapporo 060-8556, Japan Recent advances in genome and transcriptome analysis have  enabled identification of numerous members of a new class of noncoding RNA, long noncoding RNA (lncRNA).",Non-OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
"Long noncoding RNA involvement in cance r Reo Maruyama and Hiromu Suzuki 605 http://bmbreports.org BMB ReportsName Size Cancer type Biological function Molecular function References Oncogenic 　HOTAIR 　ANRIL  　MALAT1 　PCAT-1 　PCGEM1 　TUC338 　uc.73a 　SPRY4-IT1 　ncRAN 　PRNCR1 　H19 Tumor suppressive 　GAS5 　MEG3 　PTENP1 　LincRNA-p21 Unknown, Biomarker 　HULC 　PCA3 　PANDA2.2 kb 2.2 kb 8.7 kb 1.9 kb1.6 kb 0.6 kb 0.2 kb 0.7 kb 2.3 kb 13 kb 2.3 kb 0.6-1.8 kb 1.6-1.8 kb 3.9 kb 3.1 kb 0.5 kb 3.6 kb 1.5 kbBreast, hepatocellular,  colorectal, pancreatic, GIST Prostate, leukemia,  neural system, melanomaLung, prostate, breast,  colon, hepatocellular Prostate Prostate Hepatocellular Leukemia, colorectal Melanoma Neuroblastoma, bladderProstate Breast, hepatocellular Breast Meningioma, hepatocellular,  leukemia, pituitary Prostate, colon Mouse models of lung,  sarcoma, lymphoma Hepatocellular Prostate UnknownPromotes invasion and metastasis, Modulates cancer epigenome Suppresses senescence via INK4A Regulates alternative splicing of  pre-mRNA  Promotes cell proliferation, inhibits BRCA2 Inhibits apoptosis, promotes cell  proliferationPromotes cell proliferation Inhibits apoptosis, promotes cell  proliferationPromotes cell proliferation and  invasion, Inhibits apoptosis Promotes cell proliferation and invasion Promotes cell proliferation Promotes cell proliferation, both oncogenic and tumor suppressive  functions reported Induces growth arrest and  apoptosis Mediates p53 signalingInhibits cell proliferation Inhibits cell growth Induces apoptosis by repressing  p53 targets Unknown Unknown Inhibits apoptosis by sequestering  NF-YAScaffold (PRC2, LSD1), Guide ( in trans ) Scaffold (PRC1, PRC2),  Guide ( in cis ) Scaffold (nuclear paraspeckle) UnknownUnknown Unknown Unknown Unknown UnknownUnknown Unknown Decoy  (glucocorticoid receptor) Unknown Decoy  (PTEN-suppressing miRNAs)Guide (hnRNP-k, in trans ) Decoy (miR-372) Unknown Decoy (NF-YA)(11, 26-29) (30-35) (36-40, 47) (42) (48, 49) (50) (51) (52) (53, 54) (55) (56, 57) (21, 44) (58, 59) (23) (10) (60, 61) (62) (4)Table 1.",Non-OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
Long noncoding RNA involvement in cancer Reo Maruyama and Hiromu Suzuki 606 BMB Reports http://bmbreports.orgthroughout the genome and to identify a set of 832 HOTAIR  binding sites in human breast cancer cells.,OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
Long noncoding RNA involvement in cance r Reo Maruyama and Hiromu Suzuki 607 http://bmbreports.org BMB Reportsectal cancer and pancreatic cancer (26-28).,Non-OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
Long noncoding RNA involvement in cancer Reo Maruyama and Hiromu Suzuki 608 BMB Reports http://bmbreports.orgwhere it acts as a decoy preventing the GR from interacting  with cognate glucocorticoid response elements (GRE).,Non-OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
Long noncoding RNA involvement in cance r Reo Maruyama and Hiromu Suzuki 609 http://bmbreports.org BMB ReportsMol.,OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
"Long noncoding RNA involvement in cancer Reo Maruyama and Hiromu Suzuki 610 BMB Reports http://bmbreports.orgMuller-Tidow, C. (2003) MALAT-1, a novel noncoding  RNA and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.",OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
"Long noncoding RNA involvement in cance r Reo Maruyama and Hiromu Suzuki 611 http://bmbreports.org BMB Reports(2010) Maternally expressed gene 3, an imprinted non- coding RNA gene, is associated with meningioma patho-genesis and progression.",Non-OADS,/arxiv_data1/oa_pdf/bd/6f/BMB-45-604.PMC4133807.pdf
"Tel: +82-42-860-4133; Fax: +82-42-879-  8498; E-mail: jhko@kribb.re.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.11.233 Received 8 November 2012Keywords:  Aberrant glycosylation, Cancer progression, MMP ,  TIMP-1, Tumor microenvironment ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Expression level and glycan dynamics determine the net effects  of TIMP-1 on cancer progression  Yong-Sam Kim, Sun-Hee Kim, Jeong-Gu Kang & Jeong-Heon Ko * Division of KRIBB Strategy Projects, KRIBB, 125 Gwahak-ro, Yuseong-gu, Deajeon 805-306, Korea Tissue inhibitor of metalloproteinases (TIMPs; TIMP-1, -2, -3 and  -4) are endogenous inhibitor for matrix metalloproteinases (MMPs) that are responsible for remodeling the extracellular  matrix (ECM) and involved in migration, invasion and metastasis  of tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/87/6e/BMB-45-623.PMC4133808.pdf
"624 BMB Reports http://bmbreports.orgcentral role in the growth and spread of cancer, are inhibited  by TIMP-1 binding (15).",Non-OADS,/arxiv_data1/oa_pdf/87/6e/BMB-45-623.PMC4133808.pdf
625 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/6e/BMB-45-623.PMC4133808.pdf
626 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/6e/BMB-45-623.PMC4133808.pdf
"627 http://bmbreports.org BMB ReportsAcknowledgements This work was supported by the ‘Convergence Research  Center Program (2011K000891)’ of the Ministry of Education, Science and Technology and grants from the KRIBB Research  Initiative Program (KGM3231211).",Non-OADS,/arxiv_data1/oa_pdf/87/6e/BMB-45-623.PMC4133808.pdf
628 BMB Reports http://bmbreports.org29.,Non-OADS,/arxiv_data1/oa_pdf/87/6e/BMB-45-623.PMC4133808.pdf
"Tel: +82-41-570-2470; Fax: +82-41-574-  1770; E-mail: dskim@sch.ac.kr http://dx.doi.org/10.5483/BMBRep.2012.45.11.091 Received 26 April 2012, Revised 12 May 2012, Accepted 6 June 2012Keywords: Epilepsy, HCN channels, Hippocampus, Immunohisto- chemistry, Status epilepticus Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Alterations in hyperpolarization-activated cyclic nucleotide-  gated cation channel (HCN) expression in the hippocampus following pilocarpine-induced status epilepticus Yun-Jung Oh, Jongju Na, Ji-Heon Jeong, Dae-Kyoon Park, Kyung-Ho Park, Jeong-Sik Ko & Duk-Soo Kim * Department of Anatomy, College of Medicine, Soonchunhyang University, Cheonan 330-090, Korea To understand the effects of HCN as potential mediators in the  pathogenesis of epilepsy that evoke long-term impaired excitability; the present study was designed to elucidate whether  the alterations of HCN expression induced by status epilepticus  (SE) is responsible for epileptogenesis.",Non-OADS,/arxiv_data1/oa_pdf/43/99/BMB-45-635.PMC4133809.pdf
636 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/43/99/BMB-45-635.PMC4133809.pdf
"637 http://bmbreports.org BMB Reports　Since many previous studies have demonstrated that selective  down-regulation of HCN1 mRNA expression occurs in response to increased hyperpolarizing input and consequent enhanced ac- tivation of this channel (13), this may be the consequence of an  enhanced compensatory response to suppressing enhanced ex-citatory hippocampal circuitry.",Non-OADS,/arxiv_data1/oa_pdf/43/99/BMB-45-635.PMC4133809.pdf
638 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/43/99/BMB-45-635.PMC4133809.pdf
639 http://bmbreports.org BMB Reports30 min at room temperature.,Non-OADS,/arxiv_data1/oa_pdf/43/99/BMB-45-635.PMC4133809.pdf
640 BMB Reports http://bmbreports.orgrole of I(h) in the pacing of subthreshold oscillations in en- torhinal cortex layer II neurons.,OADS,/arxiv_data1/oa_pdf/43/99/BMB-45-635.PMC4133809.pdf
"Tel: +82-41-530-2677; Fax: +82-41-530-  2279; E-mail: tjoh3782@sunmoon.ac.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.12.080 Received 16 April 2012, Revised 23 May 2012, Accepted 6 July 2012Keywords:  Cytochrome P450, Epoxidation, Homology Modeling /  docking; In silico , Streptomyces peucetius ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.In-silico  and In-vitro  based studies of Streptomyces peucetius   CYP107N3 for oleic acid epoxidation Saurabh Bhattarai, Narayan Prasad Niraula, Jae Kyung Sohng & Tae-Jin Oh * Institute of Biomolecule Reconstruction (IBR), Department of Pharmaceutical Engineering, SunMoon University, Asan 336-708, Kore a Certain members of the cytochromes P450 superfamily meta- bolize polyunsaturated long-chain fatty acids to several classes of oxygenated metabolites.",Non-OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
737 http://bmbreports.org BMB Reports (A) (B) Fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
738 BMB Reports http://bmbreports.org                 (A) (B) Fig.,OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
739 http://bmbreports.org BMB Reportssearch and identified CYP107N3 as having high identity with  previously reported epoxidase from Streptomyces  sp.,OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
The homologue search was done from the ExPASy web site (http://swissmodel.expasy.org).,OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
"740 BMB Reports http://bmbreports.orgcompared with standard molecular mass protein markers  (Novagen, USA).",OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
"741 http://bmbreports.org BMB Reportssubstitution, F87V, converts cytochrome P450 BM-3 into a re- gio- and stereoselective (14S,15R)-arachidonic acid epoxy-genase.",Non-OADS,/arxiv_data1/oa_pdf/e2/0c/BMB-45-736.PMC4133810.pdf
"Asan Medical Center Education and Training  Department, Intern, Seoul 138-736, Koreahttp://dx.doi.org/10.5483/BMBRep.2012.45.12.156 Received 30 July 2012, Revised 8 August 2012,  Accepted 16 August 2012 Keywords: Cysteine, Enzyme inhibition, Glutamate dehydrogenase,  Isozymes, Palmitoyl-CoA ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Roles of cysteine residues in the inhibition of human glutamate  dehydrogenase by palmitoyl-CoA Hyo Jeong Son1,#,†, Seung Cheol Ha1,#, Eun Young Hwang1, Eun-A Kim1, Jee-Yin Ahn2, Soo Young Choi3 &  Sung-Woo Cho1,* 1Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 138-736, 2Departments of Molecular  Cell Biology and Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medici ne,  Suwon 440-746, 3Department of Biomedical Science and Research Institute of  Bioscience and Biotechnology, Hallym University, Chnchoen  200-702, Korea Human glutamate dehydrogenase isozymes (hGDH1 and  hGDH2) have been known to be inhibited by palmitoyl-CoA with a high affinity.",Non-OADS,/arxiv_data1/oa_pdf/c1/a4/BMB-45-707.PMC4133811.pdf
708 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c1/a4/BMB-45-707.PMC4133811.pdf
709 http://bmbreports.org BMB ReportsGTP (μM) K3 (μM) WT C59A C93A C119A C201A C274A 0.0 1.82 2.15 2.60 1.98 2.47 2.31 0.4 1.77 2.09 2.57 2.00 2.42 2.30 0.8 1.84 2.10 2.62 2.04 2.40 2.331.2 1.80 2.11 2.61 2.08 2.41 2.31 1.6 1.80 2.20 2.59 1.99 2.50 2.36 2.0 1.79 2.09 2.62 1.99 2.49 2.29Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c1/a4/BMB-45-707.PMC4133811.pdf
710 BMB Reports http://bmbreports.orgphysiological condition.,Non-OADS,/arxiv_data1/oa_pdf/c1/a4/BMB-45-707.PMC4133811.pdf
711 http://bmbreports.org BMB Reportsof hGDH2 was analyzed by an unpaired two-tailed t test.,OADS,/arxiv_data1/oa_pdf/c1/a4/BMB-45-707.PMC4133811.pdf
712 BMB Reports http://bmbreports.orgSome physical properties of palmityl-coenzyme A  micelles.,Non-OADS,/arxiv_data1/oa_pdf/c1/a4/BMB-45-707.PMC4133811.pdf
"Tel & Fax: 021-82884717; E-mail: khajeh  @modares.ac.irhttp://dx.doi.org/10.5483/BMBRep.2012.45.12.11-138 Received 1 August 2011, Revised 11 August 2011,  Accepted 19 December 2011 Keyword:  Allosteric pathway, Cooperativity, Hill coefficient, Me- thylglyoxal synthase, Structural compactness ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Rationalization of allosteric pathway in Thermus sp.",Non-OADS,/arxiv_data1/oa_pdf/04/c1/BMB-45-748.PMC4133812.pdf
749 http://bmbReports.org BMB ReportsKm (mM) k cat (s−1)k cat/Km nHa Thermus  sp.,Non-OADS,/arxiv_data1/oa_pdf/04/c1/BMB-45-748.PMC4133812.pdf
750 BMB Reports http://bmbreports.org A B C Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/c1/BMB-45-748.PMC4133812.pdf
751 http://bmbReports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/c1/BMB-45-748.PMC4133812.pdf
752 BMB Reports http://bmbreports.organnealing temperature of 72oC) using polymerase chain re- action thermocycler.,Non-OADS,/arxiv_data1/oa_pdf/04/c1/BMB-45-748.PMC4133812.pdf
753 http://bmbReports.org BMB Reportsquartz cell at the protein concentration of 0.2 mg/ml in 20 mM  tris buffer (pH 8.0).,Non-OADS,/arxiv_data1/oa_pdf/04/c1/BMB-45-748.PMC4133812.pdf
"Tel: +82-2-2123-5698; Fax: +82-2-362-8096; E-mail: hwl@yonsei.ac.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.12.242 Received 23 November 2012Keywords: Gene targeting, Knockout, TALEN, ZFN ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Mouse genetics: Catalogue and scissors Young Hoon Sung1, In-Jeoung Baek2, Je Kyung Seong3, Jin-Soo Kim4 & Han-Woong Lee1,* 1Department of Biochemistry, College of Life Science and Biotechnology, Laboratory Animal Research Center, Yonsei University, Se oul  120-749, 2Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul 138-736, 3College of Veterinary Medicine, Research  Institute for Veterinary Science, Seoul National University, 4Department of Chemistry, Seoul National University, Seoul 151-747, Korea Phenotypic analysis of gene-specific knockout (KO) mice has  revolutionized our understanding of in vivo  gene functions.",Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
687 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
"As of October, 2012, ES cell clones with conditional alleles  for 8,897 genes, deletion alleles for 3,622 genes, and gene trap alleles for 9,583 genes are generated by the IKMC, and a  small number of mutant mice are also produced using these ES  cell clones (http://www.knockoutmouse.org/about/geneprogres ssummary).",Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
The targeted ES cell lines and mutant mice can be  easily searched at the IKMC web site (http://www.knock- outmouse.org/).,Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
688 BMB Reports http://bmbreports.orgso generated using Protamin-Cre transgenic mice (10).,OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
"Diverse Cre transgenic mouse lines that were previously developed can be searched in the web site of  Mouse Genome Informatics (MGI, http://www.informatics.jax.",OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
"To  improve the current insufficiency of and accessibility to appro- priate Cre mouse lines, the CREATE (Coordination of resources for conditional expression of mutated mouse alleles) project  (http://www.creline.org/) and EUCOMMTOOLS are planning  to maximize the utility of the conditional IKMC resources by integrating and generating conditional Cre mouse lines (12).",Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
689 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
"690 BMB Reports http://bmbreports.orgtions induced by small insertions, deletions, and even sub- stitutions frequently appear at the targeted locus (17).",Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
"691 http://bmbreports.org BMB Reportsnogenomics, toolbox for functional annotation of human  genome.",OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
692 BMB Reports http://bmbreports.org33.,Non-OADS,/arxiv_data1/oa_pdf/d2/7f/BMB-45-686.PMC4133813.pdf
"Tel: +82-42-860-4155; Fax: +82-42-861-  1759; E-mail: ewcho@kribb.re.krhttp://dx.doi.org/10.5483/BMBRep.2012.45.12.236 Received 15 November 2012Keywords: Biomarker, Diagnostic, Prognostic, T umor-associated au- toantibody, Tumor-associated autoantigen ISSN: 1976-6696 (print edition) / 1976-670X (electronic edition) Copyright ⓒ 2012 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Tumor-associated autoantibodies as diagnostic and prognostic  biomarkers Chang-Kyu Heo1, Young Yil Bahk2 & Eun-Wie Cho1,* 1Cancer Biomarkers Development Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 305-80 6,  2Department of Biotechnology, Konkuk University, Cheongju 380-701, Korea In the process of tumorigenesis, normal cells are remodeled  to cancer cells and protein expression patterns are changed to those of tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/79/61/BMB-45-677.PMC4133814.pdf
